<?xml version='1.0' encoding='UTF-8'?>
<chapter id="ch0153">
    <title>132 Microsporidia</title>
    <sect1 id="ch0153s0001">
      <title>132 Microsporidia</title>
      <anchor id="ch0153s0001a0001"/>
      <anchor id="ch0153s0000a0001"/>
      <para id="ch0153s0000p0001" role="chapterAuthor">LOUIS M. WEISS</para>
      <sect2 id="ch0153s0001s0001">
        <title>TAXONOMY</title>
        <anchor id="ch0153s0001a0002"/>
        <anchor id="ch0153s0000a0002"/>
        <para id="ch0153s0000p0002">Microsporidia are obligate intracellular, unicellular, spore-forming eukaryotes that were initially appreciated as pathogens with the identification by Nageli in 1857 of<emphasis>Nosema bombycis</emphasis> as the etiologic agent of pébrine in silkworms (<link linkend="ch0153s0000li0001">1</link>). Since that time, approximately 220 genera and 1,700 species of microsporidia have been identified. Microsporidia are found in invertebrates and vertebrates, infecting every major animal group (<link linkend="ch0153s0000li0002">2</link>–<link linkend="ch0153s0000li0008">8</link>). While initially thought to be “primitive protozoa,” they are now understood to be closely related to fungi (<link linkend="ch0153s0000li0008">8</link>). The class or order Microsporidia was originally elevated to the phylum Microspora by Sprague in 1977 (<link linkend="ch0153s0000li0009">9</link>); however, in 1998, Sprague and Becnel indicated that Microsporidia should instead be utilized as the phylum name (<link linkend="ch0153s0000li0010">10</link>). In human infections, the following microsporidian genera have been described as etiologic agents (<link linkend="ch0153s0000li0008">8</link>) (<anchor id="ch0153s0000a0003"/><link linkend="ch0153s0000a0007">Table 1</link>): <emphasis>Nosema</emphasis> (<emphasis>Nosema corneum</emphasis>, reclassified as <emphasis>Vittaforma corneae</emphasis> [11]; <emphasis>Nosema algerae</emphasis>, reclassified initially as <emphasis>Brachiola algerae</emphasis> [12] and then <emphasis>Anncaliia algerae</emphasis> [13]); <emphasis>Enterocytozoon</emphasis> (<link linkend="ch0153s0000li0014">14</link>); <emphasis>Septata</emphasis> (<link linkend="ch0153s0000li0015">15</link>) (reclassified as <emphasis>Encephalitozoon</emphasis> [16]); <emphasis>Encephalitozoon</emphasis> (<link linkend="ch0153s0000li0017">17</link>–<link linkend="ch0153s0000li0021">21</link>); <emphasis>Pleistophora</emphasis> (<link linkend="ch0153s0000li0022">22</link>–<link linkend="ch0153s0000li0024">24</link>); <emphasis>Trachipleistophora</emphasis> (<link linkend="ch0153s0000li0025">25</link>, <link linkend="ch0153s0000li0026">26</link>); <emphasis>Brachiola</emphasis> (reclassified as <emphasis>Anncaliia</emphasis>)(<link linkend="ch0153s0000li0012">12</link>); <emphasis>Anncaliia</emphasis> (<link linkend="ch0153s0000li0013">13</link>); <emphasis>Tubulinosema</emphasis> (<link linkend="ch0153s0000li0027">27</link>, <link linkend="ch0153s0000li0028">28</link>); <emphasis>Endoreticulatus</emphasis> (<link linkend="ch0153s0000li0029">29</link>); and <emphasis>Microsporidium</emphasis> (<link linkend="ch0153s0000li0030">30</link>) (a collective group used to indicate an unclassified organism). While the majority of cases of human microsporidiosis involve the gastrointestinal tract, microsporidiosis can involve almost any human organ system (<link linkend="ch0153s0000li0002">2</link>, <link linkend="ch0153s0000li0008">8</link>).</para>
        <para id="ch0153s0000p0003">Microsporidia develop completely intracellularly, and there are no metabolically active stages found outside of their host cells. Development may occur in direct contact with host cell cytoplasm (<emphasis>Nosema, Anncaliia</emphasis>, and <emphasis>Enterocytozoon</emphasis>), in isolation within a vacuole formed by host cell membranes (<emphasis>Vittaforma</emphasis> and <emphasis>Encephalitozoon</emphasis>), or in a cyst-like sporophorous vesicle of pathogen origin (<emphasis>Pleistophora</emphasis> and <emphasis>Trachipleistophora</emphasis>) (<anchor id="ch0153s0000a0004"/><link linkend="ch0153s0000a0025">Table 2</link>). Microsporidia produce distinctive, environmentally resistant spores, and the shape and size of these spores vary depending on the species (<link linkend="ch0153s0000li0008">8</link>). In general, the microsporidia described as etiologic in human infections have ovoid, 1- to 4-μm spores (<link linkend="ch0153s0000li0031">31</link>). An important and characteristic feature of all microsporidia is the presence of an extrusion apparatus consisting of a polar tube that forms 4 to approximately 30 coils around the sporoplasm in the spore and that is attached to the anterior end of the spore by the anchoring disk (<anchor id="ch0153s0000a0005"/><link linkend="ch0153s0000a0029">Fig. 1</link>). The polar tube may be of uniform diameter (isofilar) or show a sharp decrease in diameter in the most posterior coils (anisofilar). When exposed to specific environmental conditions, such as passage though the host’s gastrointestinal tract, spore germination occurs and the polar tube rapidly everts, forming a hollow tube that acts as a conduit to deliver the sporoplasm to the host cell. The mechanism by which the polar tube interacts with the host cell membrane during invasion is not well understood and is a focus of active scientific investigation. If a spore is phagocytosed by a host cell, germination can also occur, enabling the polar tube to pierce the phagocytic vacuole, resulting in the sporoplasm being delivered into the host cell cytoplasm or into an adjacent host cell.</para>
        <para id="ch0153s0000p0004">The majority of species of microsporidia have simple single-host life cycles; however, a few species have complex life cycles with multiple hosts and can form morphologically distinct spores in different hosts (e.g.,<emphasis>Amblyospora</emphasis> sp. in mosquitoes) (<link linkend="ch0153s0000li0032">32</link>, <link linkend="ch0153s0000li0033">33</link>). The life cycle of microsporidia can be divided into three stages (<anchor id="ch0153s0000a0006"/><link linkend="ch0153s0000a0033">Fig. 2</link>): the infective or environmental stage (i.e., spores, which are the only stage that can survive outside of the host cell); the proliferative stage (merogonic sequence); and the sporogonic or spore-forming stage. During development, various microsporidian genera demonstrate different relationships with their host cell (<link linkend="ch0153s0000li0034">34</link>, <link linkend="ch0153s0000li0035">35</link>) (<link linkend="ch0153s0000a0025">Table 2</link>), which probably reflects physiological and nutritional differences among the various microsporidian genera (<link linkend="ch0153s0000li0036">36</link>–<link linkend="ch0153s0000li0038">38</link>).</para>
        <para id="ch0153s0000p0005">When spores are exposed to appropriate environmental conditions, germination occurs, and the sporoplasm is transported into the host cell via the hollow polar tube (<link linkend="ch0153s0000li0039">39</link>, <link linkend="ch0153s0000li0040">40</link>). As soon as the sporoplasm enters the host cell, it initiates a reproduction cycle which terminates with the production of mature spores. Merogony follows, during which the injected sporoplasm develops into meronts (the proliferative stage), which multiply, depending on the species, by binary fission or multiple fission. While most microsporidia develop within the host cell cytoplasm, some genera of microsporidia will infect the nucleoplasm of the host cell or develop in both the cytoplasm and nucleus (<link linkend="ch0153s0000li0041">41</link>–<link linkend="ch0153s0000li0044">44</link>). The merogony stage is responsible for a massive increase in the number of infecting organisms (<link linkend="ch0153s0000li0045">45</link>). During merogony, many microsporidia have a simple plasma membrane, but a surface coat is present in <emphasis>Anncaliia, Pleistophora</emphasis>, and <emphasis>Trachipleistophora.</emphasis> Division can be by binary or multiple fission into two or more individuals. At the end of merogony, an electron-dense material is formed on the external face of the merozoite plasma membrane, which indicates the switch from merogony to sporogony (this step is delayed in <emphasis>Enterocytozoon</emphasis>) (<link linkend="ch0153s0000li0046">46</link>). Sporonts give rise to sporoblasts via binary or multiple fission (depending on the species); the sporoblasts go on to form mature spores without additional multiplication. In most species, the dense material on the plasma membrane in sporogony becomes the primordium of the exospore layer of the spore wall (<link linkend="ch0153s0000li0047">47</link>). The polar tube and Golgi also develop in the sporoplasm of the sporoblast (<link linkend="ch0153s0000li0048">48</link>–<link linkend="ch0153s0000li0050">50</link>). The sporoblast plasma membrane is covered by a continuous layer of dense material, which can form tubular or fibrillar expansions that protrude from the surface of the sporoblast into the parasitophorous vacuole (<link linkend="ch0153s0000li0047">47</link>). Once a host cell becomes distended with mature spores, the cell ruptures, releasing mature spores into the environment and completing the life cycle. The combination of merogony and sporogony results in a large number of spores being produced from a single infection and underlies the huge reproductive potential of these organisms.</para>
        <table id="ch0153s0000t0001"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0153s0000a0007"/><link linkend="ch0153s0000a0003">TABLE 1</link></phrase></emphasis> Microsporidia that infect humans<superscript><emphasis><anchor id="ch0153s0000a0008"/><link linkend="ch0153s0000a0016">a</link></emphasis></superscript>
</title>
          
          <tgroup cols="3">
            <tbody>
              <row>
                <entry><phrase role="center">Microsporidia</phrase>
                </entry>
                <entry><phrase role="center">Clinical manifestations</phrase>
                </entry>
              </row>
              <row>
                <entry><phrase role="center">Immunocompromised hosts</phrase>
                </entry>
                <entry><phrase role="center">Immunocompetent hosts</phrase>
                </entry>
              </row>
              <row>
                <entry><emphasis>Anncaliia algerae</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0153s0000a0009"/>
                      <link linkend="ch0153s0000a0017">b</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry>Myositis, nodular cutaneous lesions</entry>
                <entry>Keratitis, vocal cord infection, myositis</entry>
              </row>
              <row>
                <entry><emphasis>Anncaliia connori</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0153s0000a0010"/>
                      <link linkend="ch0153s0000a0018">c</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry>Disseminated infection</entry>
                <entry>Not described</entry>
              </row>
              <row>
                <entry><emphasis>Anncaliia vesicularum</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0153s0000a0011"/>
                      <link linkend="ch0153s0000a0019">d</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry>Myositis</entry>
                <entry>Not described</entry>
              </row>
              <row>
                <entry><emphasis>Encephalitozoon cuniculi</emphasis>
                </entry>
                <entry>Encephalitis, nephritis, hepatitis, gastrointestinal infection, peritonitis, disseminated infection, keratoconjunctivitis, bronchitis, pneumonia, sinusitis, endocarditis</entry>
                <entry>Encephalitis, hip implant failure, endocarditis</entry>
              </row>
              <row>
                <entry><emphasis>Encephalitozoon hellem</emphasis>
                </entry>
                <entry>Keratoconjunctivitis, sinusitis, pneumonia, bronchitis, urogenital infection, prostatitis, disseminated infection</entry>
                <entry>Gastrointestinal infection</entry>
              </row>
              <row>
                <entry><emphasis>Encephalitozoon intestinalis</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0153s0000a0012"/>
                      <link linkend="ch0153s0000a0020">e</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry>Gastrointestinal infection, cholangitis, gastrointestinal perforation, bone infection, nodular cutaneous lesions, sinusitis, bronchitis, pneumonitis, nephritis</entry>
                <entry>Gastrointestinal infection (self-limiting diarrhea)</entry>
              </row>
              <row>
                <entry><emphasis>Endoreticulatus</emphasis> spp.</entry>
                <entry>Not described</entry>
                <entry>Myositis, disseminated infection</entry>
              </row>
              <row>
                <entry><emphasis>Enterocytozoon bieneusi</emphasis>
                </entry>
                <entry>Gastrointestinal infection (chronic diarrhea), wasting syndrome, cholangitis (“AIDS cholangiopathy” and acalculous cholecystitis), rhinitis, bronchitis, sinusitis</entry>
                <entry>Gastrointestinal infection (self-limiting diarrhea, traveler’s diarrhea)</entry>
              </row>
              <row>
                <entry><para id="ch0153s0000p0006"><emphasis>Microsporidium</emphasis>
                  </para>
                  <para id="ch0153s0000p0007">(<emphasis>M. africanum, M. ceylonensis</emphasis><superscript><emphasis><anchor id="ch0153s0000a0013"/><link linkend="ch0153s0000a0021">f</link></emphasis></superscript>)</para>
                </entry>
                <entry>Not described</entry>
                <entry>Corneal ulcer, keratitis</entry>
              </row>
              <row>
                <entry><emphasis>Nosema ocularum</emphasis>
                </entry>
                <entry>Not described</entry>
                <entry>Keratitis</entry>
              </row>
              <row>
                <entry><emphasis>Pleistophora</emphasis> sp.</entry>
                <entry>Myositis</entry>
                <entry>Not described</entry>
              </row>
              <row>
                <entry><emphasis>Pleistophora ronneafiei</emphasis>
                </entry>
                <entry>Myositis</entry>
                <entry>Not described</entry>
              </row>
              <row>
                <entry><emphasis>Trachipleistophora anthropophthera</emphasis>
                </entry>
                <entry>Disseminated infection (including brain, heart, kidney), keratitis</entry>
                <entry>Not described</entry>
              </row>
              <row>
                <entry><emphasis>Trachipleistophora hominis</emphasis>
                </entry>
                <entry>Myositis, myocarditis, keratoconjunctivitis, sinusitis</entry>
                <entry>Keratitis</entry>
              </row>
              <row>
                <entry><emphasis>Tubulinosema acridophagus</emphasis>
                </entry>
                <entry>Disseminated infection, myositis, hepatitis; pulmonary, peritoneal, and skin infection</entry>
                <entry>Not described</entry>
              </row>
              <row>
                <entry><emphasis>Vittaforma corneae</emphasis>
                  <superscript>
                    <emphasis>
                      <anchor id="ch0153s0000a0014"/>
                      <link linkend="ch0153s0000a0022">g</link>
                    </emphasis>
                  </superscript>
                </entry>
                <entry>Keratoconjunctivitis, disseminated infection, urinary tract infection</entry>
                <entry>Keratoconjunctivitis</entry>
              </row>
              <row>
                <entry>Unidentified<emphasis>Microsporidium</emphasis> spp.<superscript><emphasis><anchor id="ch0153s0000a0015"/><link linkend="ch0153s0000a0023">h</link></emphasis></superscript></entry>
                <entry>Ocular infection; keratitis after collagen cross-linking</entry>
                <entry>Reactive arthritis</entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0153s0000a0016"/><link linkend="ch0153s0000a0008">a</link></emphasis></superscript>Table adapted from reference <link linkend="ch0153s0000li0278">278</link>.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0153s0000a0017"/><link linkend="ch0153s0000a0009">b</link></emphasis></superscript>Formerly <emphasis>Brachiola algerae, Nosema algerae.</emphasis></para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0153s0000a0018"/><link linkend="ch0153s0000a0010">c</link></emphasis></superscript>Formerly <emphasis>Brachiola connori, Nosema connori.</emphasis></para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0153s0000a0019"/><link linkend="ch0153s0000a0011">d</link></emphasis></superscript>Formerly <emphasis>Brachiola vesicularum.</emphasis></para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0153s0000a0020"/><link linkend="ch0153s0000a0012">e</link></emphasis></superscript>Formerly <emphasis>Septata intestinalis.</emphasis></para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0153s0000a0021"/><link linkend="ch0153s0000a0013">f</link></emphasis></superscript><emphasis>Microsporidium</emphasis> is a collective generic name for microsporidia that cannot be classified because available information is not sufficient.</para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0153s0000a0022"/><link linkend="ch0153s0000a0014">g</link></emphasis></superscript>Formerly <emphasis>Nosema corneum.</emphasis></para>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0153s0000a0023"/><link linkend="ch0153s0000a0015">h</link></emphasis></superscript>No classification provided for these reported cases.</para>
        <para id="ch0153s0000p0008">Microsporidia have many typical eukaryote features such as a membrane-bound nucleus, an intracytoplasmic membrane system, and chromosome separation on mitotic spindles. However, unlike typical eukaryotes, they lack recognizable mitochondria, having instead a remnant organelle termed a mitosome (<link linkend="ch0153s0000li0051">51</link>); they also lack peroxisomes and have a simple vesicular Golgi complex. In addition, they have highly reduced prokaryotic-size ribosomes (<link linkend="ch0153s0000li0052">52</link>) which lack a 5.8S ribosome subunit, although sequence homologous to the 5.8S region is observed in the 23S subunit (<link linkend="ch0153s0000li0053">53</link>). Depending on the species, the genome size varies from ~2.2 Mbp (e.g., <emphasis>Encephalitozoon</emphasis> spp.) to 51 Mbp (e.g., <emphasis>Edhazardia aedis</emphasis>), and these genomes code for 2,000 to 5,000 proteins (<link linkend="ch0153s0000li0008">8</link>, <link linkend="ch0153s0000li0054">54</link>). Genome data for the microsporidia are available online at <ulink url="http://MicrosporidiaDB.org">MicrosporidiaDB.org</ulink> (<ulink url="http://microsporidiadb.org/micro/">http://microsporidiadb.org/micro/</ulink>). Compared with those of other eukaryotes, the genomes of microsporidia are reduced in size and complexity; e.g., the <emphasis>Encephalitozoon cuniculi</emphasis> genome is 2.24 Mbp. In this compact genome, gene density is high, there are almost no introns, and encoded proteins are significantly shorter than orthologous proteins in other eukaryotes (<link linkend="ch0153s0000li0055">55</link>). It is likely that this reflects an early bottleneck in the evolution of the microsporidia, with a massive gene loss resulting in a core set of conserved genes. This core set has been complemented by the expansion of transporters that facilitate the obligate intracellular life cycle of these pathogens (<link linkend="ch0153s0000li0056">56</link>). Expansion from this core set of genes has been driven by the acquisition of noncoding DNA (such as transposable elements, etc.); e.g., only 9% of the 51-Mbp <emphasis>Edhazardia aedis</emphasis> genome codes for proteins, whereas 90% of the 2.24-Mbp <emphasis>Encephalitozoon cuniculi</emphasis> genome codes for proteins (<link linkend="ch0153s0000li0057">57</link>, <link linkend="ch0153s0000li0058">58</link>).</para>
        <anchor id="ch0153s0000a0024"/>
        <beginpage pagenum="2598"/>
        <table id="ch0153s0000t0002"><title><emphasis role="strong"><phrase role="figureLabel"><anchor id="ch0153s0000a0025"/><link linkend="ch0153s0000a0004">TABLE 2</link></phrase></emphasis> Developmental relationships of microsporidia with their host cell<superscript><emphasis><anchor id="ch0153s0000a0026"/><link linkend="ch0153s0000a0027">a</link></emphasis></superscript>
</title>
          
          <tgroup cols="2">
            <tbody>
              <row>
                <entry><phrase role="center">Type</phrase>
                </entry>
                <entry><phrase role="center">Details</phrase>
                </entry>
              </row>
              <row>
                <entry><para id="ch0153s0000p0009">Type I.</para>
                  <para id="ch0153s0000p0010">Direct contact</para>
                </entry>
                <entry>Direct contact of microsporidian plasmalemma with the host cell cytoplasm. This is seen in<emphasis>Enterocytozoon bieneusi, Anncaliia</emphasis>, and <emphasis>Nosema.</emphasis></entry>
              </row>
              <row>
                <entry><para id="ch0153s0000p0011">Type II.</para>
                  <para id="ch0153s0000p0012">Indirect contact due to host-produced isolation</para>
                </entry>
                <entry><para id="ch0153s0000p0013">Subtype A. Microsporidia are in a parasitophorous vacuole (PV), i.e., a host-formed single membrane that surrounds the developing organism. The PV is seen in the proliferative and sporogonic phases of development, but the relationship of the developing microsporidia changes during development. Early in development, the organism has a close association with the PV membrane until the development of a thickened sporont plasmalemma, at which time they appear loose within the PV. This type of development is seen in<emphasis>Encephalitozoon hellem</emphasis> and <emphasis>Encephalitozoon cuniculi.</emphasis></para>
                  <para id="ch0153s0000p0014">Subtype B. Throughout development, the microsporidia are surrounded by the host endoplasmic reticulum (ER), which appears as a double membrane surrounding the developing microsporidian cells. In the proliferative phase, these host ER double membranes closely follow the dividing microsporidian plasmalemma and no vacuole is seen. During sporogony, a double membraned PV, formed by the host ER, surrounds the cluster of organisms formed in sporogony. This type of development is seen in<emphasis>Endoreticulatus</emphasis> and <emphasis>Vittaforma.</emphasis></para>
                </entry>
              </row>
              <row>
                <entry><para id="ch0153s0000p0015">Type III.</para>
                  <para id="ch0153s0000p0016">Indirect contact due to parasite-produced isolation</para>
                </entry>
                <entry><para id="ch0153s0000p0017">Subtype A. During development, microsporidia secrete an envelope that surrounds the developing organisms. In sporogony this envelope becomes a sporophorous vesicle (SPOV) as the microsporidian plasmalemma thickens and pulls away from the secreted envelope. This type of development is seen in<emphasis>Pleistophora.</emphasis></para>
                  <para id="ch0153s0000p0018">Subtype B. During early development, the microsporidia are in direct contact with the host cell cytoplasm. As development proceeds, a membrane formed by the microsporidia isolates sporonts from contact with the host cell cytoplasm. This type of development is seen in<emphasis>Vairimorpha.</emphasis></para>
                </entry>
              </row>
              <row>
                <entry><para id="ch0153s0000p0019">Type IV.</para>
                  <para id="ch0153s0000p0020">Indirect contact due to host- and parasite-produced isolation</para>
                </entry>
                <entry><para id="ch0153s0000p0021">Subtype A. During merogony, the host ER closely associates with the microsporidian plasmalemma. As development proceeds, the developing microsporidia forms an interfacial envelope by producing “blisters” that arise from the plasmalemma, resulting in an SPOV, which can contain tubules, being formed in sporogony. This type of development is seen in<emphasis>Glugea</emphasis> and <emphasis>Loma.</emphasis></para>
                  <para id="ch0153s0000p0022">Subtype B. During development, both the host and parasite contribute to the formation of a thick interfacial envelope surrounding the developing organisms. This type of development is seen in<emphasis>Trachipleistophora.</emphasis></para>
                  <para id="ch0153s0000p0023">Subtype C. During development, a PV formed by the host surrounds the organisms. Within the PV, microsporidian-secreted material surrounds each organism. This type of development is seen in<emphasis>Encephalitozoon intestinalis.</emphasis></para>
                </entry>
              </row>
            </tbody>
          </tgroup>
        </table>
        <para role="table-footnote"><superscript><emphasis><anchor id="ch0153s0000a0027"/><link linkend="ch0153s0000a0026">a</link></emphasis></superscript>Table adapted from reference <link linkend="ch0153s0000li0277">277</link>.</para>
        <para id="ch0153s0000p0024">It had been postulated, based on phylogenic analysis of their rRNA genes (<link linkend="ch0153s0000li0059">59</link>), that microsporidia were “ancient” protists (i.e., Archezoa) that diverged before the mitochondrial endosymbiosis. However, it is now appreciated, based on genome data, that microsporidia at one point in their evolution did possess mitochondria and that they still have a relic mitochondrial organelle, the mitosome, as well as possessing mitochondrial genes in their genomes (<link linkend="ch0153s0000li0051">51</link>, <link linkend="ch0153s0000li0060">60</link>). Genome-wide sequence and synteny analyses indicate that microsporidia belong to the kingdom Fungi as either a basal branch or a sister group (<link linkend="ch0153s0000li0061">61</link>, <link linkend="ch0153s0000li0062">62</link>). In addition, structural features seen in microsporidia, such as the presence of chitin in the spore wall, diplokaryotic nuclei, and electron-dense spindle plaques associated with their nuclear envelope, are consistent with a possible relationship between fungi and microsporidia. Recent molecular genome analysis indicates that microsporidia are derived from an endoparasitic chytrid ancestor on the earliest diverging branch of the fungal phylogenetic tree (<link linkend="ch0153s0000li0063">63</link>, <link linkend="ch0153s0000li0064">64</link>). Phylogenetic studies suggest that the microsporidia should be placed with the Cryptomycota (<link linkend="ch0153s0000li0065">65</link>, <link linkend="ch0153s0000li0066">66</link>) as a basal branch of the fungal kingdom (<link linkend="ch0153s0000li0067">67</link>). The Cryptomycota have been identified by environmental microbiome studies, and while poorly described at the biological level, they are closely related to the microsporidia (<link linkend="ch0153s0000li0065">65</link>). Cryptomycota that grow as intranuclear parasites of amebae have been discovered, and these parasites bear strong morphological similarities to microsporidia (<link linkend="ch0153s0000li0009">9</link>, <link linkend="ch0153s0000li0068">68</link>). These and other microsporidia-like organisms, such as <emphasis>Nucleophaga terricola, Mitosporidium daphniae</emphasis>, and <emphasis>Paramicrosporidium</emphasis>, demonstrate that additional environmental sampling is required to completely ascertain the relationship of fungi and microsporidia, and to provide a better understanding of the Cryptomycota and the origin of microsporidia.</para>
        <anchor id="ch0153s0000a0028"/>
        <beginpage pagenum="2599"/>
        <figure id="ch0153s0000f0001"><title><phrase role="figureLabel"><anchor id="ch0153s0000a0029"/><link linkend="ch0153s0000a0005"><emphasis role="strong">FIGURE 1</emphasis></link></phrase> Diagram of a microsporidian spore. <emphasis role="strong">(A)</emphasis> Microsporidian spores vary in size from 1 to 10 μm, with those infecting humans being from 1 to 4 μm. The spore coat is thinner at the anterior end of the spore and consists of an electron-lucent endospore (En), an electron-dense exospore (Ex), and the plasma membrane (Pm). The sporoplasm (Sp) contains ribosomes, the posterior vacuole (PV), and a single nucleus (Nu). The anchoring disk (AD) at the anterior end of the spore is the site of attachment of the polar tube. It should be noted that the polar tube is often called the polar filament when it is within the spore prior to germination. The anterior or straight region of the polar tube that connects to the anchoring disk is called the manubroid (M), and the posterior region of the tube coils around the sporoplasm. The number of coils and their arrangement (i.e., single row or multiple rows) are used in microsporidian taxonomic classification. The lamellar polaroplast (Pl) and vesicular polaroplast (VPl) surround the manubroid region of the polar tube. The insert depicts the five polar tube coils in this figure in a cross section, illustrating that the polar tube within the spore (i.e., polar filament) has several layers of different electron density by electron microscopy. <emphasis role="strong">(B)</emphasis> Scanning electron micrograph (SEM) of <emphasis>Encephalitozoon intestinalis</emphasis> infecting a host cell (Vero E6) in tissue culture. The white arrow points to the extruded polar tube. (Both panels reprinted with permission from reference <link linkend="ch0153s0000li0040">40</link>.)
</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0153f07.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
      </sect2>
      <sect2 id="ch0153s0001s0002">
        <title>DESCRIPTION OF THE GENERA AND SPECIES</title>
        <anchor id="ch0153s0001a0003"/>
        <anchor id="ch0153s0000a0030"/>
        <anchor id="ch0153s0000a0031"/>
        <para id="ch0153s0000p0025">Microsporidia are classically classified by their ultrastructural features, which include the number of coils of their polar tube; the size, shape, and morphology of their spores; the features of their developmental life cycle; and their host-parasite relationship (<link linkend="ch0153s0000a0033">Fig. 2</link> and <anchor id="ch0153s0000a0032"/><link linkend="ch0153s0000a0035">3</link>). Molecular phylogenetic data, such as 16S small subunit rRNA sequences, provide a complementary set of data for assigning microsporidia to specific genera as well as distinguishing morphologically similar microsporidia at the species level (<link linkend="ch0153s0000li0069">69</link>, <link linkend="ch0153s0000li0070">70</link>). These molecular data demonstrate the polyphyletic nature of the current classification of microsporidia based on ultrastructural features. Overviews of the ultrastructural and structural characteristics, life cycle differences, and microsporidian taxa can be found in work by Tuzet et al. (<link linkend="ch0153s0000li0071">71</link>), Sprague (<link linkend="ch0153s0000li0009">9</link>), Larsson (<link linkend="ch0153s0000li0072">72</link>), Issi (<link linkend="ch0153s0000li0073">73</link>), Weiser (<link linkend="ch0153s0000li0074">74</link>), and Sprague et al. (<link linkend="ch0153s0000li0075">75</link>). Microsporidia are currently separated into three main groups: (i) the “primitive” microsporidia (Metchnikovellidae), which are hyperparasites of gregarines found in annelids and have a rudimentary polar filament and lack a polaroplast in their spores; (ii) the Burkeidae, Chytridopsidae, and Hesseidsae, which have a short polar filament and minimal development of a polaroplast and endospore; and (iii) the “higher” microsporidia, which possess a well-developed polar filament, a polaroplast, and a posterior vacuole. Differences among modern classifications of microsporidia focus on the characteristics used to divide the third group, the higher microsporidia, into subgroups. The microsporidia that infect humans (<link linkend="ch0153s0000a0007">Table 1</link>) are found in the higher microsporidia. The developmental characteristics of these species are illustrated in <link linkend="ch0153s0000a0035">Fig. 3</link>.</para>
        <para id="ch0153s0000p0026"><emphasis>Anncaliia</emphasis> spp. have diplokaryotic nuclei, develop in direct contact with their host cell cytoplasm, and produce electron-dense extracellular secretions and vesiculotubular appendages. <emphasis>Anncaliia vesicularum</emphasis> (formerly <emphasis>Brachiola vesicularum</emphasis>) produces 2.5- by 2-μm diplokaryotic spores containing 7 to 10 anisofilar coils of the polar filament arranged in one to three rows, usually two (<link linkend="ch0153s0000li0012">12</link>). On the basis of diplokaryotic nuclei, disporoblastic sporogony, and the formation of vesiculotubular secretions, <emphasis>Brachiola</emphasis> (<emphasis>Nosema</emphasis>) <emphasis>connori</emphasis> and <emphasis>Brachiola</emphasis> (<emphasis>Nosema</emphasis>) <emphasis>algerae</emphasis>, which also cause human infections, were also reclassified as species of <emphasis>Anncaliia</emphasis> (<link linkend="ch0153s0000li0013">13</link>). Spores of <emphasis>Anncaliia connori</emphasis> measure 2.0 to 2.5 by 4.0 to 4.5 μm and contain polar tubes with 10 to 12 coils (<link linkend="ch0153s0000li0076">76</link>). Spores of <emphasis>Anncaliia algerae</emphasis> measure 3.7 to 5.4 by 2.3 to 3.9 μm and have 8 to 11 coils of the polar tube (<link linkend="ch0153s0000li0077">77</link>).</para>
        <para id="ch0153s0000p0027"><emphasis>Encephalitozoon</emphasis> spp. develop intracellularly in parasitophorous vacuoles bounded by a membrane that is probably of host cell origin. Nuclei of all stages are unpaired. Meronts divide repeatedly by binary fission and lie close to the vacuolar membrane. Sporonts appear free in the center of the vacuole and divide into two or four sporoblasts, which mature into spores. The spores measure 1.0 to 1.5 by 2.0 to 3.0 μm, and the polar tube has four to eight isofilar coils.</para>
        <para id="ch0153s0000p0028"><emphasis>Encephalitozoon cuniculi</emphasis> was identified and isolated from many animals before human infections were identified. Human and animal isolates of <emphasis>Encephalitozoon cuniculi</emphasis> are morphologically identical. <emphasis>Encephalitozoon hellem</emphasis> was identified in 1991 on the basis of different SDS-PAGE protein patterns than seen in <emphasis>Encephalitozoon cuniculi</emphasis> isolates (<link linkend="ch0153s0000li0020">20</link>). <emphasis>Encephalitozoon</emphasis> (<emphasis>Septata</emphasis>) <emphasis>intestinalis</emphasis> was described in 1993 as belonging to a new genus <emphasis>Septata</emphasis> on the basis of a pathogen-secreted fibrillar network that surrounds the developing organisms, giving the parasitophorous vacuoles a septate appearance (<link linkend="ch0153s0000li0015">15</link>); however, based on molecular phylogenetic data, it was reassigned to the genus <emphasis>Encephalitozoon.</emphasis> Based on differences in the sequence of the internal transcribed spacer (ITS) region of rRNA, four “groups” of <emphasis>Encephalitozoon cuniculi</emphasis> have been identified which differ in animal-host preferences and geographic distributions (<link linkend="ch0153s0000li0078">78</link>, <link linkend="ch0153s0000li0079">79</link>).</para>
        <figure id="ch0153s0000f0002"><title><phrase role="figureLabel"><anchor id="ch0153s0000a0033"/><link linkend="ch0153s0000a0006"><emphasis role="strong">FIGURE 2</emphasis></link></phrase> Developmental life cycle of the microsporidia. Spores germinate when they are exposed to specific environmental conditions, which vary depending on the species of microsporidia. Upon germination, the polar tube is extruded and interacts with the host cell membrane, allowing invasion. The sporoplasm transverses the polar tube, is introduced into the host cell cytoplasm, and begins to proliferate. The morphology of the organism during the proliferative phase (indicated by the region above the dotted line) is used in classification systems defining the various microsporidian genera. Relationships of the various microsporidia with their host cells during the proliferative phase are described in <link linkend="ch0153s0000a0025">Table 2</link>. The left side of the figure illustrates the uninucleate sporoplasm: the microsporidian genera that are defined during the development of spores—i.e., the sporogenic phase (indicated by the region below the dotted line)—are all uninucleate. On the right, the sporoplasm is diplokaryotic and all of the microsporidia genera defined during spore development have diplokaryotic developmental patterns. Regardless of whether they are uninucleate or diplokarytoic, there are three basic types of developmental forms. The first developmental pathway, as illustrated by <emphasis>Anncaliia</emphasis> spp., involves cell division by binary fission that immediately follows karyokinesis. The second type of pathway, as illustrated by some <emphasis>Nosema</emphasis> spp., involves multiple fission of elongated moniliform multinucleate cells. The third type of developmental pathway, as illustrated by <emphasis>Endoreticulatus</emphasis> spp., involves the division by plasmotomy of rounded plasmodial multinucleate cells. During the proliferative phase, cells can have one to several division cycles. Many microsporidia are either in direct contact with the host cell cytoplasm or closely abutted to the host endoplasmic reticulum; however, other microsporidia are found within a parasitophorous vacuole (e.g., <emphasis>Encephalitozoon</emphasis> spp. and probably <emphasis>Tetramicra</emphasis> spp.) or are separated from the host cell cytoplasm by a thick layer of their own secretions (e.g., <emphasis>Pleistophora</emphasis> spp.). In the sporogenic phase, this thick layer of microsporidian secretions becomes the sporophorous vesicle. During sporogony, several of the microsporidian genera, such as <emphasis>Enterocytozoon, Nosema, Anncaliia, Ichthyosporidium</emphasis>, and <emphasis>Tetramicra</emphasis>, maintain direct contact with the host cell cytoplasm. A sporophorous vesicle, illustrated by the circle around the developing sporogonial stage, is formed by the other microsporidian genera. During the developmental cycle of <emphasis>Thelohania</emphasis> and the <emphasis>Thelohania</emphasis>-like part of the <emphasis>Vairimorpha</emphasis> cycle, it should be noted that the diplokarya separate and continue their development as cells with isolated nuclei. (Reprinted with permission from reference <link linkend="ch0153s0000li0277">277</link>.)
</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0153f08.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
        <para id="ch0153s0000p0029"><emphasis>Endoreticulatus</emphasis> spp. have been identified as causing human infection in two patients on the basis of molecular phylogenetic findings; however, ultrastructural information is not available on these cases (<link linkend="ch0153s0000li0029">29</link>).</para>
        <anchor id="ch0153s0000a0034"/>
        <beginpage pagenum="2601"/>
        <para id="ch0153s0000p0030"><emphasis>Enterocytozoon bieneusi</emphasis> develops in direct contact with the host cell cytoplasm. The proliferative and sporogonial forms are rounded, multinucleate plasmodia with unpaired nuclei, measuring up to 6 μm in diameter. The oval spores measure 0.7 to 1.0 by 1.1 to 1.6 μm. The polar tube, derived from electron-dense disks in sporonts, has five to seven isofilar coils that appear in two rows when seen in transverse section by transmission electron microscopy (<link linkend="ch0153s0000li0014">14</link>). Numerous genotypes have been identified, with differences in host specificity and zoonotic potential (<link linkend="ch0153s0000li0080">80</link>).</para>
        <figure id="ch0153s0000f0003"><title><phrase role="figureLabel"><anchor id="ch0153s0000a0035"/><link linkend="ch0153s0000a0032"><emphasis role="strong">FIGURE 3</emphasis></link></phrase> Identifying developmental characteristics of the microsporidian genera described as etiologic in human infections. <emphasis role="strong">(A)</emphasis> <emphasis>Anncaliia.</emphasis> Members of this genus are diplokaryotic and disporoblastic; the life cycle is like that of <emphasis>Nosema</emphasis>, but meronts are bizarrely shaped and possess a surface coat with vesiculotubular structures (vt) embedded in it and extending from it. <emphasis role="strong">(B)</emphasis> <emphasis>Vittaforma.</emphasis> Members of this genus are diplokaryotic and polysporoblastic; all stages, including spores, are isolated in a close-fitting, ribosome-studded cisterna of host endoplasmic reticulum (er). <emphasis role="strong">(C)</emphasis> <emphasis>Pleistophora.</emphasis> Members of this genus are monokaryotic and polysporoblastic; meronts and sporonts are multinucleate stages called plasmodia; a thick surface coat is already present on meronts and sporonts (<link linkend="ch0153s0000li0001">1</link>); this coat separates from the sporogonial plasmodium to form a cyst-like vesicle, the sporophorous vesicle; the plasmodium divides within it to produce numerous spores (<link linkend="ch0153s0000li0002">2</link>). <emphasis role="strong">(D)</emphasis> <emphasis>Trachipleistophora.</emphasis> Members of this genus are monokaryotic and polysporoblastic. The meront surface coat has branched extensions (<link linkend="ch0153s0000li0001">1</link>); these are withdrawn when the coat separates to form the sporophorous vesicle around a uninucleate sporont; the sporont undergoes a series of binary fissions (<link linkend="ch0153s0000li0002">2</link>, <link linkend="ch0153s0000li0003">3</link>) and finally encloses numerous spores (<link linkend="ch0153s0000li0004">4</link>). <emphasis role="strong">(E)</emphasis> <emphasis>Encephalitozoon.</emphasis> Members of this genus are monokaryotic and di- or tetrasporoblastic; all stages of the life cycle, developing from the sporoplasm, occur concurrently within a host cell vacuole (parasitophorous vacuole); merogonic stages are appressed against the vacuole wall; sporogonic stages are free; the vacuole is finally packed with spores, so that it superficially resembles a sporophorous vesicle. <emphasis role="strong">(F)</emphasis> <emphasis>Enterocytozoon.</emphasis> Members of this genus are monokaryotic and polysporoblastic; meronts (<link linkend="ch0153s0000li0001">1</link>) have irregular nuclei and lucent clefts; sporonts (<link linkend="ch0153s0000li0002">2</link>) are multinucleate with rounded nuclei and have highly characteristic electron-dense disks, which are polar tube precursors; all spore organelles are formed prematurely, so that constriction around the sets of organelles and a nucleus (<link linkend="ch0153s0000li0003">3</link>) gives rise directly to almost mature spores. The surface coat is deposited only during constriction. (Adapted with permission from reference <link linkend="ch0153s0000li0278">278</link>.)
</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0153f09.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
        <para id="ch0153s0000p0031"><emphasis>Nosema</emphasis> spp. develop in direct contact with host cell cytoplasm; nuclei are paired (diplokaryotic); divisions are by binary fission, and sporonts are disporoblastic. The majority of <emphasis>Nosema</emphasis> species that have been described in humans have been reclassified to other genera. Currently, <emphasis>Nosema ocularum</emphasis> is the only human infection that has been retained in this genus, and it is only known from a single case description (<link linkend="ch0153s0000li0081">81</link>). Spores measure 3 by 5 μm and have polar tubes with 9 to 12 coils.</para>
        <anchor id="ch0153s0000a0036"/>
        <beginpage pagenum="2602"/>
        <para id="ch0153s0000p0032"><emphasis>Pleistophora</emphasis> spp., including <emphasis>Pleistophora ronneafiei</emphasis>, have unpaired nuclei, and all stages are multinucleate plasmodia, which divide into smaller multinucleate segments. Meronts have a thick, amorphous coat, which separates from the surface in sporogony to form a sporophorous vesicle. Sporogonic divisions give rise to a large and variable number of spores, packaged in the persistent sporophorous vesicle. The spores contain polar tubes with 9 to 12 coils and measure 2 to 2.8 by 3.3 to 4.0 μm (<link linkend="ch0153s0000li0022">22</link>).</para>
        <para id="ch0153s0000p0033"><emphasis>Trachipleistophora hominis</emphasis> forms spores in sporophorous vesicles; these arise from repeated binary fissions and not from multinucleate plasmodia. The vesicles, which contain 2 to more than 32 spores, enlarge as the spore number increases. The nuclei are unpaired in all stages of development. The pear-shaped spores measure 2.4 by 4.0 μm and have about 11 anisofilar coils (<link linkend="ch0153s0000li0082">82</link>). <emphasis>Trachipleistophora anthropophthera</emphasis> is similar to <emphasis>Trachipleistophora hominis</emphasis> but appears to be dimorphic, as two different forms of sporophorous vesicles and spores have been observed (<link linkend="ch0153s0000li0083">83</link>).</para>
        <para id="ch0153s0000p0034"><emphasis>Tubulinosema acridophagus</emphasis> was identified based on molecular phylogenetic data in two cases (<link linkend="ch0153s0000li0027">27</link>, <link linkend="ch0153s0000li0028">28</link>) and has also been documented by electron microscopy (<link linkend="ch0153s0000li0084">84</link>). Ultrastructurally, all developing stages are in direct contact with the host cell cytoplasm. Spore size ranges from 1.4 to 2.4 μm in length; nuclei are diplokaryotic, and polar filaments are anisofilar and contain 11 coils arranged mostly in single rows, although in some spores double rows are present.</para>
        <para id="ch0153s0000p0035"><emphasis>Vittaforma corneae</emphasis> was originally classified as <emphasis>Nosema corneum</emphasis>, but was transferred to a new genus on the basis of its ultrastructural features (<link linkend="ch0153s0000li0011">11</link>). Nuclei are diplokaryotic; sporogony is polysporoblastic; sporonts are ribbon-shaped, and all stages, including spores, are individually enveloped by a cisterna of host endoplasmic reticulum studded with ribosomes. The spores contain polar tubes with five to seven coils and measure 1.2 by 3.8 μm (<link linkend="ch0153s0000li0085">85</link>).</para>
        <para id="ch0153s0000p0036"><emphasis>Microsporidium</emphasis> is a collective generic name for microsporidia that cannot be classified because available information is not sufficient. <emphasis>Microsporidium ceylonensis</emphasis> and <emphasis>Microsporidium africanum</emphasis> were each described in case reports of single cases of infection (<link linkend="ch0153s0000li0086">86</link>).</para>
        <anchor id="ch0153s0000a0037"/>
        <beginpage pagenum="2603"/>
      </sect2>
      <sect2 id="ch0153s0001s0003">
        <title>EPIDEMIOLOGY AND TRANSMISSION</title>
        <anchor id="ch0153s0001a0004"/>
        <anchor id="ch0153s0000a0038"/>
        <para id="ch0153s0000p0037">Infections in humans due to microsporidia occur globally and have been detected in molecular paleontology investigations of samples from Neanderthals (<link linkend="ch0153s0000li0087">87</link>). An epidemic of microsporidian infections, mainly <emphasis>Enterocytozoon bieneusi</emphasis> or <emphasis>Encephalitozoon intestinalis</emphasis>, was reported in humans due to the AIDS pandemic prior to the availability of combination antiretroviral therapy (cART). A recent meta-analysis in 2018 of 131 studies examining microsporidia, <emphasis>Cryptosporidium</emphasis>, and <emphasis>Cystoisospora</emphasis> infections in HIV-infected individuals, using a random effects model, found a pooled prevalence of 11.8% (CI: 10.1% to 13.4%) for human gastrointestinal microsporidiosis (<link linkend="ch0153s0000li0088">88</link>). A lower prevalence of infection was found in high-income countries and a higher prevalence in low-income countries, especially in sub-Saharan Africa (<link linkend="ch0153s0000li0088">88</link>). While it is clear from several studies that cART can hasten the resolution of microsporidiosis, the literature contains many reports that microsporidia can still be a problem despite cART, especially if the CD4 count remains low (<link linkend="ch0153s0000li0089">89</link>–<link linkend="ch0153s0000li0092">92</link>). Microsporidia are opportunistic pathogens, and depressed cell-mediated immunity (<link linkend="ch0153s0000li0093">93</link>, <link linkend="ch0153s0000li0094">94</link>) is a major risk factor, with individuals with a CD4 T-lymphocyte count below 50 to 100 cells/mm<superscript>3</superscript> having high susceptibility to infection (<link linkend="ch0153s0000li0095">95</link>). Other immune-suppressed patients are also at risk; i.e., cases have occurred in patients on chemotherapy, in organ transplant recipients, and in bone marrow graft recipients (<link linkend="ch0153s0000li0096">96</link>–<link linkend="ch0153s0000li0106">106</link>). There have been several cases of the transmission of microsporidiosis due to various transplanted organs (<link linkend="ch0153s0000li0107">107</link>, <link linkend="ch0153s0000li0108">108</link>); for example, <emphasis>Encephalitozoon cuniculi</emphasis> infections were diagnosed in three patients with neurological symptoms following solid organ transplantation (kidney, liver, and heart/kidney) (<link linkend="ch0153s0000li0108">108</link>). <emphasis>Encephalitozoon cuniculi</emphasis> and <emphasis>Enterocytozoon bieneusi</emphasis> infections have been reported in transplant recipients who presented with fever of unknown origin (<link linkend="ch0153s0000li0101">101</link>, <link linkend="ch0153s0000li0102">102</link>, <link linkend="ch0153s0000li0105">105</link>, <link linkend="ch0153s0000li0107">107</link>, <link linkend="ch0153s0000li0109">109</link>).</para>
        <para id="ch0153s0000p0038">In addition to immune-suppressed patients, microsporidiosis has also been reported in immune-competent hosts including travelers and residents of tropical countries (3.3 to 10%), children with and without diarrhea (1.7 to 17.4%), and the elderly (17.2%) (<link linkend="ch0153s0000li0110">110</link>–<link linkend="ch0153s0000li0114">114</link>). Latent infection associated with spore passage has also been reported in immune-competent humans (<link linkend="ch0153s0000li0115">115</link>). While self-limited diarrhea is the most common manifestation of microsporidiosis in immune-competent hosts, keratoconjunctivitis due to <emphasis>Vittaforma corneae</emphasis> has been reported in numerous immune-competent patients in Asia, including several outbreak clusters associated with soil exposure (<link linkend="ch0153s0000li0008">8</link>, <link linkend="ch0153s0000li0116">116</link>, <link linkend="ch0153s0000li0117">117</link>), and cases of conjunctivitis due to <emphasis>Vittaforma corneae</emphasis> have occurred in patients who have traveled to Asia (<link linkend="ch0153s0000li0118">118</link>). Anecdotally, sporadic cases have occurred in other countries in Europe and North America.</para>
        <para id="ch0153s0000p0039">Microsporidia are pathogens of numerous invertebrates and vertebrates, infecting virtually every major animal group (<link linkend="ch0153s0000li0002">2</link>–<link linkend="ch0153s0000li0008">8</link>), and spores are shed into the environment, increasing the probability for human exposure. The exact sources of microsporidia infecting humans and their modes of transmission are uncertain, but ingestion of the environmentally highly resistant spores is probably the most important mode of transmission. Microsporidian spores are often found in surface water, and human pathogenic microsporidia have been found in municipal water supplies (<link linkend="ch0153s0000li0119">119</link>), hospital effluent (<link linkend="ch0153s0000li0120">120</link>), tertiary sewage effluent, and ground water (<link linkend="ch0153s0000li0121">121</link>, <link linkend="ch0153s0000li0122">122</link>). Direct contact with water during bathing in hot spring spas was associated with keratoconjunctivitis due to microsporidia (<link linkend="ch0153s0000li0123">123</link>). The consumption of untreated water has been a risk factor for infection among travelers and residents; contact lens use is a strongly associated risk factor in microsporidian keratoconjunctivitis; and both young and advanced age have been identified as risk factors for infection (<link linkend="ch0153s0000li0110">110</link>, <link linkend="ch0153s0000li0124">124</link>–<link linkend="ch0153s0000li0127">127</link>). Transmission by dust or aerosol has also been considered on the basis of respiratory or ocular infections (<link linkend="ch0153s0000li0021">21</link>, <link linkend="ch0153s0000li0128">128</link>). Microsporidiosis in humans has occurred in the respiratory mucosa, prostate, and urogenital tract of patients, suggesting that respiratory and sexual transmission are possible routes of human transmission (<link linkend="ch0153s0000li0129">129</link>, <link linkend="ch0153s0000li0130">130</link>). <emphasis>Encephalitozoon cuniculi</emphasis> has been demonstrated to be transmissible via rectal infection in rabbits (<link linkend="ch0153s0000li0131">131</link>). In humans, both oral-anal contact and anal penetration during sex have been identified as risk factors for gastrointestinal microsporidiosis (<link linkend="ch0153s0000li0132">132</link>–<link linkend="ch0153s0000li0134">134</link>). Foodborne outbreaks associated with microsporidia have been reported (<link linkend="ch0153s0000li0135">135</link>, <link linkend="ch0153s0000li0136">136</link>). In a study conducted in agricultural markets in the Central Valley of Costa Rica, microsporidia were detected in cilantro, parsley, lettuce, blackberries, and strawberries (<link linkend="ch0153s0000li0137">137</link>), and microsporidian DNA has been detected in milk from dairy cows (<link linkend="ch0153s0000li0138">138</link>). While congenital transmission of microsporidia occurs in many mammals, it has not been seen in humans (<link linkend="ch0153s0000li0139">139</link>).</para>
        <para id="ch0153s0000p0040">Direct zoonotic transmission of microsporidia is probable, as microsporidia species that infect humans also infect many other animals (<link linkend="ch0153s0000li0004">4</link>, <link linkend="ch0153s0000li0008">8</link>). Direct evidence of zoonotic transmission is provided by a case report of a child who was infected with <emphasis>Encephalitozoon cuniculi</emphasis> after being exposed to an infected litter of puppies, and a 2-year-old child who was infected with <emphasis>Enterocytozoon bieneusi</emphasis> after being exposed to infected guinea pigs (<link linkend="ch0153s0000li0140">140</link>, <link linkend="ch0153s0000li0141">141</link>). Molecular studies of the <emphasis>Encephalitozoon cuniculi</emphasis> rRNA ITS region have defined four strains causing natural infections in rabbits, rodents, tamarins, cats, dogs, and a variety of wild animals (<link linkend="ch0153s0000li0079">79</link>). HIV-infected patients have been identified with infections due to strain I (“rabbit strain”), II (“mouse strain”), and III (“dog strain”) (<link linkend="ch0153s0000li0004">4</link>, <link linkend="ch0153s0000li0078">78</link>, <link linkend="ch0153s0000li0079">79</link>, <link linkend="ch0153s0000li0142">142</link>, <link linkend="ch0153s0000li0143">143</link>), and strain IV (“human strain”) has been seen in a renal transplant recipient (<link linkend="ch0153s0000li0018">18</link>) as well as in cats and dogs (<link linkend="ch0153s0000li0079">79</link>). <emphasis>Encephalitozoon</emphasis> spp. have been detected in psittacines kept in aviaries, in a variety of wild birds including pigeons (<link linkend="ch0153s0000li0144">144</link>), in domestic animals in Mexico (<link linkend="ch0153s0000li0145">145</link>), and in gorillas in Uganda. Studies of urban pigeons suggested potential zoonotic transmission of <emphasis>Encephalitozoon intestinalis</emphasis> and <emphasis>Encephalitozoon hellem</emphasis> between birds and humans, and visiting urban parks was identified as a high-risk factor for microsporidiosis in children and the elderly (<link linkend="ch0153s0000li0146">146</link>). <emphasis>Enterocytozoon bieneusi</emphasis>, while originally described in humans, has been found in a wide variety of animals, including wildlife, livestock, and companion animals, and in several reports the onset of human infection has been associated with exposure to fowl, budgerigars, lovebirds, or livestock (<link linkend="ch0153s0000li0004">4</link>, <link linkend="ch0153s0000li0135">135</link>, <link linkend="ch0153s0000li0143">143</link>, <link linkend="ch0153s0000li0147">147</link>, <link linkend="ch0153s0000li0148">148</link>). Genetic analyses of <emphasis>Enterocytozoon bieneusi</emphasis> revealed two major groups, one comprising anthroponotic genotypes and the other containing multiple genotypes with zoonotic potential (<link linkend="ch0153s0000li0149">149</link>, <link linkend="ch0153s0000li0150">150</link>). <emphasis>Tubulinosema</emphasis> and <emphasis>Anncaliia</emphasis> are pathogens of insects (<link linkend="ch0153s0000li0062">62</link>, <link linkend="ch0153s0000li0063">63</link>). <emphasis>Nosema</emphasis> and <emphasis>Vittaforma</emphasis> infections in humans are thought to be due to the inoculation of environmental spores of insect pathogens into the cornea (<link linkend="ch0153s0000li0004">4</link>).</para>
      </sect2>
      <sect2 id="ch0153s0001s0004">
        <title>CLINICAL SIGNIFICANCE</title>
        <anchor id="ch0153s0001a0005"/>
        <anchor id="ch0153s0000a0039"/>
        <anchor id="ch0153s0000a0040"/>
        <para id="ch0153s0000p0041">While microsporidia are seen in patients with advanced HIV infection, they are not limited to this condition and have been reported in other immunocompromised and immune-competent hosts (<link linkend="ch0153s0000li0005">5</link>, <link linkend="ch0153s0000li0007">7</link>, <link linkend="ch0153s0000li0008">8</link>, <link linkend="ch0153s0000li0031">31</link>, <link linkend="ch0153s0000li0061">61</link>, <link linkend="ch0153s0000li0151">151</link>–<link linkend="ch0153s0000li0153">153</link>). Microsporidia associated with human infection and related clinical manifestations are summarized in <link linkend="ch0153s0000a0007">Table 1</link>. There are limited data in humans on the immune response to microsporidiosis; however, from studies in mice it is clear that T cells are critically important in this infection (<link linkend="ch0153s0000li0154">154</link>–<link linkend="ch0153s0000li0156">156</link>). In addition to patients with AIDS, microsporidiosis has been described in solid-organ transplant recipients (<link linkend="ch0153s0000li0105">105</link>, <link linkend="ch0153s0000li0107">107</link>, <link linkend="ch0153s0000li0108">108</link>), allogeneic hematopoietic stem cell transplant recipients (<link linkend="ch0153s0000li0157">157</link>, <link linkend="ch0153s0000li0158">158</link>), patients with hematologic malignancies receiving monoclonal antibody therapy (<link linkend="ch0153s0000li0159">159</link>), patients with rheumatic disease undergoing anti-tumor necrosis factor therapy (<link linkend="ch0153s0000li0160">160</link>), the elderly (<link linkend="ch0153s0000li0110">110</link>), and malnourished children (<link linkend="ch0153s0000li0161">161</link>). In immune-competent hosts, infections due to microsporidia have presented as self-limiting diarrhea (<link linkend="ch0153s0000li0162">162</link>), latent asymptomatic infections (<link linkend="ch0153s0000li0115">115</link>), central nervous system infection (<link linkend="ch0153s0000li0002">2</link>, <link linkend="ch0153s0000li0017">17</link>, <link linkend="ch0153s0000li0019">19</link>, <link linkend="ch0153s0000li0108">108</link>, <link linkend="ch0153s0000li0151">151</link>, <link linkend="ch0153s0000li0163">163</link>–<link linkend="ch0153s0000li0167">167</link>), and various ocular infections including keratoconjunctivitis (<link linkend="ch0153s0000li0116">116</link>, <link linkend="ch0153s0000li0117">117</link>, <link linkend="ch0153s0000li0123">123</link>, <link linkend="ch0153s0000li0168">168</link>–<link linkend="ch0153s0000li0171">171</link>), keratoconjunctivitis in contact lens wearers (<link linkend="ch0153s0000li0127">127</link>), and keratoconjunctivitis after corneal collagen cross-linking (a noninvasive technique to treat keratoconus) (<link linkend="ch0153s0000li0172">172</link>). The clinical manifestations of microsporidiosis are diverse, varying according to the mode of transmission, the causal species, and the underlying host immune status and response (<link linkend="ch0153s0000li0061">61</link>). Although most reported cases of microsporidiosis involve diarrhea, the gamut of diseases caused by these organisms includes myositis, kidney and urogenital infection, cholangitis, ascites, sinusitis, hepatitis, keratoconjunctivitis, and disseminated infection, as well as asymptomatic infection (<link linkend="ch0153s0000li0008">8</link>, <link linkend="ch0153s0000li0031">31</link>, <link linkend="ch0153s0000li0061">61</link>, <link linkend="ch0153s0000li0093">93</link>, <link linkend="ch0153s0000li0173">173</link>).</para>
      </sect2>
    </sect1>
    <sect1 id="ch0153s0002">
      <title>Enterocytozoon bieneusi</title>
      <anchor id="ch0153s0002a0001"/>
      <anchor id="ch0153s0000a0041"/>
      <para id="ch0153s0000p0042"><emphasis>Enterocytozoon bieneusi</emphasis> infection was initially reported in a Haitian AIDS patient with diarrhea and wasting (<link linkend="ch0153s0000li0014">14</link>); subsequently, infection causing diarrhea was recognized in non-immune-compromised travelers (<link linkend="ch0153s0000li0126">126</link>) and in organ transplant recipients (<link linkend="ch0153s0000li0158">158</link>, <link linkend="ch0153s0000li0174">174</link>–<link linkend="ch0153s0000li0177">177</link>). In immunocompetent adults and in children, <emphasis>Enterocytozoon bieneusi</emphasis> can cause self-limited watery diarrhea (lasting up to 2 to 3 weeks), particularly among persons who reside or have traveled in tropical countries (<link linkend="ch0153s0000li0178">178</link>); diarrhea in malnourished children in the tropics (<link linkend="ch0153s0000li0161">161</link>); and acute and chronic diarrhea in elderly individuals in resource-rich countries (<link linkend="ch0153s0000li0110">110</link>). It is the most commonly seen microsporidium in human infections, causing 90% of cases of chronic diarrhea in patients with AIDS (<link linkend="ch0153s0000li0002">2</link>, <link linkend="ch0153s0000li0153">153</link>). <emphasis>Enterocytozoon bieneusi</emphasis> infects the enterocytes of the small intestine, leading to increased cell turnover and villous blunting; the epithelial cells of the pancreas; and the epithelial cells of the biliary tree, causing cholangiopathy. Clinical disease is associated with decreased brush border enzyme activities and malabsorption. There are also reports of this pathogen being seen in epithelial cells of the respiratory tract (<link linkend="ch0153s0000li0179">179</link>). Endoscopic retrograde cholangiopancreatography, computerized axial tomography, abdominal ultrasonography, or endoscopic ultrasonography often demonstrates irregularities of the bile duct wall, dilated biliary ducts, and gallbladder abnormalities such as distention, thickening, or the presence of sludge. Spores are found within the apical portion of the enterocyte cytoplasm rather than the basilar cytoplasm, and infection is not seen in cells in the lamina propria (<link linkend="ch0153s0000li0002">2</link>, <link linkend="ch0153s0000li0061">61</link>, <link linkend="ch0153s0000li0180">180</link>–<link linkend="ch0153s0000li0182">182</link>).</para>
    </sect1>
    <sect1 id="ch0153s0003">
      <title>Encephalitozoon spp.</title>
      <anchor id="ch0153s0003a0001"/>
      <anchor id="ch0153s0000a0042"/>
      <para id="ch0153s0000p0043"><emphasis>Encephalitozoon</emphasis> species including <emphasis>E. intestinalis, E. hellem</emphasis>, and <emphasis>E. cuniculi</emphasis> are widely distributed in mammals and have been identified in both immune-competent and immune-compromised humans (<link linkend="ch0153s0000li0005">5</link>, <link linkend="ch0153s0000li0182">182</link>). Consistent with their ability to disseminate widely in their hosts and to infect numerous organs, these pathogens can infect a wide variety of host cells including epithelial cells, endothelial cells, fibroblasts, and macrophages (<link linkend="ch0153s0000li0002">2</link>, <link linkend="ch0153s0000li0008">8</link>, <link linkend="ch0153s0000li0031">31</link>, <link linkend="ch0153s0000li0183">183</link>). Infection with <emphasis>Encephalitozoon</emphasis> spp. was first described in two children with a seizure disorder (<link linkend="ch0153s0000li0163">163</link>, <link linkend="ch0153s0000li0164">164</link>), and since then other cases of encephalitis have been identified (<link linkend="ch0153s0000li0002">2</link>, <link linkend="ch0153s0000li0017">17</link>, <link linkend="ch0153s0000li0019">19</link>, <link linkend="ch0153s0000li0108">108</link>, <link linkend="ch0153s0000li0151">151</link>, <link linkend="ch0153s0000li0163">163</link>–<link linkend="ch0153s0000li0167">167</link>). Encephalitozoonidae have been described as etiologic in cases of sinusitis, bronchiolitis, nephritis, keratitis, peritonitis, hepatitis, fulminant hepatic failure, gastroenteritis, cerebritis, cystitis, urethritis, prostatitis, nodular skin lesions, and disseminated infection (<link linkend="ch0153s0000li0002">2</link>, <link linkend="ch0153s0000li0008">8</link>, <link linkend="ch0153s0000li0017">17</link>, <link linkend="ch0153s0000li0020">20</link>, <link linkend="ch0153s0000li0031">31</link>, <link linkend="ch0153s0000li0142">142</link>, <link linkend="ch0153s0000li0165">165</link>, <link linkend="ch0153s0000li0184">184</link>–<link linkend="ch0153s0000li0190">190</link>). Clinical manifestations may vary substantially, ranging from an asymptomatic carrier state to organ failure. <emphasis>Encephalitozoon cuniculi</emphasis> endocarditis has been reported in a non-immunocompromised patient with a dual-chamber pacemaker (<link linkend="ch0153s0000li0191">191</link>). <emphasis>Encephalitozoon cuniculi</emphasis> has been found in the periprosthetic tissue of several patients in Poland who presented with hip implant loosening requiring hip replacement, despite an absence of symptoms associated with infection (<link linkend="ch0153s0000li0192">192</link>). <emphasis>Encephalitozoon intestinalis</emphasis> infects primarily enterocytes, but the organism is also found in intestinal lamina propria, and dissemination to the kidneys, airways, and biliary tract appears to occur via infected macrophages (<link linkend="ch0153s0000li0015">15</link>). Chronic diarrhea and disseminated disease due to <emphasis>Encephalitozoon intestinalis</emphasis> have been diagnosed mainly in immune-deficient patients, and ~10% of cases of diarrhea and wasting in immune-deficient patients with AIDS are caused by <emphasis>Encephalitozoon intestinalis</emphasis> (<link linkend="ch0153s0000li0193">193</link>). A case of nodular cutaneous <emphasis>Encephalitozoon intestinalis</emphasis> infection was observed in a patient with AIDS (<link linkend="ch0153s0000li0188">188</link>). Furthermore, <emphasis>Encephalitozoon intestinalis</emphasis> has been detected in stool specimens from healthy children and adults, with or without diarrhea, living in Mexico (<link linkend="ch0153s0000li0194">194</link>), and among travelers with diarrhea returning from tropical countries (<link linkend="ch0153s0000li0195">195</link>).</para>
    </sect1>
    <sect1 id="ch0153s0004">
      <title>Other Microsporidia</title>
      <anchor id="ch0153s0004a0001"/>
      <anchor id="ch0153s0000a0043"/>
      <para id="ch0153s0000p0044">Several other microsporidia have been isolated from both immune-competent and immune-deficient persons (<link linkend="ch0153s0000li0151">151</link>, <link linkend="ch0153s0000li0152">152</link>) (<link linkend="ch0153s0000a0007">Table 1</link>). These presentations have included keratoconjunctivitis, keratitis, corneal ulcers (<link linkend="ch0153s0000li0171">171</link>), and reactive arthritis (<link linkend="ch0153s0000li0196">196</link>). <emphasis>Vittaforma corneae</emphasis> was first described as <emphasis>Nosema corneum</emphasis> in a stromal biopsy from a patient without HIV, and it is now recognized to be responsible for keratoconjunctivitis in healthy persons (with over 300 cases being reported associated with water or soil exposure) and HIV-infected patients (<link linkend="ch0153s0000li0011">11</link>, <link linkend="ch0153s0000li0085">85</link>, <link linkend="ch0153s0000li0197">197</link>–<link linkend="ch0153s0000li0201">201</link>). Disseminated infections and myositis have been seen due to infection with <emphasis>Pleistophora</emphasis> spp. (<link linkend="ch0153s0000li0202">202</link>), <emphasis>Pleistophora ronneafiei</emphasis> (<link linkend="ch0153s0000li0022">22</link>), <emphasis>Trachipleistophora hominis</emphasis> (<link linkend="ch0153s0000li0025">25</link>), <emphasis>Anncaliia vesicularum</emphasis> (<emphasis>Brachiola vesicularum</emphasis>) (<link linkend="ch0153s0000li0012">12</link>), <emphasis>Anncaliia algerae</emphasis> (<emphasis>Nosema/Brachiola algerae</emphasis>) (<link linkend="ch0153s0000li0203">203</link>, <link linkend="ch0153s0000li0204">204</link>), and <emphasis>Tubulinosema acridophagus</emphasis> (<link linkend="ch0153s0000li0027">27</link>, <link linkend="ch0153s0000li0028">28</link>). <emphasis>Anncaliia algerae</emphasis> has also been isolated from erythematous skin nodules from a child with acute lymphocytic leukemia (<link linkend="ch0153s0000li0205">205</link>). Disseminated infection due to <emphasis>Anncaliia connori</emphasis> (<emphasis>Nosema connori</emphasis>) was found at autopsy in a 4-month-old athymic male infant (<link linkend="ch0153s0000li0076">76</link>). Myositis due to <emphasis>Endoreticulatus</emphasis> spp. was diagnosed in an otherwise healthy man in Thailand (<link linkend="ch0153s0000li0029">29</link>). Disseminated <emphasis>Trachipleistophora anthropophthera</emphasis> involving cerebral, cardiac, renal, pancreatic, thyroid, hepatic, splenic, lymphoid, and bone marrow tissues was identified at autopsy in patients with AIDS who presented with seizures (<link linkend="ch0153s0000li0026">26</link>).</para>
      <anchor id="ch0153s0000a0044"/>
      <beginpage pagenum="2605"/>
      <sect2 id="ch0153s0004s0001">
        <title>COLLECTION, TRANSPORT, AND STORAGE OF SPECIMENS</title>
        <anchor id="ch0153s0004a0002"/>
        <anchor id="ch0153s0000a0045"/>
        <para id="ch0153s0000p0045">As a consequence of the recognition of microsporidia as opportunistic pathogens, the diagnostic procedures for detection of these organisms have dramatically improved (<link linkend="ch0153s0000li0206">206</link>). With these improved techniques there has been increasing recognition of microsporidia infection in immune-competent humans (<link linkend="ch0153s0000li0114">114</link>, <link linkend="ch0153s0000li0153">153</link>, <link linkend="ch0153s0000li0169">169</link>, <link linkend="ch0153s0000li0207">207</link>). Enteric microsporidia can be detected in fresh or fixed (10% formalin or in sodium acetate-acetic acid-formalin) stool specimens, duodenal aspirates, or biopsy samples. Furthermore, spores from disseminated microsporidian infection are often detectable in fresh or fixed (usually with formalin) urine sediments and other body fluids such as sputum, bronchoalveolar lavage fluid, nasal secretions, cerebrospinal fluid, and conjunctival smears, as well as in corneal scrapings or tissue biopsy material. Identification of microsporidia at the species level can be done by molecular techniques (e.g., a species-specific PCR assay) or by ultrastructural examination (e.g., electron microscopy of tissue fixed using glutaraldehyde). Isolation of microsporidia using tissue culture has not been useful for routine clinical diagnosis; however, these organisms have been cultured in a variety of commonly used cell lines, and the collection of clinical samples (without fixative) can be extremely important for the identification and characterization of novel microsporidia. It should be appreciated that microsporidian spores are environmentally resistant and can remain infectious for several years if protected from desiccation (<link linkend="ch0153s0000li0208">208</link>).</para>
      </sect2>
      <sect2 id="ch0153s0004s0002">
        <title>DETECTION PROCEDURES</title>
        <anchor id="ch0153s0004a0003"/>
        <anchor id="ch0153s0000a0046"/>
        <para id="ch0153s0000p0046">The most robust technique for the diagnosis of infection is the detection of spores of microsporidia in clinical material by light microscopy. This is accomplished by the use of stains that produce differential contrast between the spores of microsporidia and the cells and debris in clinical samples (<anchor id="ch0153s0000a0047"/><link linkend="ch0153s0000a0049">Fig. 4</link> and <anchor id="ch0153s0000a0048"/><link linkend="ch0153s0000a0053">5</link>). Chromotrope 2R stains and chemofluorescent stains have markedly improved the detection of microsporidia in body fluids and stool samples (<link linkend="ch0153s0000li0180">180</link>).</para>
        <para id="ch0153s0000p0047">Microsporidia pathogenic to humans have spores that range in size from 1 to 4 μm. Examination of stool specimens by light microscopy is the standard technique for diagnosing gastrointestinal microsporidiosis. The differences in the sizes of<emphasis>Enterocytozoon bieneusi</emphasis> spores (1 to 1.5 μm) and Encephalitozoonidae spores (2 to 3 μm) often permit a tentative identification of the genus from light-microscopic examination of stool specimens. Since renal involvement, with shedding of spores in the urine, is common in microsporidia that disseminate, urine specimens should be obtained whenever the diagnosis of microsporidiosis is being considered. In contrast to stool, it is easier to identify microsporidial spores in body fluids because of the absence of bacteria and debris that could be confused with microsporidial spores. This has therapeutic implications, as microsporidia that disseminate (e.g., Encephalitozoonidae) are susceptible to albendazole, whereas those that do not disseminate (e.g., <emphasis>Enterocytozoon bieneusi</emphasis>) are resistant. Determination of the definitive characterization of the species of microsporidia causing an infection can be accomplished by electron microscopy or genetic analysis (<link linkend="ch0153s0000li0005">5</link>, <link linkend="ch0153s0000li0008">8</link>, <link linkend="ch0153s0000li0208">208</link>).</para>
        <figure id="ch0153s0000f0004"><title><phrase role="figureLabel"><anchor id="ch0153s0000a0049"/><link linkend="ch0153s0000a0047"><emphasis role="strong">FIGURE 4</emphasis></link></phrase> Smear of a stool specimen from a patient with AIDS and chronic diarrhea, showing pinkish red-stained spores of <emphasis>Enterocytozoon bieneusi</emphasis> that measure 0.7 to 1.0 by 1.1 to 1.6 μm. Chromotrope staining was used. Magnification, ×1,000 (oil immersion). (Reprinted with permission from reference <link linkend="ch0153s0000li0278">278</link>.)
</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0153f10.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
      </sect2>
    </sect1>
    <sect1 id="ch0153s0005">
      <title>Examination of Stool Specimens</title>
      <anchor id="ch0153s0005a0001"/>
      <anchor id="ch0153s0000a0050"/>
      <sect2 id="ch0153s0005s0001">
        <title>Preparation of Smears, Staining, and Microscopic Examination</title>
        <anchor id="ch0153s0005a0002"/>
        <anchor id="ch0153s0000a0051"/>
        <para id="ch0153s0000p0048">Smears are usually prepared from 10 to 20 μl of unconcentrated stool which is very thinly spread onto slides, as coprological procedures used to concentrate ova and parasites (i.e., helminth eggs and protozoa) fail to concentrate microsporidia spores. It should be noted, however, that formalin-ethyl acetate concentration and other different flotation methods can remove significant amounts of fecal debris, and smears prepared from such concentrates can be easier to read by light microscopy, though such smears are less sensitive (<link linkend="ch0153s0000li0209">209</link>). Chromotrope-based stains (<link linkend="ch0153s0000li0209">209</link>) and chemofluorescent optical brightening agents (<link linkend="ch0153s0000li0210">210</link>, <link linkend="ch0153s0000li0211">211</link>), including calcofluor white and other chemofluorescent stains, are the most commonly used stains for detecting microsporidia. The proteinaceous exospore and the chitinous endospore of microsporidia make it possible to stain spores with different methods such as Giemsa, Gram, or trichrome stains and fluorescent dyes (i.e., Uvitex 2B and calcofluor white). It is important, no matter which staining technique is utilized, to use positive-control material when performing stains for microsporidia. Demonstration of microsporidia by light microscopy requires the use of stains that produce differential contrast between the spores of microsporidia and the cells and debris in clinical samples. As spores are 1 to 4 μm in size, magnification using a 60× to 100× objective is required for their visualization.</para>
      </sect2>
      <sect2 id="ch0153s0005s0002">
        <title>Chromotrope-Based Staining Procedures</title>
        <anchor id="ch0153s0005a0003"/>
        <anchor id="ch0153s0000a0052"/>
        <para id="ch0153s0000p0049">The Chromotrope 2R staining technique described by Weber et al. is based on a modification of routine trichrome staining using a 10-fold higher concentration of Chromotrope 2R and a longer staining time (<link linkend="ch0153s0000li0209">209</link>). Modifications of this staining method, which are preferred by some laboratories, have been described by Ryan and coworkers (<link linkend="ch0153s0000li0212">212</link>) (using aniline blue in place of fast green) and by Kokoskin and colleagues (<link linkend="ch0153s0000li0213">213</link>) (using a higher temperature). Spores stained by Chromotrope 2R, against a green (Weber stain) or blue (Ryan stain) background, will appear as ovoid, light pink structures that are usually 1 to 3 μm in size, and these spores will often display a beltlike stripe girding them diagonally and equatorially (<link linkend="ch0153s0000a0049">Fig. 4</link> and <link linkend="ch0153s0000a0053">5B</link> and <link linkend="ch0153s0000a0048">C</link>) (<link linkend="ch0153s0000li0209">209</link>). The spore wall stains bright pinkish red and some spores appear transparent. Other fecal elements, such as <emphasis>Cyclospora, Cryptosporidia</emphasis>, yeast, and some bacteria, may also stain reddish, but they can be distinguished from microsporidial spores by their size, shape, and staining pattern. Several additional modifications of the original chromotrope-staining solution have been developed, such as the hot Gram-chromotrope technique, which stains microsporidian spores dark violet in a much shorter period of time (<link linkend="ch0153s0000li0214">214</link>), and an acid-fast trichrome stain (<link linkend="ch0153s0000li0215">215</link>), which permits visualization of acid-fast cryptosporidial oocysts and microsporidial spores on the same slide.</para>
        <figure id="ch0153s0000f0005"><title><phrase role="figureLabel"><anchor id="ch0153s0000a0053"/><link linkend="ch0153s0000a0048"><emphasis role="strong">FIGURE 5</emphasis></link></phrase> <emphasis role="strong">(A)</emphasis> Terminal ileal tissue obtained by ileocolonoscopy from a patient with AIDS and chronic diarrhea due to <emphasis>Enterocytozoon bieneusi</emphasis> infection. Microsporidial spores, measuring 0.7 to 1.0 by 1.1 to 1.6 μm, are found at a supranuclear location within small intestinal enterocytes. Brown-Brenn stain was used. Magnification, ×1,000. <emphasis role="strong">(B)</emphasis> Cytospin preparation of bronchoalveolar lavage fluid from a patient with AIDS and intestinal <emphasis>E. bieneusi</emphasis> infection, showing intracellular microsporidia. Giemsa stain was used. Magnification, ×1,000 (oil immersion). <emphasis role="strong">(C)</emphasis> Urine sediment from a patient with AIDS and disseminated <emphasis>Encephalitozoon cuniculi</emphasis> infection, showing pinkish red-stained microsporidial spores measuring 1.0 to 1.5 by 2.0 to 3.0 μm. Chromotrope stain was used. Magnification, ×1,000 (oil immersion). <emphasis role="strong">(D)</emphasis> Conjunctival scraping from a patient with <emphasis>Encephalitozoon hellem</emphasis> keratoconjunctivitis, stained with calcofluor white (chemifluorescent brightening agent that stains chitin), demonstrating the spores of this microsporidium. (Panels A, B, and C reprinted with permission from reference <link linkend="ch0153s0000li0278">278</link>; panel D reprinted with permission from reference <link linkend="ch0153s0000li0277">277</link>.)
</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0153f11.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
      </sect2>
      <sect2 id="ch0153s0005s0003">
        <title>Chemofluorescent Agents</title>
        <anchor id="ch0153s0005a0004"/>
        <anchor id="ch0153s0000a0054"/>
        <anchor id="ch0153s0000a0055"/>
        <para id="ch0153s0000p0050">Fluorescent stains that bind to chitin in the spore wall of microsporidia, such as Calcofluor White M2R, Uvitex 2B, Fungi-Fluor, Fungiqual A, Cellufluor, and other chemofluorescent optical brighteners, are also useful for visualizing microsporidian spores in various clinical samples (<link linkend="ch0153s0000a0053">Fig. 5D</link>) (<link linkend="ch0153s0000li0208">208</link>). These stains are easy and quick, but they also stain fungi and other fecal elements (<link linkend="ch0153s0000li0211">211</link>). The chitinous spore wall of a microsporidian spore fluoresces brightly, facilitating detection. However, chemofluorescent optical brighteners are not specific, and yeast, which can be present in fecal material, and other fecal elements may also be brightened. Microsporidia can be distinguished from yeast by their size and lack of budding.</para>
        <para id="ch0153s0000p0051">Epidemiological comparisons of the chromotrope-staining technique with methods that use chemofluorescent optical brighteners indicate that both of these test methods are robust for routine use and both methods have excellent sensitivity and specificity (100% for Chromotrope 2R and 90 to 100% for chemofluorescent stains) (<link linkend="ch0153s0000li0211">211</link>, <link linkend="ch0153s0000li0216">216</link>–<link linkend="ch0153s0000li0218">218</link>). The limit of detecting microsporidia by either of these techniques appears to be 50,000 organisms/ml. Some laboratories use both staining techniques because the chromotrope stains result in a highly specific visualization of spores, whereas the chemofluorescent agents may be more sensitive but may produce false-positive results (<link linkend="ch0153s0000li0218">218</link>). While spores from microsporidia can be found in food and insects and can produce a false-positive result, this has not been a significant problem in clinical practice. Neither staining method allows definitive species-specific identification of microsporidia.</para>
      </sect2>
      <sect2 id="ch0153s0005s0004">
        <title>Immunofluorescent-Antibody Tests</title>
        <anchor id="ch0153s0005a0005"/>
        <anchor id="ch0153s0000a0056"/>
        <para id="ch0153s0000p0052">Monoclonal antibodies to Encephalitozoonidae (<emphasis>Encephalitozoon hellem</emphasis> [219], <emphasis>Encephalitozoon intestinalis</emphasis> [220, 221], and <emphasis>Enterocytozoon bieneusi</emphasis> [222–224]) have been developed and evaluated for diagnostic purposes to use immunofluorescence or other immunostaining techniques to detect microsporidia in tissue sections, stool, and other body fluids. A commercial indirect fluorescent-antibody assay has become available (Bordier Affinity Products, Switzerland; CE marked but not FDA approved). For <emphasis>Enterocytozoon bieneusi</emphasis>, compared to PCR, the sensitivity was 95.2% and specificity was 100% for this indirect fluorescent-antibody assay; compared to a modified trichrome stain, sensitivity was 100% and specificity was 99.4% (<link linkend="ch0153s0000li0225">225</link>).</para>
      </sect2>
    </sect1>
    <sect1 id="ch0153s0006">
      <title>Cytological Diagnosis</title>
      <anchor id="ch0153s0006a0001"/>
      <anchor id="ch0153s0000a0057"/>
      <para id="ch0153s0000p0053">Spores from microsporidia can be detected by examination of the sediment obtained by centrifugation of body fluids for 10 min at 500 ×<emphasis>g.</emphasis> Detection by this method has been reported in duodenal aspirates, bile, biliary aspirates, urine (<link linkend="ch0153s0000a0053">Fig. 5C</link>), bronchoalveolar lavage fluid (<link linkend="ch0153s0000a0053">Fig. 5B</link>), and cerebrospinal fluid and in smears of conjunctival swabs, sputum, and nasal discharge. Examination of smears of centrifuged duodenal aspirates obtained during endoscopy has been shown to be a highly sensitive technique for the diagnosis of intestinal microsporidiosis. As microsporidia can infect multiple organs, the detection of microsporidia in virtually any tissue or body fluid should prompt a thorough search of other sites. In particular, urine specimens should be examined in cases of intestinal microsporidiosis, as the presence of microsporidia in urine can help differentiate Encephalitozoonidae infections from infection due to <emphasis>E. bieneusi</emphasis> (<link linkend="ch0153s0000li0002">2</link>, <link linkend="ch0153s0000li0208">208</link>).</para>
      <anchor id="ch0153s0000a0058"/>
      <beginpage pagenum="2607"/>
    </sect1>
    <sect1 id="ch0153s0007">
      <title>Examination of Biopsy Specimens and Corneal Scrapings</title>
      <anchor id="ch0153s0007a0001"/>
      <anchor id="ch0153s0000a0059"/>
      <para id="ch0153s0000p0054">Examination of duodenal and terminal ileal tissue has been useful for the diagnosis of intestinal microsporidiosis; however, as these pathogens are rarely found in the colon, examination of colonic biopsy has not been useful clinically for the diagnosis of intestinal microsporidiosis. Disseminated infection due to microsporidia has been reported in almost every organ system (<link linkend="ch0153s0000li0002">2</link>, <link linkend="ch0153s0000li0061">61</link>, <link linkend="ch0153s0000li0151">151</link>). The identification of microsporidia in tissue stained with routine techniques such as hematoxylin and eosin staining is difficult and requires a highly experienced pathologist. Ultrathin plastic sections stained with methylene blue-azure II-basic fuchsin or with toluidine blue may facilitate detection (<link linkend="ch0153s0000li0002">2</link>, <link linkend="ch0153s0000li0008">8</link>, <link linkend="ch0153s0000li0208">208</link>). Selective microsporidian stains improve the rate of detection of microsporidia in tissue. Tissue Gram stains (Brown-Brenn or Brown-Hopps) have proven useful for the rapid and reliable identification of HIV-associated microsporidia in routine paraffin-embedded tissue sections (<link linkend="ch0153s0000a0053">Fig. 5A</link>) and corneal scrapings (<link linkend="ch0153s0000li0002">2</link>, <link linkend="ch0153s0000li0008">8</link>, <link linkend="ch0153s0000li0208">208</link>). With this stain, spores from microsporidia are Gram variable and are easily identified because of the contrasting dark blue or reddish staining against a faint brown-yellow background. Microsporidia can also be identified in tissue using silver stains (Warthin-Starry stain) (<link linkend="ch0153s0000li0226">226</link>), chromotrope-based staining techniques, chemofluorescent agents, or a Luna stain (<link linkend="ch0153s0000li0227">227</link>).</para>
    </sect1>
    <sect1 id="ch0153s0008">
      <title>Molecular Techniques</title>
      <anchor id="ch0153s0008a0001"/>
      <anchor id="ch0153s0000a0060"/>
      <para id="ch0153s0000p0055">The successful sequencing of various microsporidia genomes has led to the application of molecular-based techniques for the diagnosis of microsporidia infections in humans (180; see Weiss and Vossbrinck [69] and Ghosh and Weiss [228] for reviews of molecular diagnostic tests for microsporidiosis). Universal panmicrosporidian and genus- or species-specific PCR primer pairs that target the 16S small subunit rRNA gene have been well characterized for diagnosis and species identification (<link linkend="ch0153s0000li0003">3</link>, <link linkend="ch0153s0000li0008">8</link>, <link linkend="ch0153s0000li0228">228</link>–<link linkend="ch0153s0000li0230">230</link>). Using PCR, <emphasis>Enterocytozoon bieneusi</emphasis> and the Encephalitozoonidae have been identified in fresh stool specimens, formalin-fixed stool specimens, intestinal tissue obtained by endoscopic biopsy, urine specimens, and other body fluids. Nucleic acids are isolated from clinical specimens by mechanical disruption of the microsporidia spores, combined with using lyticase and/or chitinase to increase the efficiency of DNA extraction (<link linkend="ch0153s0000li0180">180</link>, <link linkend="ch0153s0000li0231">231</link>). PCR-based methods have been shown to be able to detect 100 to 1,000 spores/ml in clinical samples (<link linkend="ch0153s0000li0232">232</link>, <link linkend="ch0153s0000li0233">233</link>). A real-time PCR method was developed for quantitation of <emphasis>Enterocytozoon bieneusi</emphasis> DNA (<link linkend="ch0153s0000li0119">119</link>) and <emphasis>Encephalitozoon intestinalis</emphasis> DNA (<link linkend="ch0153s0000li0234">234</link>) in stool specimens. An assay based on the loop-mediated isothermal amplification (LAMP) technique has been developed for <emphasis>Enterocytozoon bieneusi</emphasis> (<link linkend="ch0153s0000li0235">235</link>), as well as an <emphasis>in situ</emphasis> hybridization assay for identifying <emphasis>Enterocytozoon bieneusi</emphasis> in tissue sections (<link linkend="ch0153s0000li0236">236</link>).</para>
      <sect2 id="ch0153s0008s0001">
        <title>ISOLATION OF MICROSPORIDIA</title>
        <anchor id="ch0153s0008a0002"/>
        <anchor id="ch0153s0000a0061"/>
        <para id="ch0153s0000p0056">The isolation of microsporidia is not used for routine diagnostic purposes, but is an important research tool and should be attempted for all atypical or novel microsporidia seen in clinical samples. Microsporidia cannot be grown axenically.<emphasis>Encephalitozoon</emphasis> spp., <emphasis>Trachipleistophora hominis, Vittaforma corneae</emphasis>, and <emphasis>Ancaliia algerae</emphasis> have all been grown in various host cells including RK-13 (rabbit kidney), MDCK (Madin-Darby canine kidney), MRC-5 (human embryonic lung fibroblast), and other cells (<link linkend="ch0153s0000li0086">86</link>, <link linkend="ch0153s0000li0237">237</link>, <link linkend="ch0153s0000li0238">238</link>). More than 13 isolates of <emphasis>Encephalitozoon cuniculi</emphasis>, 30 isolates of <emphasis>Encephalitozon hellem</emphasis>, and 30 isolates of <emphasis>Encephalitozon intestinalis</emphasis> have been reported to be successfully cultured <emphasis>in vitro.</emphasis> These microsporidia parasites were isolated from various clinical samples including corneal scrapings, conjunctival biopsies, urine, sputum, bronchoalveolar lavage fluid, nasal mucosal biopsies, duodenal biopsies, and stool. A system for continuous <emphasis>in vitro</emphasis> culture of <emphasis>Enterocytozoon bieneusi</emphasis> has not been established (<link linkend="ch0153s0000li0193">193</link>, <link linkend="ch0153s0000li0239">239</link>); however, short-term <emphasis>in vitro</emphasis> culture, with limited spore production, has been reported (<link linkend="ch0153s0000li0239">239</link>, <link linkend="ch0153s0000li0240">240</link>).</para>
      </sect2>
      <sect2 id="ch0153s0008s0002">
        <title>IDENTIFICATION</title>
        <anchor id="ch0153s0008a0003"/>
        <anchor id="ch0153s0000a0062"/>
        <para id="ch0153s0000p0057">The identification of microsporidia and their taxonomy has traditionally been reliant on their ultrastructure and developmental life cycle as determined by electron microscopy, although molecular methods are now being used to help classify these organisms; e.g., the Encephalitozoonidae share most of their morphologic features, and genetic analyses are important for their identification and can also reveal subtype-specific variation (<link linkend="ch0153s0000li0020">20</link>, <link linkend="ch0153s0000li0078">78</link>). Electron microscopy is the “gold standard” for diagnostic confirmation and species identification of microsporidia; however, it is not routinely used for diagnosis as it is less sensitive than light microscopy or molecular diagnostic tests (<link linkend="ch0153s0000li0208">208</link>). While mature spores seen in body fluids or stool samples can provide important ultrastructural data for species identification, definitive identification requires examination of the developmental life cycle seen in tissue samples (<link linkend="ch0153s0000li0008">8</link>, <link linkend="ch0153s0000li0061">61</link>, <link linkend="ch0153s0000li0180">180</link>, <link linkend="ch0153s0000li0241">241</link>) (<anchor id="ch0153s0000a0063"/><link linkend="ch0153s0000a0066">Fig. 6</link>). Such ultrastructural studies are particularly important for the classification of new or novel microsporidia seen in tissue and should be accompanied by phylogenetic analyses of 16S small subunit ribosomal gene sequences derived from PCR using panmicrosporidian primers (<link linkend="ch0153s0000li0008">8</link>, <link linkend="ch0153s0000li0061">61</link>, <link linkend="ch0153s0000li0085">85</link>, <link linkend="ch0153s0000li0142">142</link>, <link linkend="ch0153s0000li0242">242</link>).</para>
      </sect2>
      <sect2 id="ch0153s0008s0003">
        <title>SEROLOGIC TESTS</title>
        <anchor id="ch0153s0008a0004"/>
        <anchor id="ch0153s0000a0064"/>
        <para id="ch0153s0000p0058">Serologic assays such as carbon immunoassay, indirect immunofluorescence test, enzyme-linked immunosorbent assay, and immunoblot assays have been used to demonstrate microsporidian-specific antibodies in several species of animals. The utility of such tests in humans has not been demonstrated, as seroconversion has not been demonstrated to be useful for the diagnosis of active infection. The seroprevalence rate reported in human studies has been variable depending on the population studied, but rates as high as 42% have been seen (<link linkend="ch0153s0000li0112">112</link>, <link linkend="ch0153s0000li0132">132</link>, <link linkend="ch0153s0000li0243">243</link>–<link linkend="ch0153s0000li0245">245</link>). This suggests that asymptomatic infection is probably common with various microsporidia. Results of these serologic studies with humans, however, were not supported by the simultaneous detection of organisms in individuals with antibody responses. The use of recombinant polar tube protein antigens from <emphasis>Encephalitozoon cuniculi</emphasis> has been reported to provide improved specificity for such serological assays (<link linkend="ch0153s0000li0246">246</link>).</para>
      </sect2>
      <sect2 id="ch0153s0008s0004">
        <title>ANTIMICROBIAL SUSCEPTIBILITY</title>
        <anchor id="ch0153s0008a0005"/>
        <anchor id="ch0153s0000a0065"/>
        <para id="ch0153s0000p0059">Microsporidiosis is often seen in immune-compromised hosts, especially in patients with advanced AIDS and CD4+ cell counts lower than 50/μl. Improved immune function can result in a clinical response in patients with gastrointestinal microsporidiosis, leading to elimination of the organism and normalization of the intestinal architecture (<link linkend="ch0153s0000li0247">247</link>–<link linkend="ch0153s0000li0252">252</link>). Based on these observations, the institution of effective cART is important as part of the primary treatment of microsporidiosis in the setting of AIDS.</para>
        <figure id="ch0153s0000f0006"><title><phrase role="figureLabel"><anchor id="ch0153s0000a0066"/><link linkend="ch0153s0000a0063"><emphasis role="strong">FIGURE 6</emphasis></link></phrase> Transmission electron micrograph showing the duodenal epithelium of an HIV-infected patient infected with <emphasis>Enterocytozoon bieneusi.</emphasis> The different developmental stages between the enterocyte nuclei and the microvillus border include a proliferative plasmodium (<link linkend="ch0153s0000li0001">1</link>), late sporogonial plasmodia (<link linkend="ch0153s0000li0002">2</link>), and mature spores (arrow). Magnification, ×5,370. (Reprinted with permission from reference <link linkend="ch0153s0000li0278">278</link>.)
</title>
          
          <mediaobject>
            <imageobject>
              <imagedata fileref="Ch0153f06.jpg" width="100%" scalefit="1"/>
            </imageobject>
          </mediaobject>
        </figure>
        <para id="ch0153s0000p0060">Based on studies<emphasis>in vitro</emphasis> and <emphasis>in vivo</emphasis> in animal models, as well as clinical data on microsporidiosis in humans, albendazole (which inhibits β-tubulin) and fumagillin (which inhibits methionine aminopeptidase type 2) have the most consistent activity against the microsporidia that cause human infections (<link linkend="ch0153s0000li0151">151</link>, <link linkend="ch0153s0000li0181">181</link>, <link linkend="ch0153s0000li0253">253</link>–<link linkend="ch0153s0000li0260">260</link>). Albendazole has been found to cause growth deformities of <emphasis>Encephalitozoon</emphasis> and <emphasis>Vittaforma</emphasis> and to reduce or eradicate these organisms in cell cultures; however, albendazole does not destroy mature microsporidial spores, and thus treatment may result in latent infection (<link linkend="ch0153s0000li0261">261</link>). Fumagillin, its analog TNP-470, nikkomycin Z, and fluoroquinolones have been shown <emphasis>in vitro</emphasis> to inhibit completely or partially the replication or spore germination of <emphasis>Encephalitozoon</emphasis> and <emphasis>Vittaforma</emphasis> (<link linkend="ch0153s0000li0261">261</link>, <link linkend="ch0153s0000li0262">262</link>). Albendazole (2 to 4 weeks, 400 mg twice daily) can result in clinical cure of HIV-associated Encephalitozoonidae infection in parallel with the cessation of spore excretion (<link linkend="ch0153s0000li0129">129</link>, <link linkend="ch0153s0000li0257">257</link>–<link linkend="ch0153s0000li0260">260</link>). Successful treatment of a case of disseminated <emphasis>Trachipleistophora acridophagus</emphasis> infection has been reported (<link linkend="ch0153s0000li0084">84</link>). Albendazole has been effective in patients with microsporidiosis due to <emphasis>Trachipleistophora hominis</emphasis> and in patients with infections due to <emphasis>Anncaliia</emphasis> spp. (<link linkend="ch0153s0000li0012">12</link>, <link linkend="ch0153s0000li0025">25</link>, <link linkend="ch0153s0000li0203">203</link>, <link linkend="ch0153s0000li0263">263</link>). Albendazole is not effective against <emphasis>Enterocytozoon</emphasis> infection and does not reduce pathogen load, although previous observations had suggested that clinical improvement may occur in some patients. The sequences of both the <emphasis>Enterocytozoon</emphasis> (<link linkend="ch0153s0000li0264">264</link>) and <emphasis>Vittaforma</emphasis> β-tubulins contain amino acid residues associated with albendazole resistance, consistent with the observation that albendazole is less effective for the treatment of <emphasis>Enterocytozoon bieneusi</emphasis> infection (<link linkend="ch0153s0000li0265">265</link>). Fumagillin and its semisynthetic analogues (due to inhibition of microsporidian methionine aminopeptidase type 2) have both <emphasis>in vitro</emphasis> and <emphasis>in vivo</emphasis> activity against the Encephalitozoonidae and <emphasis>Vittaforma corneae.</emphasis> For the treatment of <emphasis>Enterocytozoon bieneusi</emphasis> gastrointestinal infections in patients with AIDS and in patients with various organ transplants, fumagillin (20 mg three times a day) has been effective (<link linkend="ch0153s0000li0158">158</link>, <link linkend="ch0153s0000li0253">253</link>, <link linkend="ch0153s0000li0254">254</link>, <link linkend="ch0153s0000li0260">260</link>, <link linkend="ch0153s0000li0266">266</link>–<link linkend="ch0153s0000li0270">270</link>). The main adverse event seen with fumagillin therapy has been reversible thrombocytopenia (<link linkend="ch0153s0000li0253">253</link>, <link linkend="ch0153s0000li0271">271</link>).</para>
        <anchor id="ch0153s0000a0067"/>
        <beginpage pagenum="2608"/>
        <para id="ch0153s0000p0061">Keratoconjunctivitis due to microsporidia (Encephalitozoonidae and<emphasis>Vittaforma corneae</emphasis>) can be a self-limiting disease (<link linkend="ch0153s0000li0116">116</link>), may be cleared by repeated corneal swabbing or debridement (<link linkend="ch0153s0000li0272">272</link>–<link linkend="ch0153s0000li0274">274</link>), and may respond to systemic albendazole treatment (<link linkend="ch0153s0000li0275">275</link>) or to topical voriconazole application (<link linkend="ch0153s0000li0276">276</link>). Topical fumagillin has been used to treat ocular microsporidiosis due to Encephalitozoonidae in immune-compromised hosts (<link linkend="ch0153s0000li0151">151</link>, <link linkend="ch0153s0000li0181">181</link>, <link linkend="ch0153s0000li0253">253</link>–<link linkend="ch0153s0000li0256">256</link>).</para>
      </sect2>
      <sect2 id="ch0153s0008s0005">
        <title>EVALUATION, INTERPRETATION, AND REPORTING OF RESULTS</title>
        <anchor id="ch0153s0008a0006"/>
        <anchor id="ch0153s0000a0068"/>
        <para id="ch0153s0000p0062">In immune-competent hosts, microsporidia can cause self-limited diarrhea or keratoconjunctivitis. Microsporidia are, however, predominantly opportunistic pathogens that cause disease in immune-deficient HIV-infected patients (with CD4 cell counts below 200/μl) and other immune-compromised patients, such as patients who have had an organ transplant. Stool examination or examination of other specimens is, therefore, indicated for these patient groups in particular, and microsporidia should be considered etiologic agents when detected in clinical specimens from such patients. Microsporidia have been reported to cause infection in almost every organ system, and examination for these pathogens should be considered in cases where other pathogens have been excluded.</para>
        <anchor id="ch0153s0000a0069"/>
        <beginpage pagenum="2609"/>
        <para id="ch0153s0000p0063">Routine diagnosis of microsporidiosis is based upon microscopic detection of the spores of these pathogens in various clinical samples. While light-microscopic examination is sensitive and specific (especially in immune-compromised hosts), it does not allow identification of microsporidia to the genus and species level. Identification of species can be achieved by electron microscopy, which is relatively insensitive for the detection of microsporidia because only small samples are examined and sampling errors may occur, or by PCR assays and sequence analyses. Immune-competent hosts with microsporidiosis can excrete lower numbers of spores in feces or urine; therefore, light-microscopic detection procedures may not be as sensitive in this group, and molecular tests (PCR) should be considered in cases where the diagnosis is strongly suspected but the light microscopy is negative.</para>
        <para id="ch0153s0000p0064"><emphasis>I thank Rainer Weber, Peter Deplazes, and Alexander Mathis for their excellent chapter on microsporidiosis in the 12th edition of this</emphasis> Manual<emphasis>, which forms the basis for this revised chapter</emphasis>.</para>
        <para id="ch0153s0000p0065"><emphasis>I thank David Schwartz, Peter M. Takvorian, Imtiaz Khan, Rainer Weber, Max A. Spycher, Donald P. Kotler, Jan M. Orenstein, and Elizabeth Didier for sharing photographs over the years</emphasis>.</para>
        <para id="ch0153s0000p0066"><emphasis>This work was supported by grants no. R01 AI124753 and R01 AI132614 to L.M.W</emphasis>.</para>
      </sect2>
      <sect2 id="ch0153s0008s0006">
        <title>REFERENCES</title>
        <anchor id="ch0153s0008a0007"/>
        <anchor id="ch0153s0000a0070"/>
        <itemizedlist mark="none" role="biblioEntryList">
          <listitem id="ch0153s0000li0001" role="bibliographyEntry">
            <para>1.<emphasis role="strong">Franzen C.</emphasis> 2008. Microsporidia: a review of 150 years of research. <citetitle><emphasis>Open Parasitol J</emphasis></citetitle> <emphasis role="strong">2:</emphasis>1–34.</para>
          </listitem>
          <listitem id="ch0153s0000li0002" role="bibliographyEntry">
            <para>2.<emphasis role="strong">Weber R, Bryan RT, Schwartz DA, Owen RL.</emphasis> 1994. Human microsporidial infections. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">7:</emphasis>426–461.</para>
          </listitem>
          <listitem id="ch0153s0000li0003" role="bibliographyEntry">
            <para>3.<emphasis role="strong">Wittner M, Weiss LM (ed).</emphasis> 1999. <citetitle><emphasis>The Microsporidia and Microsporidiosis.</emphasis></citetitle> ASM Press, Washington, DC.</para>
          </listitem>
          <listitem id="ch0153s0000li0004" role="bibliographyEntry">
            <para>4.<emphasis role="strong">Mathis A, Weber R, Deplazes P.</emphasis> 2005. Zoonotic potential of the microsporidia. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">18:</emphasis>423–445.</para>
          </listitem>
          <listitem id="ch0153s0000li0005" role="bibliographyEntry">
            <para>5.<emphasis role="strong">Didier ES, Weiss LM.</emphasis> 2011. Microsporidiosis: not just in AIDS patients. <citetitle><emphasis>Curr Opin Infect Dis</emphasis></citetitle> <emphasis role="strong">24:</emphasis>490–495.</para>
          </listitem>
          <listitem id="ch0153s0000li0006" role="bibliographyEntry">
            <para>6.<emphasis role="strong">Vávra J, Lukeš J.</emphasis> 2013. Microsporidia and ‘the art of living together’. <citetitle><emphasis>Adv Parasitol</emphasis></citetitle> <emphasis role="strong">82:</emphasis>253–319.</para>
          </listitem>
          <listitem id="ch0153s0000li0007" role="bibliographyEntry">
            <para>7.<emphasis role="strong">Weber R, Deplazes P, Mathis A.</emphasis> 2015. Microsporidia, p 2209–2219. <citetitle><emphasis>In</emphasis></citetitle> Jorgensen JH, Pfaller MA, Carroll KC, Funke G, Landry ML, Richter SS, Warnock DW (ed), <citetitle><emphasis>Manual of Clinical Microbiology</emphasis></citetitle>, 11th ed, vol 2. ASM Press, Washington, DC.</para>
          </listitem>
          <listitem id="ch0153s0000li0008" role="bibliographyEntry">
            <para>8.<emphasis role="strong">Weiss LM, Bechnel JJ (ed).</emphasis> 2014. <citetitle><emphasis>Microsporidia: Pathogens of Opportunity.</emphasis></citetitle> Wiley Press, New York, NY.</para>
          </listitem>
          <listitem id="ch0153s0000li0009" role="bibliographyEntry">
            <para>9.<emphasis role="strong">Sprague V.</emphasis> 1977. Systematics of the microsporidia, p 1–30. <citetitle><emphasis>In</emphasis></citetitle> Bulla LA, Cheng TC (ed), <citetitle><emphasis>Comparative Pathobiology</emphasis></citetitle>, vol 2. Plenum Press, New York, NY.</para>
          </listitem>
          <listitem id="ch0153s0000li0010" role="bibliographyEntry">
            <para>10.<emphasis role="strong">Sprague V, Becnel JJ.</emphasis> 1998. Note on the name-author-date combination for the taxon MICROSPORIDIES Balbiani, 1882, when ranked as a phylum. <citetitle><emphasis>J Invertebr Pathol</emphasis></citetitle> <emphasis role="strong">71:</emphasis>91–94.</para>
          </listitem>
          <listitem id="ch0153s0000li0011" role="bibliographyEntry">
            <para>11.<emphasis role="strong">Silveira H, Canning EU.</emphasis> 1995. <citetitle><emphasis>Vittaforma corneae</emphasis></citetitle> n. comb. for the human microsporidium <citetitle><emphasis>Nosema corneum</emphasis></citetitle> Shadduck, Meccoli, Davis &amp; Font, 1990, based on its ultrastructure in the liver of experimentally infected athymic mice. <citetitle><emphasis>J Eukaryot Microbiol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>158–165.</para>
          </listitem>
          <listitem id="ch0153s0000li0012" role="bibliographyEntry">
            <para>12.<emphasis role="strong">Cali A, Takvorian PM, Lewin S, Rendel M, Sian CS, Wittner M, Tanowitz HB, Keohane E, Weiss LM.</emphasis> 1998. <citetitle><emphasis>Brachiola vesicularum</emphasis></citetitle>, n. g., n. sp., a new microsporidium associated with AIDS and myositis. <citetitle><emphasis>J Eukaryot Microbiol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>240–251.</para>
          </listitem>
          <listitem id="ch0153s0000li0013" role="bibliographyEntry">
            <para>13.<emphasis role="strong">Franzen C, Nassonova ES, Schölmerich J, Issi IV.</emphasis> 2006. Transfer of the members of the genus <citetitle><emphasis>Brachiola</emphasis></citetitle> (microsporidia) to the genus <citetitle><emphasis>Anncaliia</emphasis></citetitle> based on ultrastructural and molecular data. <citetitle><emphasis>J Eukaryot Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>26–35.</para>
          </listitem>
          <listitem id="ch0153s0000li0014" role="bibliographyEntry">
            <para>14.<emphasis role="strong">Desportes I, Le Charpentier Y, Galian A, Bernard F, Cochand-Priollet B, Lavergne A, Ravisse P, Modigliani R.</emphasis> 1985. Occurrence of a new microsporidan: <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> n.g., n. sp., in the enterocytes of a human patient with AIDS. <citetitle><emphasis>J Protozool</emphasis></citetitle> <emphasis role="strong">32:</emphasis>250–254.</para>
          </listitem>
          <listitem id="ch0153s0000li0015" role="bibliographyEntry">
            <para>15.<emphasis role="strong">Cali A, Kotler DP, Orenstein JM.</emphasis> 1993. <citetitle><emphasis>Septata intestinalis</emphasis></citetitle> n. g., n. sp., an intestinal microsporidian associated with chronic diarrhea and dissemination in AIDS patients. <citetitle><emphasis>J Eukaryot Microbiol</emphasis></citetitle> <emphasis role="strong">40:</emphasis>101–112.</para>
          </listitem>
          <listitem id="ch0153s0000li0016" role="bibliographyEntry">
            <para>16.<emphasis role="strong">Hartskeerl RA, Van Gool T, Schuitema AR, Didier ES, Terpstra WJ.</emphasis> 1995. Genetic and immunological characterization of the microsporidian <citetitle><emphasis>Septata intestinalis</emphasis></citetitle> Cali, Kotler and Orenstein, 1993: reclassification to <citetitle><emphasis>Encephalitozoon intestinalis. Parasitology</emphasis></citetitle> <emphasis role="strong">110:</emphasis>277–285.</para>
          </listitem>
          <listitem id="ch0153s0000li0017" role="bibliographyEntry">
            <para>17.<emphasis role="strong">Weber R, Deplazes P, Flepp M, Mathis A, Baumann R, Sauer B, Kuster H, Lüthy R.</emphasis> 1997. Cerebral microsporidiosis due to <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> in a patient with human immunodeficiency virus infection. <citetitle><emphasis>N Engl J Med</emphasis></citetitle> <emphasis role="strong">336:</emphasis>474–478.</para>
          </listitem>
          <listitem id="ch0153s0000li0018" role="bibliographyEntry">
            <para>18.<emphasis role="strong">Talabani H, Sarfati C, Pillebout E, van Gool T, Derouin F, Menotti J.</emphasis> 2010. Disseminated infection with a new genovar of <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> in a renal transplant recipient. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">48:</emphasis>2651–2653.</para>
          </listitem>
          <listitem id="ch0153s0000li0019" role="bibliographyEntry">
            <para>19.<emphasis role="strong">Ditrich O, Chrdle A, Sak B, Chmelík V, Kubále J, Dyková I, Kvác M.</emphasis> 2011. <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> genotype I as a causative agent of brain abscess in an immunocompetent patient. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">49:</emphasis>2769–2771.</para>
          </listitem>
          <listitem id="ch0153s0000li0020" role="bibliographyEntry">
            <para>20.<emphasis role="strong">Didier ES, Didier PJ, Friedberg DN, Stenson SM, Orenstein JM, Vee RW, Tio FO, Davis RM, Vossbrinck C, Millichamp N, Shadduck JA.</emphasis> 1991. Isolation and characterization of a new human microsporidian, <citetitle><emphasis>Encephalitozoon hellem</emphasis></citetitle> (n. sp.), from three AIDS patients with keratoconjunctivitis. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">163:</emphasis>617–621.</para>
          </listitem>
          <listitem id="ch0153s0000li0021" role="bibliographyEntry">
            <para>21.<emphasis role="strong">Weber R, Kuster H, Visvesvara GS, Bryan RT, Schwartz DA, Lüthy R.</emphasis> 1993. Disseminated microsporidiosis due to <citetitle><emphasis>Encephalitozoon hellem</emphasis></citetitle>: pulmonary colonization, microhematuria, and mild conjunctivitis in a patient with AIDS. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">17:</emphasis>415–419.</para>
          </listitem>
          <listitem id="ch0153s0000li0022" role="bibliographyEntry">
            <para>22.<emphasis role="strong">Cali A, Takvorian PM.</emphasis> 2003. Ultrastructure and development of <citetitle><emphasis>Pleistophora ronneafiei</emphasis></citetitle> n. sp., a microsporidium (Protista) in the skeletal muscle of an immune-compromised individual. <citetitle><emphasis>J Eukaryot Microbiol</emphasis></citetitle> <emphasis role="strong">50:</emphasis>77–85.</para>
          </listitem>
          <listitem id="ch0153s0000li0023" role="bibliographyEntry">
            <para>23.<emphasis role="strong">Chupp GL, Alroy J, Adelman LS, Breen JC, Skolnik PR.</emphasis> 1993. Myositis due to <citetitle><emphasis>Pleistophora</emphasis></citetitle> (Microsporidia) in a patient with AIDS. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">16:</emphasis>15–21.</para>
          </listitem>
          <listitem id="ch0153s0000li0024" role="bibliographyEntry">
            <para>24.<emphasis role="strong">Grau A, Valls ME, Williams JE, Ellis DS, Muntané MJ, Nadal C.</emphasis> 1996. [Myositis caused by <citetitle><emphasis>Pleistophora</emphasis></citetitle> in a patient with AIDS]. <citetitle><emphasis>Med Clin (Barc)</emphasis></citetitle> <emphasis role="strong">107:</emphasis>779–781.</para>
          </listitem>
          <listitem id="ch0153s0000li0025" role="bibliographyEntry">
            <para>25.<emphasis role="strong">Field AS, Marriott DJ, Milliken ST, Brew BJ, Canning EU, Kench JG, Darveniza P, Harkness JL.</emphasis> 1996. Myositis associated with a newly described microsporidian, <citetitle><emphasis>Trachipleistophora hominis</emphasis></citetitle>, in a patient with AIDS. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">34:</emphasis>2803–2811.</para>
          </listitem>
          <listitem id="ch0153s0000li0026" role="bibliographyEntry">
            <para>26.<emphasis role="strong">Yachnis AT, Berg J, Martinez-Salazar A, Bender BS, Diaz L, Rojiani AM, Eskin TA, Orenstein JM.</emphasis> 1996. Disseminated microsporidiosis especially infecting the brain, heart, and kidneys. Report of a newly recognized pansporoblastic species in two symptomatic AIDS patients. <citetitle><emphasis>Am J Clin Pathol</emphasis></citetitle> <emphasis role="strong">106:</emphasis>535–543.</para>
          </listitem>
          <listitem id="ch0153s0000li0027" role="bibliographyEntry">
            <para>27.<emphasis role="strong">Meissner EG, Bennett JE, Qvarnstrom Y, da Silva A, Chu EY, Tsokos M, Gea-Banacloche J.</emphasis> 2012. Disseminated microsporidiosis in an immunosuppressed patient. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">18:</emphasis>1155–1158.</para>
          </listitem>
          <listitem id="ch0153s0000li0028" role="bibliographyEntry">
            <para>28.<emphasis role="strong">Choudhary MM, Metcalfe MG, Arrambide K, Bern C, Visvesvara GS, Pieniazek NJ, Bandea RD, Deleon-Carnes M, Adem P, Choudhary MM, Zaki SR, Saeed MU.</emphasis> 2011. <citetitle><emphasis>Tubulinosema</emphasis></citetitle> sp. microsporidian myositis in immunosuppressed patient. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">17:</emphasis>1727–1730.</para>
          </listitem>
          <listitem id="ch0153s0000li0029" role="bibliographyEntry">
            <para>29.<emphasis role="strong">Suankratay C, Thiansukhon E, Nilaratanakul V, Putaporntip C, Jongwutiwes S.</emphasis> 2012. Disseminated infection caused by novel species of <citetitle><emphasis>Microsporidium</emphasis></citetitle>, Thailand. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">18:</emphasis>302–304.</para>
          </listitem>
          <listitem id="ch0153s0000li0030" role="bibliographyEntry">
            <para>30.<emphasis role="strong">Sharma S, Balne PK, Das S.</emphasis> 2014. Ocular microsporidiosis, p 403–419. <citetitle><emphasis>In</emphasis></citetitle> Weiss LM, Becnel JJ (ed), <citetitle><emphasis>Microsporidia: Pathologens of Opportunity.</emphasis></citetitle> John Wiley &amp; Sons, Chichester, United Kingdom.</para>
          </listitem>
          <listitem id="ch0153s0000li0031" role="bibliographyEntry">
            <anchor id="ch0153s0000a0071"/>
            <para>31.<emphasis role="strong">Weber R, Deplazes P, Schwartz D.</emphasis> 2000. Diagnosis and clinical aspects of human microsporidiosis. <citetitle><emphasis>Contrib Microbiol</emphasis></citetitle> <emphasis role="strong">6:</emphasis>166–192.</para>
          </listitem>
          <listitem id="ch0153s0000li0032" role="bibliographyEntry">
            <para>32.<emphasis role="strong">Andreadis TG.</emphasis> 1985. Experimental transmission of a microsporidian pathogen from mosquitoes to an alternate copepod host. <citetitle><emphasis>Proc Natl Acad Sci USA</emphasis></citetitle> <emphasis role="strong">82:</emphasis>5574–5577.</para>
          </listitem>
          <listitem id="ch0153s0000li0033" role="bibliographyEntry">
            <para>33.<emphasis role="strong">Sweeney AW, Hazard EI, Graham MF.</emphasis> 1985. Intermediate host for an <citetitle><emphasis>Amblyospora</emphasis></citetitle> sp. (microspora) infecting the mosquito, <citetitle><emphasis>Culex annulirostris. J Invertebr Pathol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>98–102.</para>
          </listitem>
          <listitem id="ch0153s0000li0034" role="bibliographyEntry">
            <para>34.<emphasis role="strong">Cali A, Becnel J, Takvorian P.</emphasis> 2017. Microsporidia, p 1559–1618. <citetitle><emphasis>In</emphasis></citetitle> Archibald JM, Simpson AGB, Slamovits CH, Margulis L, Melkonian M, Chapman DJ, Corliss JO (ed), <citetitle><emphasis>Handbook of the Protists.</emphasis></citetitle> Springer International Publishing, New York, NY.</para>
          </listitem>
          <listitem id="ch0153s0000li0035" role="bibliographyEntry">
            <para>35.<emphasis role="strong">Cali A, Neafie R, Takvorian PM.</emphasis> 2011. Microsporidiosis, p 61–76. <citetitle><emphasis>In</emphasis></citetitle> Meyers WM, Firpo A, Wear DJ (ed), <citetitle><emphasis>Topics on the Pathology of Protozoan and Invasive Arthropod Diseases</emphasis></citetitle>, 3rd ed. Armed Forces Institute of Pathology, Washington, DC.</para>
          </listitem>
          <listitem id="ch0153s0000li0036" role="bibliographyEntry">
            <para>36.<emphasis role="strong">Weidner E.</emphasis> 1975. Interactions between <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> and macrophages. Parasitophorous vacuole growth and the absence of lysosomal fusion. <citetitle><emphasis>Z Parasitenkd</emphasis></citetitle> <emphasis role="strong">47:</emphasis>1–9.</para>
          </listitem>
          <listitem id="ch0153s0000li0037" role="bibliographyEntry">
            <para>37.<emphasis role="strong">Cali A, Owen RL.</emphasis> 1988. Microsporidiosis, p 929–950. <citetitle><emphasis>In</emphasis></citetitle> Balows A, Hausler WJ, Ohashi M, Turano A, Lennette EH (ed), <citetitle><emphasis>Laboratory Diagnosis of Infectious Diseases.</emphasis></citetitle> Springer, New York, NY.</para>
          </listitem>
          <listitem id="ch0153s0000li0038" role="bibliographyEntry">
            <para>38.<emphasis role="strong">Overstreet RM, Weidner E.</emphasis> 1974. Differentiation of microsporidian spore-tails in <citetitle><emphasis>Inodosporus spraguei</emphasis></citetitle> gen. et sp. n. <citetitle><emphasis>Z Parasitenkd</emphasis></citetitle> <emphasis role="strong">44:</emphasis>169–186.</para>
          </listitem>
          <listitem id="ch0153s0000li0039" role="bibliographyEntry">
            <para>39.<emphasis role="strong">Weidner E.</emphasis> 1976. The microsporidian spore invasion tube. The ultrastructure, isolation, and characterization of the protein comprising the tube. <citetitle><emphasis>J Cell Biol</emphasis></citetitle> <emphasis role="strong">71:</emphasis>23–34.</para>
          </listitem>
          <listitem id="ch0153s0000li0040" role="bibliographyEntry">
            <para>40.<emphasis role="strong">Keohane EM, Weiss LM.</emphasis> 1999. The structure, function, and composition of the microsporidian polar tube, p 196–224. <citetitle><emphasis>In</emphasis></citetitle> Wittner M, Weiss LM (ed), <citetitle><emphasis>The Microsporidia and Microsporidiosis.</emphasis></citetitle> ASM Press, Washington, DC.</para>
          </listitem>
          <listitem id="ch0153s0000li0041" role="bibliographyEntry">
            <para>41.<emphasis role="strong">Docker MF, Kent ML, Hervio DM, Khattra JS, Weiss LM, Cali A, Devlin RH.</emphasis> 1997. Ribosomal DNA sequence of <citetitle><emphasis>Nucleospora salmonis</emphasis></citetitle> Hedrick, Groff and Baxa, 1991 (Microsporea:Enterocytozoonidae): implications for phylogeny and nomenclature. <citetitle><emphasis>J Eukaryot Microbiol</emphasis></citetitle> <emphasis role="strong">44:</emphasis>55–60.</para>
          </listitem>
          <listitem id="ch0153s0000li0042" role="bibliographyEntry">
            <para>42.<emphasis role="strong">Stentiford GD, Bateman KS, Longshaw M, Feist SW.</emphasis> 2007. <citetitle><emphasis>Enterospora canceri</emphasis></citetitle> n. gen., n. sp., intranuclear within the hepatopancreatocytes of the European edible crab <citetitle><emphasis>Cancer pagurus. Dis Aquat Organ</emphasis></citetitle> <emphasis role="strong">75:</emphasis>61–72.</para>
          </listitem>
          <listitem id="ch0153s0000li0043" role="bibliographyEntry">
            <para>43.<emphasis role="strong">Freeman MA, Sommerville C.</emphasis> 2009. <citetitle><emphasis>Desmozoon lepeophtherii</emphasis></citetitle> n. gen., n. sp., (Microsporidia: Enterocytozoonidae) infecting the salmon louse <citetitle><emphasis>Lepeophtheirus salmonis</emphasis></citetitle> (Copepoda: Caligidae). <citetitle><emphasis>Parasit Vectors</emphasis></citetitle> <emphasis role="strong">2:</emphasis>58–58.</para>
          </listitem>
          <listitem id="ch0153s0000li0044" role="bibliographyEntry">
            <para>44.<emphasis role="strong">Palenzuela O, Redondo MJ, Cali A, Takvorian PM, Alonso-Naveiro M, Alvarez-Pellitero P, Sitjà-Bobadilla A.</emphasis> 2014. A new intranuclear microsporidium, <citetitle><emphasis>Enterospora nucleophila</emphasis></citetitle> n. sp., causing an emaciative syndrome in a piscine host (<citetitle><emphasis>Sparus aurata</emphasis></citetitle>), prompts the redescription of the family Enterocytozoonidae. <citetitle><emphasis>Int J Parasitol</emphasis></citetitle> <emphasis role="strong">44:</emphasis>189–203.</para>
          </listitem>
          <listitem id="ch0153s0000li0045" role="bibliographyEntry">
            <para>45.<emphasis role="strong">Bigliardi E, Sacchi L.</emphasis> 2001. Cell biology and invasion of the microsporidia. <citetitle><emphasis>Microbes Infect</emphasis></citetitle> <emphasis role="strong">3:</emphasis>373–379.</para>
          </listitem>
          <listitem id="ch0153s0000li0046" role="bibliographyEntry">
            <para>46.<emphasis role="strong">Fries I, Paxton RJ, Tengö J, Slemenda SB, da Silva AJ, Pieniazek NJ.</emphasis> 1999. Morphological and molecular characterization of <citetitle><emphasis>Antonospora scoticae</emphasis></citetitle> n. gen., n. sp. (Protozoa, microsporidia) a parasite of the communal bee, <citetitle><emphasis>Andrena scotica</emphasis></citetitle> Perkins,1916 (Hymenoptera, andrenidae). <citetitle><emphasis>Eur J Protistol</emphasis></citetitle> <emphasis role="strong">35:</emphasis>183–193.</para>
          </listitem>
          <listitem id="ch0153s0000li0047" role="bibliographyEntry">
            <para>47.<emphasis role="strong">Bohne W, Ferguson DJ, Kohler K, Gross U.</emphasis> 2000. Developmental expression of a tandemly repeated, glycine- and serine-rich spore wall protein in the microsporidian pathogen <citetitle><emphasis>Encephalitozoon cuniculi. Infect Immun</emphasis></citetitle> <emphasis role="strong">68:</emphasis>2268–2275.</para>
          </listitem>
          <listitem id="ch0153s0000li0048" role="bibliographyEntry">
            <para>48.<emphasis role="strong">Yang D, Pan L, Chen Z, Du H, Luo B, Luo J, Pan G.</emphasis> 2018. The roles of microsporidia spore wall proteins in the spore wall formation and polar tube anchorage to spore wall during development and infection processes. <citetitle><emphasis>Exp Parasitol</emphasis></citetitle> <emphasis role="strong">187:</emphasis>93–100.</para>
          </listitem>
          <listitem id="ch0153s0000li0049" role="bibliographyEntry">
            <para>49.<emphasis role="strong">Beznoussenko GV, Dolgikh VV, Seliverstova EV, Semenov PB, Tokarev YS, Trucco A, Micaroni M, Di Giandomenico D, Auinger P, Senderskiy IV, Skarlato SO, Snigirevskaya ES, Komissarchik YY, Pavelka M, De Matteis MA, Luini A, Sokolova YY, Mironov AA.</emphasis> 2007. Analogs of the Golgi complex in microsporidia: structure and avesicular mechanisms of function. <citetitle><emphasis>J Cell Sci</emphasis></citetitle> <emphasis role="strong">120:</emphasis>1288–1298.</para>
          </listitem>
          <listitem id="ch0153s0000li0050" role="bibliographyEntry">
            <para>50.<emphasis role="strong">Vavra J.</emphasis> 1976. Structure of the microsporidia, p 1–85. <citetitle><emphasis>In</emphasis></citetitle> Bulla LA Jr, Cheng TC (ed), <citetitle><emphasis>Comparative Pathobiology</emphasis></citetitle>, vol 1. Plenum Press, New York, NY.</para>
          </listitem>
          <listitem id="ch0153s0000li0051" role="bibliographyEntry">
            <para>51.<emphasis role="strong">Williams BA, Hirt RP, Lucocq JM, Embley TM.</emphasis> 2002. A mitochondrial remnant in the microsporidian <citetitle><emphasis>Trachipleistophora hominis. Nature</emphasis></citetitle> <emphasis role="strong">418:</emphasis>865–869.</para>
          </listitem>
          <listitem id="ch0153s0000li0052" role="bibliographyEntry">
            <para>52.<emphasis role="strong">Curgy JJ, Vavra J, Vivares C.</emphasis> 1980. Presence of ribosomal RNAs with prokaryotic properties in Microsporidia, eukaryotic organisms. <citetitle><emphasis>Biol Cell</emphasis></citetitle> <emphasis role="strong">38:</emphasis>49–52.</para>
          </listitem>
          <listitem id="ch0153s0000li0053" role="bibliographyEntry">
            <para>53.<emphasis role="strong">Vossbrinck CR, Woese CR.</emphasis> 1986. Eukaryotic ribosomes that lack a 5.8S RNA. <citetitle><emphasis>Nature</emphasis></citetitle> <emphasis role="strong">320:</emphasis>287–288.</para>
          </listitem>
          <listitem id="ch0153s0000li0054" role="bibliographyEntry">
            <para>54.<emphasis role="strong">Weiss LM, Vossbrinck CR.</emphasis> 1999. Molecular biology, molecular phylogeny, and molecular diagnostic approaches to the microsporidia, p 129–171. <citetitle><emphasis>In</emphasis></citetitle> Wittner M, Weiss LM (ed), <citetitle><emphasis>The Microsporidia and Microsporidiosis.</emphasis></citetitle> ASM Press, Washington, DC.</para>
          </listitem>
          <listitem id="ch0153s0000li0055" role="bibliographyEntry">
            <para>55.<emphasis role="strong">Katinka MD, Duprat S, Cornillot E, Méténier G, Thomarat F, Prensier G, Barbe V, Peyretaillade E, Brottier P, Wincker P, Delbac F, El Alaoui H, Peyret P, Saurin W, Gouy M, Weissenbach J, Vivarès CP.</emphasis> 2001. Genome sequence and gene compaction of the eukaryote parasite <citetitle><emphasis>Encephalitozoon cuniculi. Nature</emphasis></citetitle> <emphasis role="strong">414:</emphasis>450–453.</para>
          </listitem>
          <listitem id="ch0153s0000li0056" role="bibliographyEntry">
            <para>56.<emphasis role="strong">Nakjang S, Williams TA, Heinz E, Watson AK, Foster PG, Sendra KM, Heaps SE, Hirt RP, Martin Embley T.</emphasis> 2013. Reduction and expansion in microsporidian genome evolution: new insights from comparative genomics. <citetitle><emphasis>Genome Biol Evol</emphasis></citetitle> <emphasis role="strong">5:</emphasis>2285–2303.</para>
          </listitem>
          <listitem id="ch0153s0000li0057" role="bibliographyEntry">
            <para>57.<emphasis role="strong">Wadi L, Reinke AW.</emphasis> 2020. Evolution of microsporidia: an extremely successful group of eukaryotic intracellular parasites. <citetitle><emphasis>PLoS Pathog</emphasis></citetitle> <emphasis role="strong">16:</emphasis>e1008276.</para>
          </listitem>
          <listitem id="ch0153s0000li0058" role="bibliographyEntry">
            <para>58.<emphasis role="strong">Williams BA, Lee RC, Becnel JJ, Weiss LM, Fast NM, Keeling PJ.</emphasis> 2008. Genome sequence surveys of <citetitle><emphasis>Brachiola algerae</emphasis></citetitle> and <citetitle><emphasis>Edhazardia aedis</emphasis></citetitle> reveal microsporidia with low gene densities. <citetitle><emphasis>BMC Genomics</emphasis></citetitle> <emphasis role="strong">9:</emphasis>200.</para>
          </listitem>
          <listitem id="ch0153s0000li0059" role="bibliographyEntry">
            <para>59.<emphasis role="strong">Vossbrinck CR, Maddox JV, Friedman S, Debrunner-Vossbrinck BA, Woese CR.</emphasis> 1987. Ribosomal RNA sequence suggests microsporidia are extremely ancient eukaryotes. <citetitle><emphasis>Nature</emphasis></citetitle> <emphasis role="strong">326:</emphasis>411–414.</para>
          </listitem>
          <listitem id="ch0153s0000li0060" role="bibliographyEntry">
            <para>60.<emphasis role="strong">Hirt RP, Healy B, Vossbrinck CR, Canning EU, Embley TM.</emphasis> 1997. A mitochondrial Hsp70 orthologue in <citetitle><emphasis>Vairimorpha necatrix</emphasis></citetitle>: molecular evidence that microsporidia once contained mitochondria. <citetitle><emphasis>Curr Biol</emphasis></citetitle> <emphasis role="strong">7:</emphasis>995–998.</para>
          </listitem>
          <listitem id="ch0153s0000li0061" role="bibliographyEntry">
            <para>61.<emphasis role="strong">Weiss LM.</emphasis> 2020. Microsporidiosis, p 825–831. <citetitle><emphasis>In</emphasis></citetitle> Ryan ET, Hill DR, Solomon T, Aronson NE, Endy TP (ed), <citetitle><emphasis>Hunter’s Tropical Medicine and Emerging Infectious Diseases.</emphasis></citetitle> Elsevier, Philadelphia, PA.</para>
          </listitem>
          <listitem id="ch0153s0000li0062" role="bibliographyEntry">
            <para>62.<emphasis role="strong">Hibbett DS, et al.</emphasis> 2007. A higher-level phylogenetic classification of the Fungi. <citetitle><emphasis>Mycol Res</emphasis></citetitle> <emphasis role="strong">111:</emphasis>509–547.</para>
          </listitem>
          <listitem id="ch0153s0000li0063" role="bibliographyEntry">
            <para>63.<emphasis role="strong">James TY, et al.</emphasis> 2006. Reconstructing the early evolution of Fungi using a six-gene phylogeny. <citetitle><emphasis>Nature</emphasis></citetitle> <emphasis role="strong">443:</emphasis>818–822.</para>
          </listitem>
          <listitem id="ch0153s0000li0064" role="bibliographyEntry">
            <para>64.<emphasis role="strong">Lee SC, Corradi N, Byrnes EJ III, Torres-Martinez S, Dietrich FS, Keeling PJ, Heitman J.</emphasis> 2008. Microsporidia evolved from ancestral sexual fungi. <citetitle><emphasis>Curr Biol</emphasis></citetitle> <emphasis role="strong">18:</emphasis>1675–1679.</para>
          </listitem>
          <listitem id="ch0153s0000li0065" role="bibliographyEntry">
            <para>65.<emphasis role="strong">Jones MD, Forn I, Gadelha C, Egan MJ, Bass D, Massana R, Richards TA.</emphasis> 2011. Discovery of novel intermediate forms redefines the fungal tree of life. <citetitle><emphasis>Nature</emphasis></citetitle> <emphasis role="strong">474:</emphasis>200–203.</para>
          </listitem>
          <listitem id="ch0153s0000li0066" role="bibliographyEntry">
            <para>66.<emphasis role="strong">Jones MD, Richards TA, Hawksworth DL, Bass D.</emphasis> 2011. Validation and justification of the phylum name Cryptomycota phyl. nov. <citetitle><emphasis>IMA Fungus</emphasis></citetitle> <emphasis role="strong">2:</emphasis>173–175.</para>
          </listitem>
          <listitem id="ch0153s0000li0067" role="bibliographyEntry">
            <para>67.<emphasis role="strong">James TY, Pelin A, Bonen L, Ahrendt S, Sain D, Corradi N, Stajich JE.</emphasis> 2013. Shared signatures of parasitism and phylogenomics unite Cryptomycota and microsporidia. <citetitle><emphasis>Curr Biol</emphasis></citetitle> <emphasis role="strong">23:</emphasis>1548–1553.</para>
          </listitem>
          <listitem id="ch0153s0000li0068" role="bibliographyEntry">
            <para>68.<emphasis role="strong">Corsaro D, Michel R, Walochnik J, Venditti D, Müller KD, Hauröder B, Wylezich C.</emphasis> 2016. Molecular identification of <citetitle><emphasis>Nucleophaga terricolae</emphasis></citetitle> sp. nov. (Rozellomycota), and new insights on the origin of the microsporidia. <citetitle><emphasis>Parasitol Res</emphasis></citetitle> <emphasis role="strong">115:</emphasis>3003–3011.</para>
          </listitem>
          <listitem id="ch0153s0000li0069" role="bibliographyEntry">
            <para>69.<emphasis role="strong">Weiss LM, Vossbrinck CR.</emphasis> 1998. Microsporidiosis: molecular and diagnostic aspects. <citetitle><emphasis>Adv Parasitol</emphasis></citetitle> <emphasis role="strong">40:</emphasis>351–395.</para>
          </listitem>
          <listitem id="ch0153s0000li0070" role="bibliographyEntry">
            <anchor id="ch0153s0000a0072"/>
            <para>70.<emphasis role="strong">Matos O, Lobo ML, Xiao L.</emphasis> 2012. Epidemiology of <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> infection in humans. <citetitle><emphasis>J Parasitol Res</emphasis></citetitle> <emphasis role="strong">2012:</emphasis>981424–981424.</para>
          </listitem>
          <listitem id="ch0153s0000li0071" role="bibliographyEntry">
            <para>71.<emphasis role="strong">Tuzet O, Maurand J, Fize JA, Michel R, Fenwick B.</emphasis> 1971. Proposition d’un nouveau cadre systematique pour les genres de Microsporidies. <citetitle><emphasis>C R Acad Sci Paris</emphasis></citetitle> <emphasis role="strong">272:</emphasis>1268–1271.</para>
          </listitem>
          <listitem id="ch0153s0000li0072" role="bibliographyEntry">
            <para>72.<emphasis role="strong">Larsson JIR.</emphasis> 1988. Identification of microsporidian genera—a guide with comments on the taxonomy. <citetitle><emphasis>Arch Protistenkd</emphasis></citetitle> <emphasis role="strong">136:</emphasis>1–37.</para>
          </listitem>
          <listitem id="ch0153s0000li0073" role="bibliographyEntry">
            <para>73.<emphasis role="strong">Issi IV.</emphasis> 1986. Microsporidia as a phylum of parasitic protozoa. <citetitle><emphasis>Protozoology</emphasis></citetitle> <emphasis role="strong">10:</emphasis>6–135. (In Russian.)</para>
          </listitem>
          <listitem id="ch0153s0000li0074" role="bibliographyEntry">
            <para>74.<emphasis role="strong">Weiser J.</emphasis> 1977. A proposal of the basis for microsporidian taxonomy. <citetitle><emphasis>Proc Int Congr Protozool</emphasis></citetitle> <emphasis role="strong">5:</emphasis>267.</para>
          </listitem>
          <listitem id="ch0153s0000li0075" role="bibliographyEntry">
            <para>75.<emphasis role="strong">Sprague V, Becnel JJ, Hazard EI.</emphasis> 1992. Taxonomy of phylum Microspora. <citetitle><emphasis>Crit Rev Microbiol</emphasis></citetitle> <emphasis role="strong">18:</emphasis>285–395.</para>
          </listitem>
          <listitem id="ch0153s0000li0076" role="bibliographyEntry">
            <para>76.<emphasis role="strong">Margileth AM, Strano AJ, Chandra R, Neafie R, Blum M, McCully RM.</emphasis> 1973. Disseminated nosematosis in an immunologically compromised infant. <citetitle><emphasis>Arch Pathol</emphasis></citetitle> <emphasis role="strong">95:</emphasis>145–150.</para>
          </listitem>
          <listitem id="ch0153s0000li0077" role="bibliographyEntry">
            <para>77.<emphasis role="strong">Cali A, Weiss LM, Takvorian PM.</emphasis> 2004. An analysis of the microsporidian genus <citetitle><emphasis>Brachiola</emphasis></citetitle>, with comparisons of human and insect isolates of <citetitle><emphasis>Brachiola algerae. J Eukaryot Microbiol</emphasis></citetitle> <emphasis role="strong">51:</emphasis>678–685.</para>
          </listitem>
          <listitem id="ch0153s0000li0078" role="bibliographyEntry">
            <para>78.<emphasis role="strong">Didier ES, Vossbrinck CR, Baker MD, Rogers LB, Bertucci DC, Shadduck JA.</emphasis> 1995. Identification and characterization of three <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> strains. <citetitle><emphasis>Parasitology</emphasis></citetitle> <emphasis role="strong">111:</emphasis>411–421.</para>
          </listitem>
          <listitem id="ch0153s0000li0079" role="bibliographyEntry">
            <para>79.<emphasis role="strong">Hinney B, Sak B, Joachim A, Kvá</emphasis>č <emphasis role="strong">M.</emphasis> 2016. More than a rabbit’s tale—<citetitle><emphasis>Encephalitozoon</emphasis></citetitle> spp. in wild mammals and birds. <citetitle><emphasis>Int J Parasitol Parasites Wildl</emphasis></citetitle> <emphasis role="strong">5:</emphasis>76–87.</para>
          </listitem>
          <listitem id="ch0153s0000li0080" role="bibliographyEntry">
            <para>80.<emphasis role="strong">Santin-Duran M.</emphasis> 2015. <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle>, p 149–174. <citetitle><emphasis>In</emphasis></citetitle> Xiao L, Ryan U, Feng Y (ed), <citetitle><emphasis>Biology of Foodborne Parasites.</emphasis></citetitle> CRC Press, Boca Raton, FL.</para>
          </listitem>
          <listitem id="ch0153s0000li0081" role="bibliographyEntry">
            <para>81.<emphasis role="strong">Cali A, Meisler DM, Lowder CY, Lembach R, Ayers L, Takvorian PM, Rutherford I, Longworth DL, McMahon J, Bryan RT.</emphasis> 1991. Corneal microsporidioses: characterization and identification. <citetitle><emphasis>J Protozool</emphasis></citetitle> <emphasis role="strong">38:</emphasis>215S–217S.</para>
          </listitem>
          <listitem id="ch0153s0000li0082" role="bibliographyEntry">
            <para>82.<emphasis role="strong">Hollister WS, Canning EU, Weidner E, Field AS, Kench J, Marriott DJ.</emphasis> 1996. Development and ultrastructure of <citetitle><emphasis>Trachipleistophora hominis</emphasis></citetitle> n.g., n. sp. after in vitro isolation from an AIDS patient and inoculation into athymic mice. <citetitle><emphasis>Parasitology</emphasis></citetitle> <emphasis role="strong">112:</emphasis>143–154.</para>
          </listitem>
          <listitem id="ch0153s0000li0083" role="bibliographyEntry">
            <para>83.<emphasis role="strong">Vávra J, Yachnis AT, Shadduck JA, Orenstein JM.</emphasis> 1998. Microsporidia of the genus <citetitle><emphasis>Trachipleistophora</emphasis></citetitle>—causative agents of human microsporidiosis: description of <citetitle><emphasis>Trachipleistophora anthropophthera</emphasis></citetitle> n. sp. (Protozoa: Microsporidia). <citetitle><emphasis>J Eukaryot Microbiol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>273–283.</para>
          </listitem>
          <listitem id="ch0153s0000li0084" role="bibliographyEntry">
            <para>84.<emphasis role="strong">Connors WJ, Carson JA, Chan WW, Parkins MD.</emphasis> 2017. Albendazole-responsive disseminated <citetitle><emphasis>Tubulinosema acridophagus</emphasis></citetitle> in a patient with chronic lymphocytic leukaemia. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">23:</emphasis>684–685.</para>
          </listitem>
          <listitem id="ch0153s0000li0085" role="bibliographyEntry">
            <para>85.<emphasis role="strong">Deplazes P, Mathis A, van Saanen M, Iten A, Keller R, Tanner I, Glauser MP, Weber R, Canning EU.</emphasis> 1998. Dual microsporidial infection due to <citetitle><emphasis>Vittaforma corneae</emphasis></citetitle> and <citetitle><emphasis>Encephalitozoon hellem</emphasis></citetitle> in a patient with AIDS. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">27:</emphasis>1521–1524.</para>
          </listitem>
          <listitem id="ch0153s0000li0086" role="bibliographyEntry">
            <para>86.<emphasis role="strong">Canning EU.</emphasis> 1993. Microsporidia, p 299–370. <citetitle><emphasis>In</emphasis></citetitle> Kreier JP (ed), <citetitle><emphasis>Parasitic Protozoa</emphasis></citetitle>, vol 6. Academic Press, London, United Kingdom.</para>
          </listitem>
          <listitem id="ch0153s0000li0087" role="bibliographyEntry">
            <para>87.<emphasis role="strong">Weyrich LS, Duchene S, Soubrier J, Arriola L, Llamas B, Breen J, Morris AG, Alt KW, Caramelli D, Dresely V, Farrell M, Farrer AG, Francken M, Gully N, Haak W, Hardy K, Harvati K, Held P, Holmes EC, Kaidonis J, Lalueza-Fox C, de la Rasilla M, Rosas A, Semal P, Soltysiak A, Townsend G, Usai D, Wahl J, Huson DH, Dobney K, Cooper A.</emphasis> 2017. Neanderthal behaviour, diet, and disease inferred from ancient DNA in dental calculus. <citetitle><emphasis>Nature</emphasis></citetitle> <emphasis role="strong">544:</emphasis>357–361.</para>
          </listitem>
          <listitem id="ch0153s0000li0088" role="bibliographyEntry">
            <para>88.<emphasis role="strong">Wang ZD, Liu Q, Liu HH, Li S, Zhang L, Zhao YK, Zhu XQ.</emphasis> 2018. Prevalence of <citetitle><emphasis>Cryptosporidium</emphasis></citetitle>, microsporidia and Isospora infection in HIV-infected people: a global systematic review and meta-analysis. <citetitle><emphasis>Parasit Vectors</emphasis></citetitle> <emphasis role="strong">11:</emphasis>28.</para>
          </listitem>
          <listitem id="ch0153s0000li0089" role="bibliographyEntry">
            <para>89.<emphasis role="strong">Pavie J, Menotti J, Porcher R, Donay JL, Gallien S, Sarfati C, Derouin F, Molina JM.</emphasis> 2012. Prevalence of opportunistic intestinal parasitic infections among HIV-infected patients with low CD4 cells counts in France in the combination antiretroviral therapy era. <citetitle><emphasis>Int J Infect Dis</emphasis></citetitle> <emphasis role="strong">16:</emphasis>e677–e679.</para>
          </listitem>
          <listitem id="ch0153s0000li0090" role="bibliographyEntry">
            <para>90.<emphasis role="strong">Logan C, Beadsworth MB, Beeching NJ.</emphasis> 2016. HIV and diarrhoea: what is new? <citetitle><emphasis>Curr Opin Infect Dis</emphasis></citetitle> <emphasis role="strong">29:</emphasis>486–494.</para>
          </listitem>
          <listitem id="ch0153s0000li0091" role="bibliographyEntry">
            <para>91.<emphasis role="strong">Greigert V, Pfaff AW, Abou-Bacar A, Candolfi E, Brunet J.</emphasis> 2018. Intestinal microsporidiosis in Strasbourg from 2014 to 2016: emergence of an <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> genotype of Asian origin. <citetitle><emphasis>Emerg Microbes Infect</emphasis></citetitle> <emphasis role="strong">7:</emphasis>97.</para>
          </listitem>
          <listitem id="ch0153s0000li0092" role="bibliographyEntry">
            <para>92.<emphasis role="strong">Wang L, Zhang H, Zhao X, Zhang L, Zhang G, Guo M, Liu L, Feng Y, Xiao L.</emphasis> 2013. Zoonotic <citetitle><emphasis>Cryptosporidium</emphasis></citetitle> species and <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> genotypes in HIV-positive patients on antiretroviral therapy. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">51:</emphasis>557–563.</para>
          </listitem>
          <listitem id="ch0153s0000li0093" role="bibliographyEntry">
            <para>93.<emphasis role="strong">Sarfati C, Liguory O, Derouin F.</emphasis> 2001. [Microsporidiosis]. <citetitle><emphasis>Presse Med</emphasis></citetitle> <emphasis role="strong">30:</emphasis>143–147.</para>
          </listitem>
          <listitem id="ch0153s0000li0094" role="bibliographyEntry">
            <para>94.<emphasis role="strong">Hennequin C, Pialoux G, Bouree P, Dupont B.</emphasis> 1992. Microsporidiosis and acquired immunodeficiency syndrome (AIDS). <citetitle><emphasis>Med Mal Infect</emphasis></citetitle> <emphasis role="strong">22:</emphasis>487–492.</para>
          </listitem>
          <listitem id="ch0153s0000li0095" role="bibliographyEntry">
            <para>95.<emphasis role="strong">Halánová M, Valenčáková A, Jarčuška P, Halán M, Danišová O, Babinská I, Dedinská K, Čisláková L.</emphasis> 2019. Screening of opportunistic <citetitle><emphasis>Encephalitozoon intestinalis</emphasis></citetitle> and <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> in immunocompromised patients in Slovakia. <citetitle><emphasis>Cent Eur J Public Health</emphasis></citetitle> <emphasis role="strong">27:</emphasis>330–334.</para>
          </listitem>
          <listitem id="ch0153s0000li0096" role="bibliographyEntry">
            <para>96.<emphasis role="strong">Hamamcı B, Çetinkaya Ü, Berk V, Kaynar L, Kuk S, Yazar S.</emphasis> 2015. [Prevalence of <citetitle><emphasis>Encephalitozoon intestinalis</emphasis></citetitle> and <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> in cancer patients under chemotherapy]. <citetitle><emphasis>Mikrobiyol Bul</emphasis></citetitle> <emphasis role="strong">49:</emphasis>105–113.</para>
          </listitem>
          <listitem id="ch0153s0000li0097" role="bibliographyEntry">
            <para>97.<emphasis role="strong">Chandramathi S, Suresh K, Anita ZB, Kuppusamy UR.</emphasis> 2012. Infections of <citetitle><emphasis>Blastocystis hominis</emphasis></citetitle> and microsporidia in cancer patients: are they opportunistic? <citetitle><emphasis>Trans R Soc Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">106:</emphasis>267–269.</para>
          </listitem>
          <listitem id="ch0153s0000li0098" role="bibliographyEntry">
            <para>98.<emphasis role="strong">Lono AR, Kumar S, Chye TT.</emphasis> 2008. Incidence of microsporidia in cancer patients. <citetitle><emphasis>J Gastrointest Cancer</emphasis></citetitle> <emphasis role="strong">39:</emphasis>124–129.</para>
          </listitem>
          <listitem id="ch0153s0000li0099" role="bibliographyEntry">
            <para>99.<emphasis role="strong">Sing A, Tybus K, Heesemann J, Mathis A.</emphasis> 2001. Molecular diagnosis of an <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> human genotype C infection in a moderately immunosuppressed human immunodeficiency virus seronegative liver-transplant recipient with severe chronic diarrhea. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">39:</emphasis>2371–2372.</para>
          </listitem>
          <listitem id="ch0153s0000li0100" role="bibliographyEntry">
            <para>100.<emphasis role="strong">Mohindra AR, Lee MW, Visvesvara G, Moura H, Parasuraman R, Leitch GJ, Xiao L, Yee J, del Busto R, Mohindra AR, Lee MW, Visvesvara G, Moura H, Parasuraman R, Leitch GJ, Xiao L, Yee J, Del Busto R.</emphasis> 2002. Disseminated microsporidiosis in a renal transplant recipient. <citetitle><emphasis>Transpl Infect Dis</emphasis></citetitle> <emphasis role="strong">4:</emphasis>102–107.</para>
          </listitem>
          <listitem id="ch0153s0000li0101" role="bibliographyEntry">
            <para>101.<emphasis role="strong">Nagpal A, Pritt BS, Lorenz EC, Amer H, Nasr SH, Cornell LD, Iqbal S, Wilhelm MP.</emphasis> 2013. Disseminated microsporidiosis in a renal transplant recipient: case report and review of the literature. <citetitle><emphasis>Transpl Infect Dis</emphasis></citetitle> <emphasis role="strong">15:</emphasis>526–532.</para>
          </listitem>
          <listitem id="ch0153s0000li0102" role="bibliographyEntry">
            <para>102.<emphasis role="strong">George B, Coates T, McDonald S, Russ G, Cherian S, Nolan J, Brealey J.</emphasis> 2012. Disseminated microsporidiosis with <citetitle><emphasis>Encephalitozoon</emphasis></citetitle> species in a renal transplant recipient. <citetitle><emphasis>Nephrology (Carlton)</emphasis></citetitle> <emphasis role="strong">17</emphasis>(Suppl 1)<emphasis role="strong">:</emphasis>5–8.</para>
          </listitem>
          <listitem id="ch0153s0000li0103" role="bibliographyEntry">
            <para>103.<emphasis role="strong">Doshi N, Thet Z, Han T, Martin J.</emphasis> 2019. A case of intestinal microsporidiosis in a renal transplant recipient. <citetitle><emphasis>J Med Cases</emphasis></citetitle> <emphasis role="strong">10:</emphasis>229–233.</para>
          </listitem>
          <listitem id="ch0153s0000li0104" role="bibliographyEntry">
            <para>104.<emphasis role="strong">Brown M, Longano A, Dendle C, Polkinghorne KR, Kanellis J.</emphasis> 2018. Confirmed microsporidial graft infection in a HIV-negative renal transplant recipient: a case report and review of the literature. <citetitle><emphasis>Transpl Infect Dis</emphasis></citetitle> <emphasis role="strong">20:</emphasis>e12888.</para>
          </listitem>
          <listitem id="ch0153s0000li0105" role="bibliographyEntry">
            <para>105.<emphasis role="strong">Kicia M, Wesolowska M, Kopacz Z, Jakuszko K, Sak B, Květonová D, Krajewska M, Kváč M.</emphasis> 2016. Prevalence and molecular characteristics of urinary and intestinal microsporidia infections in renal transplant recipients. <citetitle><emphasis>Clin Microbiol Infect</emphasis></citetitle> <emphasis role="strong">22:</emphasis>462.e5–462.e9.</para>
          </listitem>
          <listitem id="ch0153s0000li0106" role="bibliographyEntry">
            <para>106.<emphasis role="strong">Shah S, Jacob SS, Mani R, Parameswaran A, Kumar S, Annigeri RA, Mahesh R, Uppuluri R.</emphasis> 2020. Renal microsporidiosis in pediatric bone marrow transplant recipients: a case series. <citetitle><emphasis>Turk Patoloji Derg</emphasis></citetitle> <emphasis role="strong">36:</emphasis>68–72.</para>
          </listitem>
          <listitem id="ch0153s0000li0107" role="bibliographyEntry">
            <para>107.<emphasis role="strong">Hocevar SN, Paddock CD, Spak CW, Rosenblatt R, Diaz-Luna H, Castillo I, Luna S, Friedman GC, Antony S, Stoddard RA, Tiller RV, Peterson T, Blau DM, Sriram RR, da Silva A, de Almeida M, Benedict T, Goldsmith CS, Zaki SR, Visvesvara GS, Kuehnert MJ, Microsporidia Transplant Transmission Investigation Team.</emphasis> 2014. Microsporidiosis acquired through solid organ transplantation: a public health investigation. <citetitle><emphasis>Ann Intern Med</emphasis></citetitle> <emphasis role="strong">160:</emphasis>213–220.</para>
          </listitem>
          <listitem id="ch0153s0000li0108" role="bibliographyEntry">
            <anchor id="ch0153s0000a0073"/>
            <para>108.<emphasis role="strong">Smith RM, Muehlenbachs A, Schaenmann J, Baxi S, Koo S, Blau D, Chin-Hong P, Thorner AR, Kuehnert MJ, Wheeler K, Liakos A, Jackson JW, Benedict T, da Silva AJ, Ritter JM, Rollin D, Metcalfe M, Goldsmith CS, Visvesvara GS, Basavaraju SV, Zaki S.</emphasis> 2017. Three cases of neurologic syndrome caused by donor-derived microsporidiosis. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">23:</emphasis>387–395.</para>
          </listitem>
          <listitem id="ch0153s0000li0109" role="bibliographyEntry">
            <para>109.<emphasis role="strong">Ladapo TA, Nourse P, Pillay K, Frean J, Birkhead M, Poonsamy B, Gajjar P.</emphasis> 2014. Microsporidiosis in pediatric renal transplant patients in Cape Town, South Africa: two case reports. <citetitle><emphasis>Pediatr Transplant</emphasis></citetitle> <emphasis role="strong">18:</emphasis>E220–E226.</para>
          </listitem>
          <listitem id="ch0153s0000li0110" role="bibliographyEntry">
            <para>110.<emphasis role="strong">Lores B, López-Miragaya I, Arias C, Fenoy S, Torres J, del Aguila C.</emphasis> 2002. Intestinal microsporidiosis due to <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> in elderly human immunodeficiency virus-negative patients from Vigo, Spain. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">34:</emphasis>918–921.</para>
          </listitem>
          <listitem id="ch0153s0000li0111" role="bibliographyEntry">
            <para>111.<emphasis role="strong">Aoun K, Barbouche R, Bouratbine A, Béjaoui M, Dellagi K, Ben Ismail R.</emphasis> 1997. [Intestinal microsporida infections in children with primary immunologic deficiencies]. <citetitle><emphasis>Parasite</emphasis></citetitle> <emphasis role="strong">4:</emphasis>386–387.</para>
          </listitem>
          <listitem id="ch0153s0000li0112" role="bibliographyEntry">
            <para>112.<emphasis role="strong">Didier ES, Stovall ME, Green LC, Brindley PJ, Sestak K, Didier PJ.</emphasis> 2004. Epidemiology of microsporidiosis: sources and modes of transmission. <citetitle><emphasis>Vet Parasitol</emphasis></citetitle> <emphasis role="strong">126:</emphasis>145–166.</para>
          </listitem>
          <listitem id="ch0153s0000li0113" role="bibliographyEntry">
            <para>113.<emphasis role="strong">Shahrul Anuar T, M Al-Mekhlafi H, Md Salleh F, Moktar N.</emphasis> 2013. New insights of microsporidial infection among asymptomatic aboriginal population in Malaysia. <citetitle><emphasis>PLoS One</emphasis></citetitle> <emphasis role="strong">8:</emphasis>e71870–e71870.</para>
          </listitem>
          <listitem id="ch0153s0000li0114" role="bibliographyEntry">
            <para>114.<emphasis role="strong">Mumcuoglu I, Cetin F, Dogruman Al F, Oguz I, Aksu N.</emphasis> 2016. Prevalence of microsporidia in healthy individuals and immunocompetent patients with acute and chronic diarrhea. <citetitle><emphasis>Infect Dis (Lond)</emphasis></citetitle> <emphasis role="strong">48:</emphasis>133–137.</para>
          </listitem>
          <listitem id="ch0153s0000li0115" role="bibliographyEntry">
            <para>115.<emphasis role="strong">Sak B, Kváč M, Kučerová Z, Květoňová D, Saková K.</emphasis> 2011. Latent microsporidial infection in immunocompetent individuals—a longitudinal study. <citetitle><emphasis>PLoS Negl Trop Dis</emphasis></citetitle> <emphasis role="strong">5:</emphasis>e1162.</para>
          </listitem>
          <listitem id="ch0153s0000li0116" role="bibliographyEntry">
            <para>116.<emphasis role="strong">Das S, Sharma S, Sahu SK, Nayak SS, Kar S.</emphasis> 2012. Diagnosis, clinical features and treatment outcome of microsporidial keratoconjunctivitis. <citetitle><emphasis>Br J Ophthalmol</emphasis></citetitle> <emphasis role="strong">96:</emphasis>793–795.</para>
          </listitem>
          <listitem id="ch0153s0000li0117" role="bibliographyEntry">
            <para>117.<emphasis role="strong">Loh RS, Chan CM, Ti SE, Lim L, Chan KS, Tan DT.</emphasis> 2009. Emerging prevalence of microsporidial keratitis in Singapore: epidemiology, clinical features, and management. <citetitle><emphasis>Ophthalmology</emphasis></citetitle> <emphasis role="strong">116:</emphasis>2348–2353.</para>
          </listitem>
          <listitem id="ch0153s0000li0118" role="bibliographyEntry">
            <para>118.<emphasis role="strong">Arnalich-Montiel F, de-Arriba-Palomero P, de Dompablo E, Carrillo-Gijon R, Lopez-Velez R, Lorenzo-Morales J.</emphasis> 2020. <citetitle><emphasis>Vittaforma corneae</emphasis></citetitle> keratoconjunctivitis: an emerging pathology among travelers returning from Southeast Asia. <citetitle><emphasis>Arch Soc Esp Oftalmol Engl Ed</emphasis></citetitle> <emphasis role="strong">95:</emphasis>569–572.</para>
          </listitem>
          <listitem id="ch0153s0000li0119" role="bibliographyEntry">
            <para>119.<emphasis role="strong">Izquierdo F, Castro Hermida JA, Fenoy S, Mezo M, González-Warleta M, del Aguila C.</emphasis> 2011. Detection of microsporidia in drinking water, wastewater and recreational rivers. <citetitle><emphasis>Water Res</emphasis></citetitle> <emphasis role="strong">45:</emphasis>4837–4843.</para>
          </listitem>
          <listitem id="ch0153s0000li0120" role="bibliographyEntry">
            <para>120.<emphasis role="strong">Jiang W, Roellig DM, Li N, Wang L, Guo Y, Feng Y, Xiao L.</emphasis> 2020. Contribution of hospitals to the occurrence of enteric protists in urban wastewater. <citetitle><emphasis>Parasitol Res</emphasis></citetitle> <emphasis role="strong">119:</emphasis>3033–3040.</para>
          </listitem>
          <listitem id="ch0153s0000li0121" role="bibliographyEntry">
            <para>121.<emphasis role="strong">Dowd SE, Gerba CP, Pepper IL.</emphasis> 1998. Confirmation of the human-pathogenic microsporidia <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle>, <citetitle><emphasis>Encephalitozoon intestinalis</emphasis></citetitle>, and <citetitle><emphasis>Vittaforma corneae</emphasis></citetitle> in water. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">64:</emphasis>3332–3335.</para>
          </listitem>
          <listitem id="ch0153s0000li0122" role="bibliographyEntry">
            <para>122.<emphasis role="strong">Dowd SE, John D, Eliopolus J, Gerba CP, Naranjo J, Klein R, López B, de Mejía M, Mendoza CE, Pepper IL.</emphasis> 2003. Confirmed detection of <citetitle><emphasis>Cyclospora cayetanesis, Encephalitozoon intestinalis</emphasis></citetitle> and <citetitle><emphasis>Cryptosporidium parvum</emphasis></citetitle> in water used for drinking. <citetitle><emphasis>J Water Health</emphasis></citetitle> <emphasis role="strong">1:</emphasis>117–123.</para>
          </listitem>
          <listitem id="ch0153s0000li0123" role="bibliographyEntry">
            <para>123.<emphasis role="strong">Fan NW, Wu CC, Chen TL, Yu WK, Chen CP, Lee SM, Lin PY.</emphasis> 2012. Microsporidial keratitis in patients with hot springs exposure. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">50:</emphasis>414–418.</para>
          </listitem>
          <listitem id="ch0153s0000li0124" role="bibliographyEntry">
            <para>124.<emphasis role="strong">Goodgame R.</emphasis> 2003. Emerging causes of traveler’s diarrhea: <citetitle><emphasis>Cryptosporidium, Cyclospora, Isospora</emphasis></citetitle>, and microsporidia. <citetitle><emphasis>Curr Infect Dis Rep</emphasis></citetitle> <emphasis role="strong">5:</emphasis>66–73.</para>
          </listitem>
          <listitem id="ch0153s0000li0125" role="bibliographyEntry">
            <para>125.<emphasis role="strong">Tu EY, Joslin CE.</emphasis> 2012. Microsporidia and Acanthamoeba: the role of emerging corneal pathogens. <citetitle><emphasis>Eye (Lond)</emphasis></citetitle> <emphasis role="strong">26:</emphasis>222–227.</para>
          </listitem>
          <listitem id="ch0153s0000li0126" role="bibliographyEntry">
            <para>126.<emphasis role="strong">Wichro E, Hoelzl D, Krause R, Bertha G, Reinthaler F, Wenisch C.</emphasis> 2005. Microsporidiosis in travel-associated chronic diarrhea in immune-competent patients. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">73:</emphasis>285–287.</para>
          </listitem>
          <listitem id="ch0153s0000li0127" role="bibliographyEntry">
            <para>127.<emphasis role="strong">Theng J, Chan C, Ling ML, Tan D.</emphasis> 2001. Microsporidial keratoconjunctivitis in a healthy contact lens wearer without human immunodeficiency virus infection. <citetitle><emphasis>Ophthalmology</emphasis></citetitle> <emphasis role="strong">108:</emphasis>976–978.</para>
          </listitem>
          <listitem id="ch0153s0000li0128" role="bibliographyEntry">
            <para>128.<emphasis role="strong">Lam TS, Wong MH, Chuang SK.</emphasis> 2013. Microsporidial keratoconjunctivitis outbreak among athletes from Hong Kong who visited Singapore, 2012. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">19:</emphasis>516–517.</para>
          </listitem>
          <listitem id="ch0153s0000li0129" role="bibliographyEntry">
            <para>129.<emphasis role="strong">Schwartz DA, Visvesvara G, Weber R, Bryan RT.</emphasis> 1994. Male genital tract microsporidiosis and AIDS: prostatic abscess due to <citetitle><emphasis>Encephalitozoon hellem. J Eukaryot Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>61S.</para>
          </listitem>
          <listitem id="ch0153s0000li0130" role="bibliographyEntry">
            <para>130.<emphasis role="strong">Schwartz DA, Bryan RT, Hewan-Lowe KO, Visvesvara GS, Weber R, Cali A, Angritt P.</emphasis> 1992. Disseminated microsporidiosis (<citetitle><emphasis>Encephalitozoon hellem</emphasis></citetitle>) and acquired immunodeficiency syndrome. Autopsy evidence for respiratory acquisition. <citetitle><emphasis>Arch Pathol Lab Med</emphasis></citetitle> <emphasis role="strong">116:</emphasis>660–668.</para>
          </listitem>
          <listitem id="ch0153s0000li0131" role="bibliographyEntry">
            <para>131.<emphasis role="strong">Fuentealba IC, Mahoney NT, Shadduck JA, Harvill J, Wicher V, Wicher K.</emphasis> 1992. Hepatic lesions in rabbits infected with <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> administered per rectum. <citetitle><emphasis>Vet Pathol</emphasis></citetitle> <emphasis role="strong">29:</emphasis>536–540.</para>
          </listitem>
          <listitem id="ch0153s0000li0132" role="bibliographyEntry">
            <para>132.<emphasis role="strong">Bergquist R, Morfeldt-Månsson L, Pehrson PO, Petrini B, Wasserman J.</emphasis> 1984. Antibody against <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> in Swedish homosexual men. <citetitle><emphasis>Scand J Infect Dis</emphasis></citetitle> <emphasis role="strong">16:</emphasis>389–391.</para>
          </listitem>
          <listitem id="ch0153s0000li0133" role="bibliographyEntry">
            <para>133.<emphasis role="strong">Hutin YJ, Sombardier MN, Liguory O, Sarfati C, Derouin F, Modaï J, Molina JM.</emphasis> 1998. Risk factors for intestinal microsporidiosis in patients with human immunodeficiency virus infection: a case-control study. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">178:</emphasis>904–907.</para>
          </listitem>
          <listitem id="ch0153s0000li0134" role="bibliographyEntry">
            <para>134.<emphasis role="strong">Birthistle K, Moore P, Hay P.</emphasis> 1996. Microsporidia: a new sexually transmissable cause of urethritis. <citetitle><emphasis>Genitourin Med</emphasis></citetitle> <emphasis role="strong">72:</emphasis>445–445.</para>
          </listitem>
          <listitem id="ch0153s0000li0135" role="bibliographyEntry">
            <para>135.<emphasis role="strong">Stentiford GD, Becnel J, Weiss LM, Keeling PJ, Didier ES, Williams BP, Bjornson S, Kent ML, Freeman MA, Brown MJF, Troemel ER, Roesel K, Sokolova Y, Snowden KF, Solter L.</emphasis> 2016. Microsporidia: emergent pathogens in the global food chain. <citetitle><emphasis>Trends Parasitol</emphasis></citetitle> <emphasis role="strong">32:</emphasis>336–348.</para>
          </listitem>
          <listitem id="ch0153s0000li0136" role="bibliographyEntry">
            <para>136.<emphasis role="strong">Stentiford GD, Feist SW, Stone DM, Bateman KS, Dunn AM.</emphasis> 2013. Microsporidia: diverse, dynamic, and emergent pathogens in aquatic systems. <citetitle><emphasis>Trends Parasitol</emphasis></citetitle> <emphasis role="strong">29:</emphasis>567–578.</para>
          </listitem>
          <listitem id="ch0153s0000li0137" role="bibliographyEntry">
            <para>137.<emphasis role="strong">Calvo M, Carazo M, Arias ML, Chaves C, Monge R, Chinchilla M.</emphasis> 2004. [Prevalence of <citetitle><emphasis>Cyclospora sp., Cryptosporidium sp</emphasis></citetitle>., microsporidia and fecal coliform determination in fresh fruit and vegetables consumed in Costa Rica]. <citetitle><emphasis>Arch Latinoam Nutr</emphasis></citetitle> <emphasis role="strong">54:</emphasis>428–432.</para>
          </listitem>
          <listitem id="ch0153s0000li0138" role="bibliographyEntry">
            <para>138.<emphasis role="strong">Kváč M, Tomanová V, Samková E, Koubová J, Kotková M, Hlásková L, McEvoy J, Sak B.</emphasis> 2016. <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> in raw cow’s milk remains infectious after pasteurization. <citetitle><emphasis>Foodborne Pathog Dis</emphasis></citetitle> <emphasis role="strong">13:</emphasis>77–79.</para>
          </listitem>
          <listitem id="ch0153s0000li0139" role="bibliographyEntry">
            <para>139.<emphasis role="strong">Hunt RD, King NW, Foster HL.</emphasis> 1972. Encephalitozoonosis: evidence for vertical transmission. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">126:</emphasis>212–214.</para>
          </listitem>
          <listitem id="ch0153s0000li0140" role="bibliographyEntry">
            <para>140.<emphasis role="strong">McInnes EF, Stewart CG.</emphasis> 1991. The pathology of subclinical infection of <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> in canine dams producing pups with overt encephalitozoonosis. <citetitle><emphasis>J S Afr Vet Assoc</emphasis></citetitle> <emphasis role="strong">62:</emphasis>51–54.</para>
          </listitem>
          <listitem id="ch0153s0000li0141" role="bibliographyEntry">
            <para>141.<emphasis role="strong">Cama VA, Pearson J, Cabrera L, Pacheco L, Gilman R, Meyer S, Ortega Y, Xiao L.</emphasis> 2007. Transmission of <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> between a child and guinea pigs. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>2708–2710.</para>
          </listitem>
          <listitem id="ch0153s0000li0142" role="bibliographyEntry">
            <para>142.<emphasis role="strong">Deplazes P, Mathis A, Müller C, Weber R.</emphasis> 1996. Molecular epidemiology of <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> and first detection of <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> in faecal samples of pigs. <citetitle><emphasis>J Eukaryot Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>93S.</para>
          </listitem>
          <listitem id="ch0153s0000li0143" role="bibliographyEntry">
            <para>143.<emphasis role="strong">Deplazes P, Mathis A, Weber R.</emphasis> 2000. Epidemiology and zoonotic aspects of microsporidia of mammals and birds. <citetitle><emphasis>Contrib Microbiol</emphasis></citetitle> <emphasis role="strong">6:</emphasis>236–260.</para>
          </listitem>
          <listitem id="ch0153s0000li0144" role="bibliographyEntry">
            <para>144.<emphasis role="strong">Bart A, Wentink-Bonnema EM, Heddema ER, Buijs J, van Gool T.</emphasis> 2008. Frequent occurrence of human-associated microsporidia in fecal droppings of urban pigeons in Amsterdam, the Netherlands. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">74:</emphasis>7056–7058.</para>
          </listitem>
          <listitem id="ch0153s0000li0145" role="bibliographyEntry">
            <para>145.<emphasis role="strong">Bornay-Llinares FJ, da Silva AJ, Moura H, Schwartz DA, Visvesvara GS, Pieniazek NJ, Cruz-López A, Hernández-Jaúregui P, Guerrero J, Enriquez FJ.</emphasis> 1998. Immunologic, microscopic, and molecular evidence of <citetitle><emphasis>Encephalitozoon intestinalis</emphasis></citetitle> (<citetitle><emphasis>Septata intestinalis</emphasis></citetitle>) infection in mammals other than humans. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">178:</emphasis>820–826.</para>
          </listitem>
          <listitem id="ch0153s0000li0146" role="bibliographyEntry">
            <anchor id="ch0153s0000a0074"/>
            <para>146.<emphasis role="strong">Haro M, Izquierdo F, Henriques-Gil N, Andrés I, Alonso F, Fenoy S, del Águila C.</emphasis> 2005. First detection and genotyping of human-associated microsporidia in pigeons from urban parks. <citetitle><emphasis>Appl Environ Microbiol</emphasis></citetitle> <emphasis role="strong">71:</emphasis>3153–3157.</para>
          </listitem>
          <listitem id="ch0153s0000li0147" role="bibliographyEntry">
            <para>147.<emphasis role="strong">Black SS, Steinohrt LA, Bertucci DC, Rogers LB, Didier ES.</emphasis> 1997. <citetitle><emphasis>Encephalitozoon hellem</emphasis></citetitle> in budgerigars (<citetitle><emphasis>Melopsittacus undulatus</emphasis></citetitle>). <citetitle><emphasis>Vet Pathol</emphasis></citetitle> <emphasis role="strong">34:</emphasis>189–198.</para>
          </listitem>
          <listitem id="ch0153s0000li0148" role="bibliographyEntry">
            <para>148.<emphasis role="strong">Santín M, Fayer R.</emphasis> 2011. Microsporidiosis: <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> in domesticated and wild animals. <citetitle><emphasis>Res Vet Sci</emphasis></citetitle> <emphasis role="strong">90:</emphasis>363–371.</para>
          </listitem>
          <listitem id="ch0153s0000li0149" role="bibliographyEntry">
            <para>149.<emphasis role="strong">Li W, Cama V, Akinbo FO, Ganguly S, Kiulia NM, Zhang X, Xiao L.</emphasis> 2013. Multilocus sequence typing of <citetitle><emphasis>Enterocytozoon bieneusi:</emphasis></citetitle> lack of geographic segregation and existence of genetically isolated sub-populations. <citetitle><emphasis>Infect Genet Evol</emphasis></citetitle> <emphasis role="strong">14:</emphasis>111–119.</para>
          </listitem>
          <listitem id="ch0153s0000li0150" role="bibliographyEntry">
            <para>150.<emphasis role="strong">Yang J, Song M, Wan Q, Li Y, Lu Y, Jiang Y, Tao W, Li W.</emphasis> 2014. <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> genotypes in children in Northeast China and assessment of risk of zoonotic transmission. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">52:</emphasis>4363–4367.</para>
          </listitem>
          <listitem id="ch0153s0000li0151" role="bibliographyEntry">
            <para>151.<emphasis role="strong">Weiss LM.</emphasis> 2014. Clinical syndromes associated with microsporidiosis, p 371–401. <citetitle><emphasis>In</emphasis></citetitle> Weiss LM, Becnel JJ (ed), <citetitle><emphasis>Microsporidia: Pathogens of Opportunity.</emphasis></citetitle> John Wiley &amp; Sons, Chichester, United Kingdom.</para>
          </listitem>
          <listitem id="ch0153s0000li0152" role="bibliographyEntry">
            <para>152.<emphasis role="strong">Weber R, Bryan RT.</emphasis> 1994. Microsporidial infections in immunodeficient and immunocompetent patients. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">19:</emphasis>517–521.</para>
          </listitem>
          <listitem id="ch0153s0000li0153" role="bibliographyEntry">
            <para>153.<emphasis role="strong">Sak B, Brady D, Pelikánová M, Květoňová D, Rost M, Kostka M, Tolarová V, Hůzová Z, Kváč M.</emphasis> 2011. Unapparent microsporidial infection among immunocompetent humans in the Czech Republic. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">49:</emphasis>1064–1070.</para>
          </listitem>
          <listitem id="ch0153s0000li0154" role="bibliographyEntry">
            <para>154.<emphasis role="strong">Moretto MM, Khan IA, Weiss LM.</emphasis> 2012. Gastrointestinal cell mediated immunity and the microsporidia. <citetitle><emphasis>PLoS Pathog</emphasis></citetitle> <emphasis role="strong">8:</emphasis>e1002775.</para>
          </listitem>
          <listitem id="ch0153s0000li0155" role="bibliographyEntry">
            <para>155.<emphasis role="strong">Ghosh K, Weiss LM.</emphasis> 2012. T cell response and persistence of the microsporidia. <citetitle><emphasis>FEMS Microbiol Rev</emphasis></citetitle> <emphasis role="strong">36:</emphasis>748–760.</para>
          </listitem>
          <listitem id="ch0153s0000li0156" role="bibliographyEntry">
            <para>156.<emphasis role="strong">Szumowski SC, Troemel ER.</emphasis> 2015. Microsporidia-host interactions. <citetitle><emphasis>Curr Opin Microbiol</emphasis></citetitle> <emphasis role="strong">26:</emphasis>10–16.</para>
          </listitem>
          <listitem id="ch0153s0000li0157" role="bibliographyEntry">
            <para>157.<emphasis role="strong">Ambrosioni J, van Delden C, Krause KH, Bouchuiguir-Wafa C, Nagy M, Passweg J, Chalandon Y.</emphasis> 2010. Invasive microsporidiosis in allogeneic haematopoietic SCT recipients. <citetitle><emphasis>Bone Marrow Transplant</emphasis></citetitle> <emphasis role="strong">45:</emphasis>1249–1251.</para>
          </listitem>
          <listitem id="ch0153s0000li0158" role="bibliographyEntry">
            <para>158.<emphasis role="strong">Bukreyeva I, Angoulvant A, Bendib I, Gagnard JC, Bourhis JH, Dargère S, Bonhomme J, Thellier M, Gachot B, Wyplosz B.</emphasis> 2017. <citetitle><emphasis>Enterocytozoon bieneusi m</emphasis></citetitle>icrosporidiosis in stem cell transplant recipients treated with fumagillin. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">23:</emphasis>1039–1041.</para>
          </listitem>
          <listitem id="ch0153s0000li0159" role="bibliographyEntry">
            <para>159.<emphasis role="strong">Desoubeaux G, Caumont C, Passot C, Dartigeas C, Bailly E, Chandenier J, Duong TH.</emphasis> 2012. Two cases of opportunistic parasite infections in patients receiving alemtuzumab. <citetitle><emphasis>J Clin Pathol</emphasis></citetitle> <emphasis role="strong">65:</emphasis>92–95.</para>
          </listitem>
          <listitem id="ch0153s0000li0160" role="bibliographyEntry">
            <para>160.<emphasis role="strong">Aikawa NE, Twardowsky AO, Carvalho JF, Silva CA, Silva IL, Ribeiro AC, Saad CG, Moraes JC, Toledo RA, Bonfá E.</emphasis> 2011. Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs? <citetitle><emphasis>Clinics (São Paulo)</emphasis></citetitle> <emphasis role="strong">66:</emphasis>1171–1175.</para>
          </listitem>
          <listitem id="ch0153s0000li0161" role="bibliographyEntry">
            <para>161.<emphasis role="strong">Mor SM, Tumwine JK, Naumova EN, Ndeezi G, Tzipori S.</emphasis> 2009. Microsporidiosis and malnutrition in children with persistent diarrhea, Uganda. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">15:</emphasis>49–52.</para>
          </listitem>
          <listitem id="ch0153s0000li0162" role="bibliographyEntry">
            <para>162.<emphasis role="strong">Wright SG.</emphasis> 2012. Protozoan infections of the gastrointestinal tract. <citetitle><emphasis>Infect Dis Clin North Am</emphasis></citetitle> <emphasis role="strong">26:</emphasis>323–339.</para>
          </listitem>
          <listitem id="ch0153s0000li0163" role="bibliographyEntry">
            <para>163.<emphasis role="strong">Matsubayashi H, Koike T, Mikata I, Takei H, Hagiwara S.</emphasis> 1959. A case of <citetitle><emphasis>Encephalitozoon</emphasis></citetitle>-like body infection in man. <citetitle><emphasis>AMA Arch Pathol</emphasis></citetitle> <emphasis role="strong">67:</emphasis>181–187.</para>
          </listitem>
          <listitem id="ch0153s0000li0164" role="bibliographyEntry">
            <para>164.<emphasis role="strong">Bergquist NR, Stintzing G, Smedman L, Waller T, Andersson T.</emphasis> 1984. Diagnosis of encephalitozoonosis in man by serological tests. <citetitle><emphasis>Br Med J (Clin Res Ed)</emphasis></citetitle> <emphasis role="strong">288:</emphasis>902.</para>
          </listitem>
          <listitem id="ch0153s0000li0165" role="bibliographyEntry">
            <para>165.<emphasis role="strong">Mertens RB, Didier ES, Fishbein MC, Bertucci DC, Rogers LB, Orenstein JM.</emphasis> 1997. <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> microsporidiosis: infection of the brain, heart, kidneys, trachea, adrenal glands, and urinary bladder in a patient with AIDS. <citetitle><emphasis>Mod Pathol</emphasis></citetitle> <emphasis role="strong">10:</emphasis>68–77.</para>
          </listitem>
          <listitem id="ch0153s0000li0166" role="bibliographyEntry">
            <para>166.<emphasis role="strong">Okuyama H, Kanamori M, Watanabe M, Kumabe T, Tominaga T.</emphasis> 2008. [Multiple intracerebral enhanced lesions strongly suspected to be microsporidiosis. A case report]. <citetitle><emphasis>No Shinkei Geka</emphasis></citetitle> <emphasis role="strong">36:</emphasis>645–650.</para>
          </listitem>
          <listitem id="ch0153s0000li0167" role="bibliographyEntry">
            <para>167.<emphasis role="strong">Loignon M, Labrecque LG, Bard C, Robitaille Y, Toma E.</emphasis> 2014. Cerebral microsporidiosis manifesting as progressive multifocal leukoencephalopathy in an HIV-infected individual—a case report. <citetitle><emphasis>AIDS Res Ther</emphasis></citetitle> <emphasis role="strong">11:</emphasis>20.</para>
          </listitem>
          <listitem id="ch0153s0000li0168" role="bibliographyEntry">
            <para>168.<emphasis role="strong">Tan J, Lee P, Lai Y, Hishamuddin P, Tay J, Tan AL, Chan KS, Lin R, Tan D, Cutter J, Goh KT.</emphasis> 2013. Microsporidial keratoconjunctivitis after rugby tournament, Singapore. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">19:</emphasis>1484–1486.</para>
          </listitem>
          <listitem id="ch0153s0000li0169" role="bibliographyEntry">
            <para>169.<emphasis role="strong">Lewis NL, Francis IC, Hawkins GS, Coroneo MT.</emphasis> 2003. Bilateral microsporidial keratoconjunctivitis in an immunocompetent non-contact lens wearer. <citetitle><emphasis>Cornea</emphasis></citetitle> <emphasis role="strong">22:</emphasis>374–376.</para>
          </listitem>
          <listitem id="ch0153s0000li0170" role="bibliographyEntry">
            <para>170.<emphasis role="strong">Mohanty A, Mitra S, Das S, Priyadarshini S, Sahu SK.</emphasis> 2020. Clinical profile of bilateral microsporidial keratoconjunctivitis in healthy individuals—a case series with long-term follow-up. <citetitle><emphasis>Cornea</emphasis></citetitle> <emphasis role="strong">39:</emphasis>902–908.</para>
          </listitem>
          <listitem id="ch0153s0000li0171" role="bibliographyEntry">
            <para>171.<emphasis role="strong">Agashe R, Radhakrishnan N, Pradhan S, Srinivasan M, Prajna VN, Lalitha P.</emphasis> 2017. Clinical and demographic study of microsporidial keratoconjunctivitis in South India: a 3-year study (2013-2015). <citetitle><emphasis>Br J Ophthalmol</emphasis></citetitle> <emphasis role="strong">101:</emphasis>1436–1439.</para>
          </listitem>
          <listitem id="ch0153s0000li0172" role="bibliographyEntry">
            <para>172.<emphasis role="strong">Gautam JV, Jhanji V, Satpathy G, Khokhar S, Agarwal T.</emphasis> 2013. Microsporidial keratitis after collagen cross-linking. <citetitle><emphasis>Ocul Immunol Inflamm</emphasis></citetitle> <emphasis role="strong">21:</emphasis>495–497.</para>
          </listitem>
          <listitem id="ch0153s0000li0173" role="bibliographyEntry">
            <para>173.<emphasis role="strong">Desportes-Livage I, Datry A.</emphasis> 2005. Infections à microsporidies, Isospora et Sarcocystis. <citetitle><emphasis>EMC—Maladies Infectieuses</emphasis></citetitle> <emphasis role="strong">2:</emphasis>178–196.</para>
          </listitem>
          <listitem id="ch0153s0000li0174" role="bibliographyEntry">
            <para>174.<emphasis role="strong">Agholi M, Hatam GR, Motazedian MH.</emphasis> 2013. Microsporidia and coccidia as causes of persistent diarrhea among liver transplant children: incidence rate and species/genotypes. <citetitle><emphasis>Pediatr Infect Dis J</emphasis></citetitle> <emphasis role="strong">32:</emphasis>185–187.</para>
          </listitem>
          <listitem id="ch0153s0000li0175" role="bibliographyEntry">
            <para>175.<emphasis role="strong">Gumbo T, Hobbs RE, Carlyn C, Hall G, Isada CM.</emphasis> 1999. Microsporidia infection in transplant patients. <citetitle><emphasis>Transplantation</emphasis></citetitle> <emphasis role="strong">67:</emphasis>482–484.</para>
          </listitem>
          <listitem id="ch0153s0000li0176" role="bibliographyEntry">
            <para>176.<emphasis role="strong">Metge S, Van Nhieu JT, Dahmane D, Grimbert P, Foulet F, Sarfati C, Bretagne S.</emphasis> 2000. A case of <citetitle><emphasis>Enterocytozoon bieneus</emphasis></citetitle>i infection in an HIV-negative renal transplant recipient. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">19:</emphasis>221–223.</para>
          </listitem>
          <listitem id="ch0153s0000li0177" role="bibliographyEntry">
            <para>177.<emphasis role="strong">Rabodonirina M, Bertocchi M, Desportes-Livage I, Cotte L, Levrey H, Piens MA, Monneret G, Celard M, Mornex JF, Mojon M.</emphasis> 1996. <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> as a cause of chronic diarrhea in a heart-lung transplant recipient who was seronegative for human immunodeficiency virus. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">23:</emphasis>114–117.</para>
          </listitem>
          <listitem id="ch0153s0000li0178" role="bibliographyEntry">
            <para>178.<emphasis role="strong">Breton J, Bart-Delabesse E, Biligui S, Carbone A, Seiller X, Okome-Nkoumou M, Nzamba C, Kombila M, Accoceberry I, Thellier M.</emphasis> 2007. New highly divergent rRNA sequence among biodiverse genotypes of <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> strains isolated from humans in Gabon and Cameroon. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">45:</emphasis>2580–2589.</para>
          </listitem>
          <listitem id="ch0153s0000li0179" role="bibliographyEntry">
            <para>179.<emphasis role="strong">Weber R, Kuster H, Keller R, Bächi T, Spycher MA, Briner J, Russi E, Lüthy R.</emphasis> 1992. Pulmonary and intestinal microsporidiosis in a patient with the acquired immunodeficiency syndrome. <citetitle><emphasis>Am Rev Respir Dis</emphasis></citetitle> <emphasis role="strong">146:</emphasis>1603–1605.</para>
          </listitem>
          <listitem id="ch0153s0000li0180" role="bibliographyEntry">
            <para>180.<emphasis role="strong">Franzen C, Müller A.</emphasis> 1999. Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">12:</emphasis>243–285.</para>
          </listitem>
          <listitem id="ch0153s0000li0181" role="bibliographyEntry">
            <para>181.<emphasis role="strong">Conteas CN, Berlin OGW, Ash LR, Pruthi JS.</emphasis> 2000. Therapy for human gastrointestinal microsporidiosis. <citetitle><emphasis>Am J Trop Med Hyg</emphasis></citetitle> <emphasis role="strong">63:</emphasis>121–127.</para>
          </listitem>
          <listitem id="ch0153s0000li0182" role="bibliographyEntry">
            <para>182.<emphasis role="strong">Kotler DP, Orenstein JM.</emphasis> 1998. Clinical syndromes associated with microsporidiosis. <citetitle><emphasis>Adv Parasitol</emphasis></citetitle> <emphasis role="strong">40:</emphasis>321–349.</para>
          </listitem>
          <listitem id="ch0153s0000li0183" role="bibliographyEntry">
            <para>183.<emphasis role="strong">Orenstein JM, Gaetz HP, Yachnis AT, Frankel SS, Mertens RB, Didier ES.</emphasis> 1997. Disseminated microsporidiosis in AIDS: are any organs spared? <citetitle><emphasis>AIDS</emphasis></citetitle> <emphasis role="strong">11:</emphasis>385–386.</para>
          </listitem>
          <listitem id="ch0153s0000li0184" role="bibliographyEntry">
            <para>184.<emphasis role="strong">Sheth SG, Bates C, Federman M, Chopra S.</emphasis> 1997. Fulminant hepatic failure caused by microsporidial infection in a patient with AIDS. <citetitle><emphasis>AIDS</emphasis></citetitle> <emphasis role="strong">11:</emphasis>553–554.</para>
          </listitem>
          <listitem id="ch0153s0000li0185" role="bibliographyEntry">
            <para>185.<emphasis role="strong">Schwartz DA, Sobottka I, Leitch GJ, Cali A, Visvesvara GS.</emphasis> 1996. Pathology of microsporidiosis: emerging parasitic infections in patients with acquired immunodeficiency syndrome. <citetitle><emphasis>Arch Pathol Lab Med</emphasis></citetitle> <emphasis role="strong">120:</emphasis>173–188.</para>
          </listitem>
          <listitem id="ch0153s0000li0186" role="bibliographyEntry">
            <para>186.<emphasis role="strong">Soule JB, Halverson AL, Becker RB, Pistole MC, Orenstein JM.</emphasis> 1997. A patient with acquired immunodeficiency syndrome and untreated <citetitle><emphasis>Encephalitozoon</emphasis></citetitle> (<citetitle><emphasis>Septata</emphasis></citetitle>) <citetitle><emphasis>intestinalis</emphasis></citetitle> microsporidiosis leading to small bowel perforation. Response to albendazole. <citetitle><emphasis>Arch Pathol Lab Med</emphasis></citetitle> <emphasis role="strong">121:</emphasis>880–887.</para>
          </listitem>
          <listitem id="ch0153s0000li0187" role="bibliographyEntry">
            <anchor id="ch0153s0000a0075"/>
            <para>187.<emphasis role="strong">Zender HO, Arrigoni E, Eckert J, Kapanci Y.</emphasis> 1989. A case of <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> peritonitis in a patient with AIDS. <citetitle><emphasis>Am J Clin Pathol</emphasis></citetitle> <emphasis role="strong">92:</emphasis>352–356.</para>
          </listitem>
          <listitem id="ch0153s0000li0188" role="bibliographyEntry">
            <para>188.<emphasis role="strong">Kester KE, Turiansky GW, McEvoy PL.</emphasis> 1998. Nodular cutaneous microsporidiosis in a patient with AIDS and successful treatment with long-term oral clindamycin therapy. <citetitle><emphasis>Ann Intern Med</emphasis></citetitle> <emphasis role="strong">128:</emphasis>911–914.</para>
          </listitem>
          <listitem id="ch0153s0000li0189" role="bibliographyEntry">
            <para>189.<emphasis role="strong">Kester KE, Visvesara GS, McEvoy P.</emphasis> 2000. Organism responsible for nodular cutaneous microsporidiosis in a patient with AIDS. <citetitle><emphasis>Ann Intern Med</emphasis></citetitle> <emphasis role="strong">133:</emphasis>925.</para>
          </listitem>
          <listitem id="ch0153s0000li0190" role="bibliographyEntry">
            <para>190.<emphasis role="strong">Schwartz DA, Visvesvara GS, Leitch GJ, Tashjian L, Pollack M, Holden J, Bryan RT.</emphasis> 1993. Pathology of symptomatic microsporidial (<citetitle><emphasis>Encephalitozoon hellem</emphasis></citetitle>) bronchiolitis in the acquired immunodeficiency syndrome: a new respiratory pathogen diagnosed from lung biopsy, bronchoalveolar lavage, sputum, and tissue culture. <citetitle><emphasis>Hum Pathol</emphasis></citetitle> <emphasis role="strong">24:</emphasis>937–943.</para>
          </listitem>
          <listitem id="ch0153s0000li0191" role="bibliographyEntry">
            <para>191.<emphasis role="strong">Filho MM, Ribeiro HB, Paula LJ, Nishioka SA, Tamaki WT, Costa R, Siqueira SF, Kawakami JT, Higuchi ML.</emphasis> 2009. Images in cardiovascular medicine. Endocarditis secondary to microsporidia: giant vegetation in a pacemaker user. <citetitle><emphasis>Circulation</emphasis></citetitle> <emphasis role="strong">119:</emphasis>e386–e388.</para>
          </listitem>
          <listitem id="ch0153s0000li0192" role="bibliographyEntry">
            <para>192.<emphasis role="strong">Kicia M, Wesolowska M, Kopacz Z, Kvác M, Sak B, Sokulska M, Cebulski K, Hendrich AB, Pozowski A.</emphasis> 2018. Disseminated infection of <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> associated with osteolysis of hip periprosthetic tissue. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">67:</emphasis>1228–1234.</para>
          </listitem>
          <listitem id="ch0153s0000li0193" role="bibliographyEntry">
            <para>193.<emphasis role="strong">van Gool T, Canning EU, Gilis H, van den Bergh Weerman MA, Eeftinck Schattenkerk JK, Dankert J.</emphasis> 1994. <citetitle><emphasis>Septata intestinalis</emphasis></citetitle> frequently isolated from stool of AIDS patients with a new cultivation method. <citetitle><emphasis>Parasitology</emphasis></citetitle> <emphasis role="strong">109:</emphasis>281–289.</para>
          </listitem>
          <listitem id="ch0153s0000li0194" role="bibliographyEntry">
            <para>194.<emphasis role="strong">Enriquez FJ, Taren D, Cruz-López A, Muramoto M, Palting JD, Cruz P.</emphasis> 1998. Prevalence of intestinal encephalitozoonosis in Mexico. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">26:</emphasis>1227–1229.</para>
          </listitem>
          <listitem id="ch0153s0000li0195" role="bibliographyEntry">
            <para>195.<emphasis role="strong">Raynaud L, Delbac F, Broussolle V, Rabodonirina M, Girault V, Wallon M, Cozon G, Vivares CP, Peyron F.</emphasis> 1998. Identification of <citetitle><emphasis>Encephalitozoon intestinalis</emphasis></citetitle> in travelers with chronic diarrhea by specific PCR amplification. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">36:</emphasis>37–40.</para>
          </listitem>
          <listitem id="ch0153s0000li0196" role="bibliographyEntry">
            <para>196.<emphasis role="strong">Mason E, Foster R, Wray L, McNulty A, Donovan B.</emphasis> 2016. Reactive arthritis following a microsporidia infection. <citetitle><emphasis>Int J STD AIDS</emphasis></citetitle> <emphasis role="strong">27:</emphasis>1239–1241.</para>
          </listitem>
          <listitem id="ch0153s0000li0197" role="bibliographyEntry">
            <para>197.<emphasis role="strong">Davis RM, Font RL, Keisler MS, Shadduck JA.</emphasis> 1990. Corneal microsporidiosis. A case report including ultrastructural observations. <citetitle><emphasis>Ophthalmology</emphasis></citetitle> <emphasis role="strong">97:</emphasis>953–957.</para>
          </listitem>
          <listitem id="ch0153s0000li0198" role="bibliographyEntry">
            <para>198.<emphasis role="strong">Font RL, Samaha AN, Keener MJ, Chevez-Barrios P, Goosey JD.</emphasis> 2000. Corneal microsporidiosis. Report of case, including electron microscopic observations. <citetitle><emphasis>Ophthalmology</emphasis></citetitle> <emphasis role="strong">107:</emphasis>1769–1775.</para>
          </listitem>
          <listitem id="ch0153s0000li0199" role="bibliographyEntry">
            <para>199.<emphasis role="strong">Font RL, Su GW, Matoba AY.</emphasis> 2003. Microsporidial stromal keratitis. <citetitle><emphasis>Arch Ophthalmol</emphasis></citetitle> <emphasis role="strong">121:</emphasis>1045–1047.</para>
          </listitem>
          <listitem id="ch0153s0000li0200" role="bibliographyEntry">
            <para>200.<emphasis role="strong">Rauz S, Tuft S, Dart JKG, Bonshek R, Luthert P, Curry A.</emphasis> 2004. Ultrastructural examination of two cases of stromal microsporidial keratitis. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">53:</emphasis>775–781.</para>
          </listitem>
          <listitem id="ch0153s0000li0201" role="bibliographyEntry">
            <para>201.<emphasis role="strong">Huang H-Y, Wu C-L, Lin S-H, Lin W-C, Huang F-C, Hung J-H, Tseng S-H.</emphasis> 2020. Microsporidial stromal keratitis: characterisation of clinical features, ultrastructural study by electron microscopy and efficacy of different surgical modalities. <citetitle><emphasis>Br J Ophthalmol</emphasis></citetitle> <emphasis role="strong">104:</emphasis>1613–1620.</para>
          </listitem>
          <listitem id="ch0153s0000li0202" role="bibliographyEntry">
            <para>202.<emphasis role="strong">Ledford DK, Overman MD, Gonzalvo A, Cali A, Mester SW, Lockey RF.</emphasis> 1985. Microsporidiosis myositis in a patient with the acquired immunodeficiency syndrome. <citetitle><emphasis>Ann Intern Med</emphasis></citetitle> <emphasis role="strong">102:</emphasis>628–630.</para>
          </listitem>
          <listitem id="ch0153s0000li0203" role="bibliographyEntry">
            <para>203.<emphasis role="strong">Coyle CM, Weiss LM, Rhodes LV III, Cali A, Takvorian PM, Brown DF, Visvesvara GS, Xiao L, Naktin J, Young E, Gareca M, Colasante G, Wittner M.</emphasis> 2004. Fatal myositis due to the microsporidian <citetitle><emphasis>Brachiola algerae</emphasis></citetitle>, a mosquito pathogen. <citetitle><emphasis>N Engl J Med</emphasis></citetitle> <emphasis role="strong">351:</emphasis>42–47.</para>
          </listitem>
          <listitem id="ch0153s0000li0204" role="bibliographyEntry">
            <para>204.<emphasis role="strong">Watts MR, Chan RC, Cheong EY, Brammah S, Clezy KR, Tong C, Marriott D, Webb CE, Chacko B, Tobias V, Outhred AC, Field AS, Prowse MV, Bertouch JV, Stark D, Reddel SW.</emphasis> 2014. <citetitle><emphasis>Anncaliia algerae</emphasis></citetitle> microsporidial myositis. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">20:</emphasis>185–191.</para>
          </listitem>
          <listitem id="ch0153s0000li0205" role="bibliographyEntry">
            <para>205.<emphasis role="strong">Visvesvara GS, Moura H, Leitch GJ, Schwartz DA, Xiao LX.</emphasis> 2005. Public health importance of <citetitle><emphasis>Brachiola algerae</emphasis></citetitle> (Microsporidia)—an emerging pathogen of humans. <citetitle><emphasis>Folia Parasitol (Praha)</emphasis></citetitle> <emphasis role="strong">52:</emphasis>83–94.</para>
          </listitem>
          <listitem id="ch0153s0000li0206" role="bibliographyEntry">
            <para>206.<emphasis role="strong">Garcia LS.</emphasis> 2002. Laboratory identification of the microsporidia. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">40:</emphasis>1892–1901.</para>
          </listitem>
          <listitem id="ch0153s0000li0207" role="bibliographyEntry">
            <para>207.<emphasis role="strong">Visvesvara GS, Belloso M, Moura H, Da Silva AJ, Moura IN, Leitch GJ, Schwartz DA, Chevez-Barrios P, Wallace S, Pieniazek NJ, Goosey JD.</emphasis> 1999. Isolation of <citetitle><emphasis>Nosema algerae</emphasis></citetitle> from the cornea of an immunocompetent patient. <citetitle><emphasis>J Eukaryot Microbiol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>10S.</para>
          </listitem>
          <listitem id="ch0153s0000li0208" role="bibliographyEntry">
            <para>208.<emphasis role="strong">Weber R, Schwartz DA, Deplazes P.</emphasis> 1999. Laboratory diagnosis of microsporidiosis, p 315–362. <citetitle><emphasis>In</emphasis></citetitle> Wittner M, Weiss LM (ed), <citetitle><emphasis>The Microsporidia and Microsporidiosis.</emphasis></citetitle> ASM Press, Washington, DC.</para>
          </listitem>
          <listitem id="ch0153s0000li0209" role="bibliographyEntry">
            <para>209.<emphasis role="strong">Weber R, Bryan RT, Owen RL, Wilcox CM, Gorelkin L, Visvesvara GS, Group EOIW, The Enteric Opportunistic Infections Working Group.</emphasis> 1992. Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. <citetitle><emphasis>N Engl J Med</emphasis></citetitle> <emphasis role="strong">326:</emphasis>161–166.</para>
          </listitem>
          <listitem id="ch0153s0000li0210" role="bibliographyEntry">
            <para>210.<emphasis role="strong">Vávra J, Dahbiová R, Hollister WS, Canning EU.</emphasis> 1993. Staining of microsporidian spores by optical brighteners with remarks on the use of brighteners for the diagnosis of AIDS associated human microsporidioses. <citetitle><emphasis>Folia Parasitol (Praha)</emphasis></citetitle> <emphasis role="strong">40:</emphasis>267–272.</para>
          </listitem>
          <listitem id="ch0153s0000li0211" role="bibliographyEntry">
            <para>211.<emphasis role="strong">van Gool T, Snijders F, Reiss P, Eeftinck Schattenkerk JK, van den Bergh Weerman MA, Bartelsman JF, Bruins JJ, Canning EU, Dankert J.</emphasis> 1993. Diagnosis of intestinal and disseminated microsporidial infections in patients with HIV by a new rapid fluorescence technique. <citetitle><emphasis>J Clin Pathol</emphasis></citetitle> <emphasis role="strong">46:</emphasis>694–699.</para>
          </listitem>
          <listitem id="ch0153s0000li0212" role="bibliographyEntry">
            <para>212.<emphasis role="strong">Ryan NJ, Sutherland G, Coughlan K, Globan M, Doultree J, Marshall J, Baird RW, Pedersen J, Dwyer B.</emphasis> 1993. A new trichrome-blue stain for detection of microsporidial species in urine, stool, and nasopharyngeal specimens. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">31:</emphasis>3264–3269.</para>
          </listitem>
          <listitem id="ch0153s0000li0213" role="bibliographyEntry">
            <para>213.<emphasis role="strong">Kokoskin E, Gyorkos TW, Camus A, Cedilotte L, Purtill T, Ward B.</emphasis> 1994. Modified technique for efficient detection of microsporidia. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">32:</emphasis>1074–1075.</para>
          </listitem>
          <listitem id="ch0153s0000li0214" role="bibliographyEntry">
            <para>214.<emphasis role="strong">Moura H, Schwartz DA, Bornay-Llinares F, Sodré FC, Wallace S, Visvesvara GS.</emphasis> 1997. A new and improved “quick-hot Gram-chromotrope” technique that differentially stains microsporidian spores in clinical samples, including paraffin-embedded tissue sections. <citetitle><emphasis>Arch Pathol Lab Med</emphasis></citetitle> <emphasis role="strong">121:</emphasis>888–893.</para>
          </listitem>
          <listitem id="ch0153s0000li0215" role="bibliographyEntry">
            <para>215.<emphasis role="strong">Ignatius R, Lehmann M, Miksits K, Regnath T, Arvand M, Engelmann E, Futh U, Hahn H, Wagner J.</emphasis> 1997. A new acid-fast trichrome stain for simultaneous detection of <citetitle><emphasis>Cryptosporidium parvum</emphasis></citetitle> and microsporidial species in stool specimens. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">35:</emphasis>446–449.</para>
          </listitem>
          <listitem id="ch0153s0000li0216" role="bibliographyEntry">
            <para>216.<emphasis role="strong">Didier ES, Orenstein JM, Aldras A, Bertucci D, Rogers LB, Janney FA.</emphasis> 1995. Comparison of three staining methods for detecting microsporidia in fluids. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">33:</emphasis>3138–3145.</para>
          </listitem>
          <listitem id="ch0153s0000li0217" role="bibliographyEntry">
            <para>217.<emphasis role="strong">DeGirolami PC, Ezratty CR, Desai G, McCullough A, Asmuth D, Wanke C, Federman M.</emphasis> 1995. Diagnosis of intestinal microsporidiosis by examination of stool and duodenal aspirate with Weber’s modified trichrome and Uvitex 2B strains. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">33:</emphasis>805–810.</para>
          </listitem>
          <listitem id="ch0153s0000li0218" role="bibliographyEntry">
            <para>218.<emphasis role="strong">Ignatius R, Henschel S, Liesenfeld O, Mansmann U, Schmidt W, Köppe S, Schneider T, Heise W, Futh U, Riecken EO, Hahn H, Ullrich R.</emphasis> 1997. Comparative evaluation of modified trichrome and Uvitex 2B stains for detection of low numbers of microsporidial spores in stool specimens. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">35:</emphasis>2266–2269.</para>
          </listitem>
          <listitem id="ch0153s0000li0219" role="bibliographyEntry">
            <para>219.<emphasis role="strong">Croppo GP, Visvesvara GS, Leitch GJ, Wallace S, Schwartz DA.</emphasis> 1998. Identification of the microsporidian <citetitle><emphasis>Encephalitozoon hellem</emphasis></citetitle> using immunoglobulin G monoclonal antibodies. <citetitle><emphasis>Arch Pathol Lab Med</emphasis></citetitle> <emphasis role="strong">122:</emphasis>182–186.</para>
          </listitem>
          <listitem id="ch0153s0000li0220" role="bibliographyEntry">
            <para>220.<emphasis role="strong">Beckers PJ, Derks GJ, Gool T, Rietveld FJ, Sauerwein RW.</emphasis> 1996. <citetitle><emphasis>Encephalocytozoon intestinalis</emphasis></citetitle>-specific monoclonal antibodies for laboratory diagnosis of microsporidiosis. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">34:</emphasis>282–285.</para>
          </listitem>
          <listitem id="ch0153s0000li0221" role="bibliographyEntry">
            <para>221.<emphasis role="strong">Enriquez FJ, Ditrich O, Palting JD, Smith K.</emphasis> 1997. Simple diagnosis of <citetitle><emphasis>Encephalitozoon</emphasis></citetitle> sp. microsporidial infections by using a panspecific antiexospore monoclonal antibody. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">35:</emphasis>724–729.</para>
          </listitem>
          <listitem id="ch0153s0000li0222" role="bibliographyEntry">
            <anchor id="ch0153s0000a0076"/>
            <para>222.<emphasis role="strong">Sheoran AS, Feng X, Singh I, Chapman-Bonofiglio S, Kitaka S, Hanawalt J, Nunnari J, Mansfield K, Tumwine JK, Tzipori S.</emphasis> 2005. Monoclonal antibodies against <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> of human origin. <citetitle><emphasis>Clin Diagn Lab Immunol</emphasis></citetitle> <emphasis role="strong">12:</emphasis>1109–1113.</para>
          </listitem>
          <listitem id="ch0153s0000li0223" role="bibliographyEntry">
            <para>223.<emphasis role="strong">Singh I, Sheoran AS, Zhang Q, Carville A, Tzipori S.</emphasis> 2005. Sensitivity and specificity of a monoclonal antibody-based fluorescence assay for detecting <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> spores in feces of simian immunodeficiency virus-infected macaques. <citetitle><emphasis>Clin Diagn Lab Immunol</emphasis></citetitle> <emphasis role="strong">12:</emphasis>1141–1144.</para>
          </listitem>
          <listitem id="ch0153s0000li0224" role="bibliographyEntry">
            <para>224.<emphasis role="strong">Accoceberry I, Thellier M, Desportes-Livage I, Achbarou A, Biligui S, Danis M, Datry A.</emphasis> 1999. Production of monoclonal antibodies directed against the microsporidium <citetitle><emphasis>Enterocytozoon bieneusi. J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">37:</emphasis>4107–4112.</para>
          </listitem>
          <listitem id="ch0153s0000li0225" role="bibliographyEntry">
            <para>225.<emphasis role="strong">Ghoshal U, Khanduja S, Pant P, Ghoshal UC.</emphasis> 2016. Evaluation of immunofluorescence antibody assay for the detection of <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> and <citetitle><emphasis>Encephalitozoon intestinalis. Parasitol Res</emphasis></citetitle> <emphasis role="strong">115:</emphasis>3709–3713.</para>
          </listitem>
          <listitem id="ch0153s0000li0226" role="bibliographyEntry">
            <para>226.<emphasis role="strong">Field AS, Marriott DJ, Hing MC.</emphasis> 1993. The Warthin-Starry stain in the diagnosis of small intestinal microsporidiosis in HIV-infected patients. <citetitle><emphasis>Folia Parasitol (Praha)</emphasis></citetitle> <emphasis role="strong">40:</emphasis>261–266.</para>
          </listitem>
          <listitem id="ch0153s0000li0227" role="bibliographyEntry">
            <para>227.<emphasis role="strong">Peterson TS, Spitsbergen JM, Feist SW, Kent ML.</emphasis> 2011. Luna stain, an improved selective stain for detection of microsporidian spores in histologic sections. <citetitle><emphasis>Dis Aquat Organ</emphasis></citetitle> <emphasis role="strong">95:</emphasis>175–180.</para>
          </listitem>
          <listitem id="ch0153s0000li0228" role="bibliographyEntry">
            <para>228.<emphasis role="strong">Ghosh K, Weiss LM.</emphasis> 2009. Molecular diagnostic tests for microsporidia. <citetitle><emphasis>Interdiscip Perspect Infect Dis</emphasis></citetitle> <emphasis role="strong">2009:</emphasis>926521.</para>
          </listitem>
          <listitem id="ch0153s0000li0229" role="bibliographyEntry">
            <para>229.<emphasis role="strong">Weiss LM.</emphasis> 2000. Molecular phylogeny and diagnostic approaches to microsporidia. <citetitle><emphasis>Contrib Microbiol</emphasis></citetitle> <emphasis role="strong">6:</emphasis>209–235.</para>
          </listitem>
          <listitem id="ch0153s0000li0230" role="bibliographyEntry">
            <para>230.<emphasis role="strong">Weidner E.</emphasis> 1972. Ultrastructural study of microsporidian invasion into cells. <citetitle><emphasis>Z Parasitenkd</emphasis></citetitle> <emphasis role="strong">40:</emphasis>227–242.</para>
          </listitem>
          <listitem id="ch0153s0000li0231" role="bibliographyEntry">
            <para>231.<emphasis role="strong">Müller A, Stellermann K, Hartmann P, Schrappe M, Fätkenheuer G, Salzberger B, Diehl V, Franzen C.</emphasis> 1999. A powerful DNA extraction method and PCR for detection of microsporidia in clinical stool specimens. <citetitle><emphasis>Clin Diagn Lab Immunol</emphasis></citetitle> <emphasis role="strong">6:</emphasis>243–246.</para>
          </listitem>
          <listitem id="ch0153s0000li0232" role="bibliographyEntry">
            <para>232.<emphasis role="strong">Polley SD, Boadi S, Watson J, Curry A, Chiodini PL.</emphasis> 2011. Detection and species identification of microsporidial infections using SYBR Green real-time PCR. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">60:</emphasis>459–466.</para>
          </listitem>
          <listitem id="ch0153s0000li0233" role="bibliographyEntry">
            <para>233.<emphasis role="strong">Wolk DM, Schneider SK, Wengenack NL, Sloan LM, Rosenblatt JE.</emphasis> 2002. Real-time PCR method for detection of <citetitle><emphasis>Encephalitozoon intestinalis</emphasis></citetitle> from stool specimens. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">40:</emphasis>3922–3928.</para>
          </listitem>
          <listitem id="ch0153s0000li0234" role="bibliographyEntry">
            <para>234.<emphasis role="strong">Menotti J, Cassinat B, Sarfati C, Liguory O, Derouin F, Molina JM.</emphasis> 2003. Development of a real-time PCR assay for quantitative detection of <citetitle><emphasis>Encephalitozoon intestinalis</emphasis></citetitle> DNA. <citetitle><emphasis>J Clin Microbiol</emphasis></citetitle> <emphasis role="strong">41:</emphasis>1410–1413.</para>
          </listitem>
          <listitem id="ch0153s0000li0235" role="bibliographyEntry">
            <para>235.<emphasis role="strong">Nur Su’aidah Nasarudin S, Shazalina Zainudin N, Bernadus M, Mohd Nawi A, Hanafiah A, Osman E.</emphasis> 2015. Loop-mediated isothermal amplification for rapid molecular detection of <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> in faecal specimens. <citetitle><emphasis>J Med Microbiol</emphasis></citetitle> <emphasis role="strong">64:</emphasis>1329–1334.</para>
          </listitem>
          <listitem id="ch0153s0000li0236" role="bibliographyEntry">
            <para>236.<emphasis role="strong">Carville A, Mansfield K, Widmer G, Lackner A, Kotler D, Wiest P, Gumbo T, Sarbah S, Tzipori S.</emphasis> 1997. Development and application of genetic probes for detection of <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> in formalin-fixed stools and in intestinal biopsy specimens from infected patients. <citetitle><emphasis>Clin Diagn Lab Immunol</emphasis></citetitle> <emphasis role="strong">4:</emphasis>405–408.</para>
          </listitem>
          <listitem id="ch0153s0000li0237" role="bibliographyEntry">
            <para>237.<emphasis role="strong">Deplazes P, Mathis A, Baumgartner R, Tanner I, Weber R.</emphasis> 1996. Immunologic and molecular characteristics of Encephalitozoon-like microsporidia isolated from humans and rabbits indicate that <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> is a zoonotic parasite. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">22:</emphasis>557–559.</para>
          </listitem>
          <listitem id="ch0153s0000li0238" role="bibliographyEntry">
            <para>238.<emphasis role="strong">Visvesvara GS.</emphasis> 2002. in vitro cultivation of microsporidia of clinical importance. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">15:</emphasis>401–413.</para>
          </listitem>
          <listitem id="ch0153s0000li0239" role="bibliographyEntry">
            <para>239.<emphasis role="strong">Visvesvara G, Leitch GJ, Pieniazek NJ, Da Silva AJ, Wallace S, Slemenda SB, Weber R, Schwartz DA, Gorelkin L, Wilcox CM, Bryan RT.</emphasis> 1995. Short-term in vitro culture and molecular analysis of the microsporidian, <citetitle><emphasis>Enterocytozoon bieneusi. J Eukaryot Microbiol</emphasis></citetitle> <emphasis role="strong">42:</emphasis>506–510.</para>
          </listitem>
          <listitem id="ch0153s0000li0240" role="bibliographyEntry">
            <para>240.<emphasis role="strong">Desportes-Livage I, Chilmonczyk S, Hedrick R, Ombrouck C, Monge D, Maiga I, Gentilini M.</emphasis> 1996. Comparative development of two microsporidian species: <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> and <citetitle><emphasis>Enterocytozoon salmonis</emphasis></citetitle>, reported in AIDS patients and salmonid fish, respectively. <citetitle><emphasis>J Eukaryot Microbiol</emphasis></citetitle> <emphasis role="strong">43:</emphasis>49–60.</para>
          </listitem>
          <listitem id="ch0153s0000li0241" role="bibliographyEntry">
            <para>241.<emphasis role="strong">Canning EU, Lom J.</emphasis> 1986. <citetitle><emphasis>The Microsporidia of Vertebrates.</emphasis></citetitle> Academic Press, London, United Kingdom.</para>
          </listitem>
          <listitem id="ch0153s0000li0242" role="bibliographyEntry">
            <para>242.<emphasis role="strong">Mathis A, Tanner I, Weber R, Deplazes P.</emphasis> 1999. Genetic and phenotypic intraspecific variation in the microsporidian <citetitle><emphasis>Encephalitozoon hellem. Int J Parasitol</emphasis></citetitle> <emphasis role="strong">29:</emphasis>767–770.</para>
          </listitem>
          <listitem id="ch0153s0000li0243" role="bibliographyEntry">
            <para>243.<emphasis role="strong">Canning EU, Lom J, Dykova I.</emphasis> 1987. The microsporidia of vertebrates. <citetitle><emphasis>J Basic Microbiol</emphasis></citetitle> <emphasis role="strong">27:</emphasis>252–252.</para>
          </listitem>
          <listitem id="ch0153s0000li0244" role="bibliographyEntry">
            <para>244.<emphasis role="strong">Hollister WS, Canning EU.</emphasis> 1987. An enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> and its use in determination of infections in man. <citetitle><emphasis>Parasitology</emphasis></citetitle> <emphasis role="strong">94:</emphasis>209–219.</para>
          </listitem>
          <listitem id="ch0153s0000li0245" role="bibliographyEntry">
            <para>245.<emphasis role="strong">Hollister WS, Canning EU, Willcox A.</emphasis> 1991. Evidence for widespread occurrence of antibodies to <citetitle><emphasis>Encephalitozoon cuniculi</emphasis></citetitle> (Microspora) in man provided by ELISA and other serological tests. <citetitle><emphasis>Parasitology</emphasis></citetitle> <emphasis role="strong">102:</emphasis>33–43.</para>
          </listitem>
          <listitem id="ch0153s0000li0246" role="bibliographyEntry">
            <para>246.<emphasis role="strong">van Gool T, Biderre C, Delbac F, Wentink-Bonnema E, Peek R, Vivarès CP.</emphasis> 2004. Serodiagnostic studies in an immunocompetent individual infected with <citetitle><emphasis>Encephalitozoon cuniculi. J Infect Dis</emphasis></citetitle> <emphasis role="strong">189:</emphasis>2243–2249.</para>
          </listitem>
          <listitem id="ch0153s0000li0247" role="bibliographyEntry">
            <para>247.<emphasis role="strong">Goguel J, Katlama C, Sarfati C, Maslo C, Leport C, Molina JM.</emphasis> 1997. Remission of AIDS-associated intestinal microsporidiosis with highly active antiretroviral therapy. <citetitle><emphasis>AIDS</emphasis></citetitle> <emphasis role="strong">11:</emphasis>1658–1659.</para>
          </listitem>
          <listitem id="ch0153s0000li0248" role="bibliographyEntry">
            <para>248.<emphasis role="strong">Foudraine NA, Weverling GJ, van Gool T, Roos MT, de Wolf F, Koopmans PP, van den Broek PJ, Meenhorst PL, van Leeuwen R, Lange JM, Reiss P.</emphasis> 1998. Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy. <citetitle><emphasis>AIDS</emphasis></citetitle> <emphasis role="strong">12:</emphasis>35–41.</para>
          </listitem>
          <listitem id="ch0153s0000li0249" role="bibliographyEntry">
            <para>249.<emphasis role="strong">Martins SA, Muccioli C, Belfort R Jr, Castelo A.</emphasis> 2001. Resolution of microsporidial keratoconjunctivitis in an AIDS patient treated with highly active antiretroviral therapy. <citetitle><emphasis>Am J Ophthalmol</emphasis></citetitle> <emphasis role="strong">131:</emphasis>378–379.</para>
          </listitem>
          <listitem id="ch0153s0000li0250" role="bibliographyEntry">
            <para>250.<emphasis role="strong">Maggi P, Larocca AM, Quarto M, Serio G, Brandonisio O, Angarano G, Pastore G.</emphasis> 2000. Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with human immunodeficiency virus type 1. <citetitle><emphasis>Eur J Clin Microbiol Infect Dis</emphasis></citetitle> <emphasis role="strong">19:</emphasis>213–217.</para>
          </listitem>
          <listitem id="ch0153s0000li0251" role="bibliographyEntry">
            <para>251.<emphasis role="strong">Miao YM, Awad-El-Kariem FM, Franzen C, Ellis DS, Müller A, Counihan HM, Hayes PJ, Gazzard BG.</emphasis> 2000. Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy. <citetitle><emphasis>J Acquir Immune Defic Syndr</emphasis></citetitle> <emphasis role="strong">25:</emphasis>124–129.</para>
          </listitem>
          <listitem id="ch0153s0000li0252" role="bibliographyEntry">
            <para>252.<emphasis role="strong">Carr A, Marriott D, Field A, Vasak E, Cooper DA.</emphasis> 1998. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy. <citetitle><emphasis>Lancet</emphasis></citetitle> <emphasis role="strong">351:</emphasis>256–261.</para>
          </listitem>
          <listitem id="ch0153s0000li0253" role="bibliographyEntry">
            <para>253.<emphasis role="strong">Molina JM, Tourneur M, Sarfati C, Chevret S, de Gouvello A, Gobert JG, Balkan S, Derouin F, Agence Nationale de Recherches sur le SIDA 090 Study Group.</emphasis> 2002. Fumagillin treatment of intestinal microsporidiosis. <citetitle><emphasis>N Engl J Med</emphasis></citetitle> <emphasis role="strong">346:</emphasis>1963–1969.</para>
          </listitem>
          <listitem id="ch0153s0000li0254" role="bibliographyEntry">
            <para>254.<emphasis role="strong">Molina J-M, Goguel J, Sarfati C, Chastang C, Desportes-Livage I, Michiels J-F, Maslo C, Katlama C, Cotte L, Leport C, Raffi F, Derouin F, Modaï J, The French Microsporidiosis Study Group.</emphasis> 1997. Potential efficacy of fumagillin in intestinal microsporidiosis due to <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> in patients with HIV infection: results of a drug screening study. <citetitle><emphasis>AIDS</emphasis></citetitle> <emphasis role="strong">11:</emphasis>1603–1610.</para>
          </listitem>
          <listitem id="ch0153s0000li0255" role="bibliographyEntry">
            <para>255.<emphasis role="strong">Dunand VA, Hammer SM, Rossi R, Poulin M, Albrecht MA, Doweiko JP, DeGirolami PC, Coakley E, Piessens E, Wanke CA.</emphasis> 1997. Parasitic sinusitis and otitis in patients infected with human immunodeficiency virus: report of five cases and review. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">25:</emphasis>267–272.</para>
          </listitem>
          <listitem id="ch0153s0000li0256" role="bibliographyEntry">
            <para>256.<emphasis role="strong">Diesenhouse MC, Wilson LA, Corrent GF, Visvesvara GS, Grossniklaus HE, Bryan RT.</emphasis> 1993. Treatment of microsporidial keratoconjunctivitis with topical fumagillin. <citetitle><emphasis>Am J Ophthalmol</emphasis></citetitle> <emphasis role="strong">115:</emphasis>293–298.</para>
          </listitem>
          <listitem id="ch0153s0000li0257" role="bibliographyEntry">
            <anchor id="ch0153s0000a0077"/>
            <para>257.<emphasis role="strong">Dore GJ, Marriott DJ, Hing MC, Harkness JL, Field AS.</emphasis> 1995. Disseminated microsporidiosis due to <citetitle><emphasis>Septata intestinalis</emphasis></citetitle> in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">21:</emphasis>70–76.</para>
          </listitem>
          <listitem id="ch0153s0000li0258" role="bibliographyEntry">
            <para>258.<emphasis role="strong">Weber R, Sauer B, Spycher MA, Deplazes P, Keller R, Ammann R, Briner J, Lüthy R.</emphasis> 1994. Detection of <citetitle><emphasis>Septata intestinalis</emphasis></citetitle> in stool specimens and coprodiagnostic monitoring of successful treatment with albendazole. <citetitle><emphasis>Clin Infect Dis</emphasis></citetitle> <emphasis role="strong">19:</emphasis>342–345.</para>
          </listitem>
          <listitem id="ch0153s0000li0259" role="bibliographyEntry">
            <para>259.<emphasis role="strong">Molina JM, Oksenhendler E, Beauvais B, Sarfati C, Jaccard A, Derouin F, Modaï J.</emphasis> 1995. Disseminated microsporidiosis due to <citetitle><emphasis>Septata intestinalis</emphasis></citetitle> in patients with AIDS: clinical features and response to albendazole therapy. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">171:</emphasis>245–249.</para>
          </listitem>
          <listitem id="ch0153s0000li0260" role="bibliographyEntry">
            <para>260.<emphasis role="strong">Molina JM, Chastang C, Goguel J, Michiels JF, Sarfati C, Desportes-Livage I, Horton J, Derouin F, Modaï J.</emphasis> 1998. Albendazole for treatment and prophylaxis of microsporidiosis due to <citetitle><emphasis>Encephalitozoon intestinalis</emphasis></citetitle> in patients with AIDS: a randomized double-blind controlled trial. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">177:</emphasis>1373–1377.</para>
          </listitem>
          <listitem id="ch0153s0000li0261" role="bibliographyEntry">
            <para>261.<emphasis role="strong">Didier ES.</emphasis> 1997. Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">41:</emphasis>1541–1546.</para>
          </listitem>
          <listitem id="ch0153s0000li0262" role="bibliographyEntry">
            <para>262.<emphasis role="strong">Didier PJ, Phillips JN, Kuebler DJ, Nasr M, Brindley PJ, Stovall ME, Bowers LC, Didier ES.</emphasis> 2006. Antimicrosporidial activities of fumagillin, TNP-470, ovalicin, and ovalicin derivatives in vitro and in vivo. <citetitle><emphasis>Antimicrob Agents Chemother</emphasis></citetitle> <emphasis role="strong">50:</emphasis>2146–2155.</para>
          </listitem>
          <listitem id="ch0153s0000li0263" role="bibliographyEntry">
            <para>263.<emphasis role="strong">Sutrave G, Maundrell A, Keighley C, Jennings Z, Brammah S, Wang M-X, Pamphlett R, Webb CE, Stark D, Englert H, Gottlieb D, Bilmon I, Watts MR.</emphasis> 2018. <citetitle><emphasis>Anncaliia algerae</emphasis></citetitle> microsporidial myositis, New South Wales, Australia. <citetitle><emphasis>Emerg Infect Dis</emphasis></citetitle> <emphasis role="strong">24:</emphasis>1528–1531.</para>
          </listitem>
          <listitem id="ch0153s0000li0264" role="bibliographyEntry">
            <para>264.<emphasis role="strong">Akiyoshi DE, Weiss LM, Feng X, Williams BA, Keeling PJ, Zhang Q, Tzipori S.</emphasis> 2007. Analysis of the beta-tubulin genes from <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> isolates from a human and rhesus macaque. <citetitle><emphasis>J Eukaryot Microbiol</emphasis></citetitle> <emphasis role="strong">54:</emphasis>38–41.</para>
          </listitem>
          <listitem id="ch0153s0000li0265" role="bibliographyEntry">
            <para>265.<emphasis role="strong">Dieterich DT, Lew EA, Kotler DP, Poles MA, Orenstein JM.</emphasis> 1994. Treatment with albendazole for intestinal disease due to <citetitle><emphasis>Enterocytozoon bieneusi</emphasis></citetitle> in patients with AIDS. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">169:</emphasis>178–183.</para>
          </listitem>
          <listitem id="ch0153s0000li0266" role="bibliographyEntry">
            <para>266.<emphasis role="strong">Coyle C, Kent M, Tanowitz HB, Wittner M, Weiss LM.</emphasis> 1998. TNP-470 is an effective antimicrosporidial agent. <citetitle><emphasis>J Infect Dis</emphasis></citetitle> <emphasis role="strong">177:</emphasis>515–518.</para>
          </listitem>
          <listitem id="ch0153s0000li0267" role="bibliographyEntry">
            <para>267.<emphasis role="strong">Higgins MJ, Kent ML, Moran JD, Weiss LM, Dawe SC.</emphasis> 1998. Efficacy of the fumagillin analog TNP-470 for <citetitle><emphasis>Nucleospora salmonis</emphasis></citetitle> and <citetitle><emphasis>Loma salmonae</emphasis></citetitle> infections in chinook salmon <citetitle><emphasis>Oncorhynchus tshawytscha. Dis Aquat Organ</emphasis></citetitle> <emphasis role="strong">34:</emphasis>45–49.</para>
          </listitem>
          <listitem id="ch0153s0000li0268" role="bibliographyEntry">
            <para>268.<emphasis role="strong">Desoubeaux G, Maakaroun-Vermesse Z, Lier C, Bailly E, Morio F, Labarthe F, Bernard L, Chandenier J.</emphasis> 2013. Successful treatment with fumagillin of the first pediatric case of digestive microsporidiosis in a liver-kidney transplant. <citetitle><emphasis>Transpl Infect Dis</emphasis></citetitle> <emphasis role="strong">15:</emphasis>E250–E259.</para>
          </listitem>
          <listitem id="ch0153s0000li0269" role="bibliographyEntry">
            <para>269.<emphasis role="strong">Champion L, Durrbach A, Lang P, Delahousse M, Chauvet C, Sarfati C, Glotz D, Molina JM.</emphasis> 2010. Fumagillin for treatment of intestinal microsporidiosis in renal transplant recipients. <citetitle><emphasis>Am J Transplant</emphasis></citetitle> <emphasis role="strong">10:</emphasis>1925–1930.</para>
          </listitem>
          <listitem id="ch0153s0000li0270" role="bibliographyEntry">
            <para>270.<emphasis role="strong">Molina JM, Goguel J, Sarfati C, Michiels JF, Desportes-Livage I, Balkan S, Chastang C, Cotte L, Maslo C, Struxiano A, Derouin F, Decazes JM.</emphasis> 2000. Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection. ANRS 054 Study Group. Agence Nationale de Recherche sur le SIDA. <citetitle><emphasis>AIDS</emphasis></citetitle> <emphasis role="strong">14:</emphasis>1341–1348.</para>
          </listitem>
          <listitem id="ch0153s0000li0271" role="bibliographyEntry">
            <para>271.<emphasis role="strong">Audemard A, Le Bellec ML, Carluer L, Dargère S, Verdon R, Castrale C, Lobbedez T, Hurault de Ligny B.</emphasis> 2012. Fumagillin-induced aseptic meningoencephalitis in a kidney transplant recipient with microsporidiosis. <citetitle><emphasis>Transpl Infect Dis</emphasis></citetitle> <emphasis role="strong">14:</emphasis>E147–E149.</para>
          </listitem>
          <listitem id="ch0153s0000li0272" role="bibliographyEntry">
            <para>272.<emphasis role="strong">Fan NW, Lin PY, Chen TL, Chen CP, Lee SM.</emphasis> 2012. Treatment of microsporidial keratoconjunctivitis with repeated corneal swabbing. <citetitle><emphasis>Am J Ophthalmol</emphasis></citetitle> <emphasis role="strong">154:</emphasis>927–933.e1.</para>
          </listitem>
          <listitem id="ch0153s0000li0273" role="bibliographyEntry">
            <para>273.<emphasis role="strong">Das S, Wallang BS, Sharma S, Bhadange YV, Balne PK, Sahu SK.</emphasis> 2014. The efficacy of corneal debridement in the treatment of microsporidial keratoconjunctivitis: a prospective randomized clinical trial. <citetitle><emphasis>Am J Ophthalmol</emphasis></citetitle> <emphasis role="strong">157:</emphasis>1151–1155.</para>
          </listitem>
          <listitem id="ch0153s0000li0274" role="bibliographyEntry">
            <para>274.<emphasis role="strong">Thanathanee O, Athikulwongse R, Anutarapongpan O, Laummaunwai P, Maleewong W, Intapan PM, Suwan-Apichon O.</emphasis> 2016. Clinical features, risk factors, and treatments of microsporidial epithelial keratitis. <citetitle><emphasis>Semin Ophthalmol</emphasis></citetitle> <emphasis role="strong">31:</emphasis>266–270.</para>
          </listitem>
          <listitem id="ch0153s0000li0275" role="bibliographyEntry">
            <para>275.<emphasis role="strong">Sangit VA, Murthy SI, Garg P.</emphasis> 2011. Microsporidial stromal keratitis successfully treated with medical therapy: a case report. <citetitle><emphasis>Cornea</emphasis></citetitle> <emphasis role="strong">30:</emphasis>1264–1266.</para>
          </listitem>
          <listitem id="ch0153s0000li0276" role="bibliographyEntry">
            <para>276.<emphasis role="strong">Khandelwal SS, Woodward MA, Hall T, Grossniklaus HE, Stulting RD.</emphasis> 2011. Treatment of microsporidia keratitis with topical voriconazole monotherapy. <citetitle><emphasis>Arch Ophthalmol</emphasis></citetitle> <emphasis role="strong">129:</emphasis>509–510.</para>
          </listitem>
          <listitem id="ch0153s0000li0277" role="bibliographyEntry">
            <para>277.<emphasis role="strong">Han B, Pan G, Weiss LM.</emphasis> 2021. Microsporidiosis in humans. <citetitle><emphasis>Clin Microbiol Rev</emphasis></citetitle> <emphasis role="strong">34:</emphasis>e0001020.</para>
          </listitem>
          <listitem id="ch0153s0000li0278" role="bibliographyEntry">
            <para>278.<emphasis role="strong">Weber R, Deplazes P, Mathis A.</emphasis> 2019. Microsporidiosis, p 2305–2316. <citetitle><emphasis>In</emphasis></citetitle> Carrol KC, Pfaller MA, Landry ML, McAdam AJ, Patel R, Richter SS, Warnock DW (ed), <citetitle><emphasis>Manual of Clinical Microbiology</emphasis></citetitle>, 12th ed. ASM Press, Washington, DC.</para>
          </listitem>
        </itemizedlist>
      </sect2>
    </sect1>
  </chapter>
